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Abstract 
 
Streptococcus pyogenes, more commonly known as Group A Streptococcus (GAS), is a Gram 
positive, obligate human bacterial pathogen responsible for two million new cases of infection and 
more than half a million deaths annually. GAS infections manifest in a variety of diseases ranging 
from mild superficial conditions such as pharyngitis and impetigo to more severe invasive ones such 
as bacteraemia, necrotizing fasciitis, and streptococcal toxic shock syndrome. Repeated infections 
may also result in immune-related sequelae including acute rheumatic fever, rheumatic heart disease 
and glomerulonephritis. Despite advances in the use of antibiotics to treat bacterial infections, GAS 
has evolved mechanisms to subvert their hosts’ cellular machinery to escape host immunity, persist, 
and cause infections.  
 
Successful cellular internalization of GAS is inferred to be important for evading host immune 
responses and antibiotic therapy. GAS has been shown to invade various non-phagocytic host cell 
types. Although not yet completely understood, a widely accepted model for GAS invasion into non-
phagocytic cells occurs via the binding of GAS fibronectin binding proteins (such as SfbI or M protein) 
to host fibronectins. This engages and activates α5β1 integrins, forming a fibronectin cross-bridge 
linking GAS to the host extracellular matrix (ECM) to facilitate attachment. In addition to this 
pathway, SfbI-expressing GAS strains have been described to invade cells via an alternative route 
that involves host caveolae. Caveolae are specialized lipid rafts that appear as small invaginations in 
the eukaryotic plasma membrane, and are implicated in a number of cellular functions such as the 
uptake of various macromolecules and regulation of invasion of some bacterial pathogens into host 
cells. The scaffolding protein component of caveolae is caveolin-1 (CAV1), which oligomerizes to 
form the primary caveolae structure. A secondary protein termed Polymerase I and Transcript Release 
Factor (PTRF) or cavin-1 is also required for formation and stabilization of the caveolae structure.  
 
Caveolae have been implicated as an entry port that GAS utilizes during invasion into human 
epithelial HEp-2 cells. To better understand the role of caveolae in GAS invasion, this thesis examines 
how loss of the caveolae component proteins CAV1 and PTRF affect GAS invasion using genetic 
knockout and knockdown approaches. Chapter 3 explores the role of CAV1 in the uptake of GAS. 
Specific CAV1 knockout and stable CAV1 knockdown cell lines were generated and GAS invasion 
into these cells was measured by enumeration of colony forming units (CFUs). The invasion process 
was imaged through immunofluorescence and transmission electron microscopy to provide 
ultrastructural visualization of invading GAS and interactions with their host cells. Contrary to 
 III 
previous findings, a new protective role of CAV1 against GAS invasion into mouse embryonic 
fibroblasts (MEFs) and human HEp-2 epithelial cells was identified. Neither CAV1 nor caveolae 
were physically associated with invading GAS, suggesting a caveolae-independent mechanism in 
eliciting this protective effect. 
 
The constituent proteins of caveolae are CAV1 and PTRF; these proteins together form and stabilize 
caveolae at the plasma membrane. Expression of CAV1 and PTRF are usually co-dependent and both 
are required for the formation of caveolae in mammalian cells. Chapter 4 explores the role of PTRF 
in the uptake of GAS, in which it was hypothesized that the lack of PTRF would similarly enhance 
GAS uptake. Invasion assays of GAS into PTRF MEFs indicated that the lack of PTRF expression 
resulted in reduced GAS invasion, which was opposite to the loss of CAV1. This result was replicated 
in HEp-2 cells, however, issues related to the re-emergence of PTRF expression may have 
confounded the results from HEp-2 cells. This chapter reports these findings and the caveats 
associated with the HEp-2 cell experiments in light of the unstable knockdown. 
 
To understand the protective role of CAV1 during GAS invasion (Chapter 3), Chapter 5 explores 
whether three known GAS virulence factors and various host cell components are involved in the 
mechanism behind caveolae protection against GAS invasion. GAS Streptolysin O (SLO), M1 protein 
and SpeB protease negative mutants were used in invasion assays into HEp-2 cells. The potential 
involvement of host cell plasma membrane mobility, lipid droplets and clathrin uptake pathways were 
also investigated. Of the three GAS virulence factors tested, only SLO appeared to be associated with 
the regulation of CAV1 over GAS invasion. Host cell plasma membrane mobility experiments 
indicated that GAS invasion was not altered by increasing membrane fluidity, and OA experiments 
indicated that GAS survival was enhanced under OA addition which was in contrast to the inferred 
bactericidal roles of lipid droplets. Clathrin inhibition experiments suggest that GAS invasion was 
linked to clathrin-mediated uptake, consistent with the accepted model of GAS uptake through a 
clathrin-dependent process. This was in agreement with electron microscopy images showing the 
GAS invasion process (Chapter 3) supporting GAS invasion through a “zipper” mechanism. These 
results are described in this chapter, and tied in to putative roles of CAV1 in protecting against GAS 
invasion. 
 
Understanding GAS pathogenesis and mechanisms underlying host cell invasion is vital for 
formulating effective countermeasures against GAS infections. The findings presented in this thesis 
 IV 
provide targets for promoting vaccine development and where successful, better control of GAS 
disease worldwide. 
 V 
Declaration by author 
 
This thesis is composed of my original work, and contains no material previously published or written 
by another person except where due reference has been made in the text. I have clearly stated the 
contribution by others to jointly-authored works that I have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical assistance, 
survey design, data analysis, significant technical procedures, professional editorial advice, and any 
other original research work used or reported in my thesis. The content of my thesis is the result of 
work I have carried out since the commencement of my research higher degree candidature and does 
not include a substantial part of work that has been submitted to qualify for the award of any other 
degree or diploma in any university or other tertiary institution. I have clearly stated which parts of 
my thesis, if any, have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, 
subject to the policy and procedures of The University of Queensland, the thesis be made available 
for research and study in accordance with the Copyright Act 1968 unless a period of embargo has 
been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright holder(s) 
of that material. Where appropriate I have obtained copyright permission from the copyright holder 
to reproduce material in this thesis. 
  
 VI 
Publications during candidature 
 
Peer-reviewed papers 
 
Barnett, T. C., Lim, J. Y., Soderholm, A. T., Rivera-Hernandez, T., West, N. P., Walker, M. J. (2015). 
Host-pathogen interaction during bacterial vaccination. Current opinion in immunology, 36, 1-7. 
 
Barnett, T. C., Liebl, D., Seymour, L. M., Gillen, C. M., Lim, J. Y., LaRock, C. N., Davies, M. R., 
Schulz, B. L., Nizet, V., Teasdale, R. D., Walker, M. J. (2013). The Globally Disseminated M1T1 
Clone of Group A Streptococcus Evades Autophagy for Intracellular Replication. Cell Host & 
Microbe 14(6), 675-682. 
 
Conference presentations 
	
BacPath 13: Molecular Analysis of Bacterial Pathogens Conference 2015, Phillip Island, Melbourne, 
Victoria, Australia. 27 - 30 September 2015. Oral presentation: The role of caveolin-1 in the uptake 
of Streptococcus pyogenes into non-phagocytic host cells. Lim, J. Y., Barnett, T. C., McMahon, K. 
A., Ferguson, C., Parton, R. G., Walker, M. J. 
 
2015 Microbial Pathogenesis & Host Response, Cold Spring Harbor Laboratory, New York, United 
States of America. 8 - 12 September 2015. Poster presentation: The role of caveolin-1 in the uptake 
of Streptococcus pyogenes into non-phagocytic host cells. Lim, J. Y., Barnett, T. C., McMahon, K. 
A., Ferguson, C., Parton, R. G., Walker, M. J. 
 
First Biennial Research Symposium, Translational Research Institute, University of Queensland, 
QLD, Australia. 28 August 2013. Oral presentation: The Group A Streptococcus M1T1 clone 
subverts autophagy for intracellular replication. Barnett, T. C., Liebl, D., Seymour, L. M., Gillen, C. 
M., Lim, J. Y., Schulz, B. L., Nizet, V., Teasdale, R. D., Walker, M. J. 
 
 
Publications included in this thesis 
 
No publications 
 VII 
Contributions by others to the thesis  
 
Chapter 3 - Investigation of the role of CAV1 in the uptake of Streptococcus pyogenes into non-
phagocytic host cells 
 
Contributor Statement of contribution 
Lim, J. Y. (Candidate) 
Experimental design (70%), performed experiments (100%), 
immunofluorescence imaging (50%), TEM experiment and 
preparation (30%), statistical analysis (100%) 
Barnett, T. C. Experimental design (30%) 
Bastiani, M. Immunofluorescence imaging (50%) 
Ferguson, C. TEM experiment and preparation (70%) 
Parton, R. G. TEM analysis and figure preparation (100%) 
 
 
Chapter 4 - Investigation of the role of PTRF in the uptake of Streptococcus pyogenes into non-
phagocytic host cells 
 
Contributor Statement of contribution 
Lim, J. Y. (Candidate) 
Experimental design (80%), performed experiments (90%), statistical 
analysis (100%) 
Barnett, T. C. Experimental design (20%) 
McMahon, K. Performed experiments (10%) 
 
 
Chapter 5 - Further characterization of possible underlying mechanism by which CAV1 proteins 
protect host cell against Streptococcus pyogenes infection 
 
Contributor Statement of contribution 
Lim, J. Y. (Candidate) 
Experimental design (80%), performed experiments (100%), TEM 
experiment and preparation (30%), statistical analysis (100%) 
Barnett, T. C. Experimental design (20%) 
Ferguson, C. TEM experiment and preparation (70%) 
Parton, R. G. TEM analysis and figure preparation (100%) 
 VIII 
 
Statement of parts of the thesis submitted to qualify for the award of 
another degree 
 
None. 
  
 IX 
Acknowledgements 
 
Never in my wildest dreams had I thought I would undertake a PhD; 17 years of studies prior to this 
was more than enough. Despite occasional hiccups and road bumps, my experience has been a 
fulfilling one thanks to the people who have supported me throughout these years. I am grateful to 
my supervisor, Mark Walker, for taking me on as a student and guiding me throughout these years. 
Thank you for your patience, knowledge, encouragement, support, and mostly for your understanding 
and generosity with my long holidays to visit home. These breaks have been a source revitalization 
for me to work harder.   
 
I also want to thank Timothy Barnett, for assistance with my project and also for proof-reading my 
work and all the encouraging pep talk every now and then. I hope I lived up to your expectations as 
your first PhD student. Robert Parton, for invaluable insights with the many workings of cell biology 
I am not familiar with, your passion for TEM experiments and other excellent ideas. You have 
constantly amazed me with the enthusiasm you carry; I know you are a busy man but you have been 
very involved with my project, and for that I am grateful.  
 
To fellow members of the Walker laboratory: I thank you for providing assistance that has made life 
so much easier. Amanda Cork and Olga Berking, for dealing with my requests with lab matters when 
I am too busy (or rather, lazy) to handle; Tania Rivera Hernandez, for being an awesome friend; 
Amelia Soderholm and Andrew Turner, for sharing the same office and the entertaining small talk. I 
wish you both the very best in your future endeavours.  
 
Not forgetting the members of the Parton laboratory: I thank you for being ever so welcoming and 
always making my visits to IMB enjoyable. Kerrie-Ann McMahon, for helping me with every aspect 
of cell biology throughout my PhD; Michele Bastiani, for being so patient and encouraging even with 
my constant failure in generating good IF images, also for always being there whenever I needed 
someone to talk to; Charles Ferguson, for helping me with the TEM studies, and those travelling 
adventures that I thoroughly enjoyed hearing about; Ye Ping Wu and Ye-Wheen Lim, for the 
occasional meals and chats (rants) that made me feel like I am not alone.  
 
I would also like to acknowledge the UQI scholarship which has funded my tuition fees and living 
expenses, and Mark for trusting me with the AID website. I am also thankful for the SCMB student 
travel grant that has funded my travels to the States and Melbourne for conferences.  
 X 
 
Yun Kit, words cannot express how treasured you are to me - this thesis is as much yours as it is mine. 
I know without a doubt that this would not have been possible without you. Thank you for always 
being there.  
 
More importantly, I thank my parents and siblings for their love and encouragement. Papa, for your 
many sacrifices and support to provide for all of us. A chance to further our studies overseas comes 
with a heavy price and without you to make sure that we all get this opportunity; I would not be who 
I am today. Mummy, for all the yummy recipes and phone calls to keep me in the loop of what is 
happening back home. I have the impression that you have no idea what I do every day besides 
studying ‘bacteria’, but please be assured that I had a great time. To Yao and San, thank you for 
always being there to listen and talk about everything and anything in the world. Nothing is better 
than family, and I love you all for that.  
 
Brutally honest Jin, signing off.  
  
 XI 
Keywords 
 
caveolae, caveolin-1, CAV1, Streptococcus pyogenes, Group A Streptococcus, GAS, uptake, 
invasion, epithelial cells, non-phagocytic 
 
 
Australian and New Zealand Standard Research Classifications 
(ANZSRC) 
 
ANZSRC code: 060501 Bacteriology (60%) 
ANZSRC code: 060199 Biochemistry and Cell Biology not elsewhere classified (40%) 
 
 
Fields of Research (FoR) Classification 
 
FoR code: 0605 Microbiology (60%) 
FoR code: 0601 Biochemistry and Cell Biology (40%) 
  
 XII 
Table of Contents 
Abstract .............................................................................................................................................. II	
Declaration by author ....................................................................................................................... V	
Publications during candidature ................................................................................................... VI	
Publications included in this thesis ................................................................................................ VI	
Contributions by others to the thesis ........................................................................................... VII	
Statement of parts of the thesis submitted to qualify for the award of another degree ........ VIII	
Acknowledgements ......................................................................................................................... IX	
Keywords ......................................................................................................................................... XI	
Australian and New Zealand Standard Research Classifications (ANZSRC) .......................... XI	
Fields of Research (FoR) Classification ........................................................................................ XI	
List of Figures ................................................................................................................................ XVI	
List of Tables ............................................................................................................................. XVIII	
List of Abbreviations .................................................................................................................... XIX	
1.	 Literature review ........................................................................................................................ 1	
1.1	 Group A Streptococcus - An overview ............................................................................... 1	
1.2	 Epidemiology and GAS diseases ........................................................................................ 1	
1.3	 Classification of Streptococcus and GAS ........................................................................... 3	
1.3.1	 M protein serotyping and emm gene sequence typing ................................................... 3	
1.3.2	 T antigen typing ............................................................................................................. 3	
1.4	 Pathogenesis ......................................................................................................................... 4	
1.4.1	 Adhesion and colonization ............................................................................................. 4	
1.4.2	 Invasion of host cells ..................................................................................................... 7	
1.4.3	 Evasion of cellular innate immune responses ................................................................ 7	
1.5	 Caveolae ............................................................................................................................... 8	
1.5.1	 Caveolin-family proteins ............................................................................................. 10	
1.5.1.1	 Caveolin-1 ............................................................................................................ 12	
1.5.1.2	 Caveolin-2 ............................................................................................................ 14	
1.5.1.3	 Caveolin-3 ............................................................................................................ 15	
1.5.2	 Caveolar coat proteins - The Cavin complex ............................................................... 16	
 XIII 
1.5.2.1	 Cavin-1 ................................................................................................................. 16	
1.5.2.2	 Cavin-2 ................................................................................................................. 19	
1.5.2.3	 Cavin-3 ................................................................................................................. 19	
1.5.2.4	 Cavin-4 ................................................................................................................. 20	
1.6	 Role of caveolae in bacterial pathogenesis ...................................................................... 21	
1.6.1	 Caveolae as a facilitator of pathogen invasion ............................................................ 21	
1.6.2	 Caveolae as an inhibitor of pathogen invasion ............................................................ 24	
1.8	 Project aims ....................................................................................................................... 26	
2.	 Materials and Methods ............................................................................................................ 27	
2.1	 Bacterial strains and cultures ........................................................................................... 27	
2.2	 Cell lines and cell culture .................................................................................................. 27	
2.3	 DNA constructs and cell transfection .............................................................................. 28	
2.4	 Antibodies .......................................................................................................................... 30	
2.5	 Preparation of cell lysates ................................................................................................. 30	
2.6	 BCA protein concentration measurement ...................................................................... 31	
2.7	 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) .............. 31	
2.8	 Western immunoblot analysis .......................................................................................... 31	
2.8.1	 Transfer ........................................................................................................................ 31	
2.8.2	 Detection ...................................................................................................................... 32	
2.9	 Cell viability assay ............................................................................................................. 33	
2.9.1	 Non-radioactive cytotoxicity assay .............................................................................. 33	
2.9.2	 Trypan blue exclusion assay ........................................................................................ 33	
2.10	 Gentamicin protection assay ......................................................................................... 34	
2.11	 Survival assay ................................................................................................................. 34	
2.12	 Flow cytometry .............................................................................................................. 35	
2.13	 Confocal immunofluorescence microscopy ................................................................. 35	
2.14	 Transmission electron microscopy (TEM) .................................................................. 36	
2.15	 Statistical analysis .......................................................................................................... 37	
3.	 Investigation of the role of CAV1 in the uptake of Streptococcus pyogenes into non-
phagocytic host cells ......................................................................................................................... 38	
3.1	 Introduction ....................................................................................................................... 38	
3.2	 Results ................................................................................................................................ 39	
3.2.1	 GAS invasion into CAV1-deficient MEFs .................................................................. 39	
3.2.2	 GAS invasion into CAV1-deficient HEp-2 cells ......................................................... 40	
 XIV 
3.2.3	 Survival of GAS in CAV1-deficient HEp-2 cells ........................................................ 43	
3.2.4	 Visualizing interactions between GAS and CAV1 in HEp-2 cells using 
immunofluorescence microscopy ............................................................................................... 44	
3.2.5	 Visualizing interactions between GAS and CAV1 in HEp-2 cells using TEM ........... 48	
3.2.6	 Invasion characteristics of GAS strain M12A40 into shCAV1 HEp-2 cells ................. 56	
3.2.7	 Determination of interaction between invading GAS and host caveolae in primary 
human tonsil epithelial cells using TEM .................................................................................... 57	
3.3	 Discussion ........................................................................................................................... 59	
4.	 Investigation of the role of PTRF in the uptake of Streptococcus pyogenes into non-
phagocytic host cells ......................................................................................................................... 61	
4.1	 Introduction ....................................................................................................................... 61	
4.2	 Results ................................................................................................................................ 62	
4.2.1	 GAS invasion into PTRF-deficient MEFs ................................................................... 62	
4.2.2	 GAS invasion into PTRF-deficient HEp-2 cells .......................................................... 63	
4.2.3	 Optimization of G418 antibiotic concentration for selection of shPTRF HEp-2 cells 66	
4.2.4	 Selection of shPTRF HEp-2 cells using G418 ............................................................. 68	
4.2.5	 Transient siRNA knockdown of PTRF in HEp-2 cells ................................................ 70	
4.3	 Discussion ........................................................................................................................... 71	
5.	 Characterization of the underlying mechanism by which CAV1 protects host cells against 
Streptococcus pyogenes infection ..................................................................................................... 73	
5.1	 Introduction ....................................................................................................................... 73	
5.2	 Results ................................................................................................................................ 74	
5.2.1	 Investigating the role of CAV1 regulation of plasma membrane mobility on GAS 
invasion into HEp-2 cells ........................................................................................................... 74	
5.2.2	 Potential GAS virulence factors involved in the GAS-caveolae interaction during 
uptake 77	
5.2.3	 Investigation of the potential involvement of host lipid droplets in facilitating bacterial 
invasion into CAV1-deficient cells ............................................................................................ 80	
5.2.3.1	 HEp-2 cell viability, GAS invasion and survival under OA treatment ................ 81	
5.2.3.2	 Localization of host lipid droplets and their interaction with GAS in HEp-2 cells
 83	
5.2.4	 Investigating the role of CAV1 in dynamin- and/or clathrin-dependent endocytic 
pathways GAS potentially utilizes to gain entry into host cells ................................................. 87	
5.3	 Discussion ........................................................................................................................... 89	
 XV 
References ......................................................................................................................................... 95	
Appendix I: Media solution and Reagents .................................................................................. 125	
Appendix II: Supplementary figures for Chapter 2 ................................................................... 129	
Appendix III: Supplementary figures for Chapter 3 ................................................................. 132	
Appendix IV: Supplementary figure for Chapter 4 ................................................................... 134	
 
 
  
 XVI 
List of Figures 
 
Figure 1.1 Morphological features of caveolae and caveolin 
Figure 1.2 Schematic representation of the domains of the CAV1 protein 
 
Figure 2.1 Schematic diagram depicting gel sandwich arrangement of protein transfer from SDS-
PAGE gel to Immobilon-FL PVDF membrane  
 
Figure 3.1 Invasion of GAS strains M1T15448 and M6JRS4 into WT and CAV1-/- MEFs 
Figure 3.2 M1T15448 invasion into HEp-2 cells 
Figure 3.3 CAV1 expression and cell viability during M1T15448 infection of HEp-2 cells 
Figure 3.4 Relative survival of M1T15448 in HEp-2 cells 
Figure 3.5 Assessment of interaction of host CAV1 and invading M1T15448 by 
immunofluorescence microscopy analysis 
Figure 3.6 Association of host CAV1 and invading M1T15448 by immunofluorescence 
microscopy analysis 
Figure 3.7 Association of invading M1T15448 with host CAV1 
Figure 3.8 Optimization of M1T15448 infection of HEp-2 cells conditions for TEM 
Figure 3.9 Quantitative assessment of association of M1T15448 with HEp-2 cell components 
Figure 3.10.1 Ultrastructural TEM analysis of GAS association with WT Hep-2 cells at early time 
points 
Figure 3.10.2 Ultrastructural TEM analysis of GAS interaction with WT Hep-2 cells 1 h post-
infection  
Figure 3.10.3 Ultrastructural TEM micrographs of intracellular GAS in WT HEp-2 cells 1 h post-
infection  
Figure 3.10.4 Ultrastructural TEM analysis of intracellular GAS in WT HEp-2 cells 2 h post-
infection 
Figure 3.10.5 Ultrastructural TEM characterization of GAS invasion into shCAV1 HEp-2 cells 1 h 
post-infection  
Figure 3.11 Invasion of Sfb1-expressing GAS into HEp-2 cells 
Figure 3.12 Ultrastructural TEM analysis of GAS interaction with primary human tonsil epithelial 
cells 
 
Figure 4.1 Invasion of GAS strains M1T15448 and M6JRS4 into WT and PTRF-/- MEFs 
 XVII 
Figure 4.2 M1T15448 invasion into HEp-2 cells 
Figure 4.3 Viability of M1T15448-infected HEp-2 cells 
Figure 4.4 Western immunoblot of PTRF and CAV1 expression levels in WT HEp-2 cells and 
derivatives 
Figure 4.5 Optimisation of G418 antibiotic treatment in shPTRF HEp-2 cells 
Figure 4.6 Western immunoblot of PTRF and CAV1 expression in G418-treated HEp-2 cells 
Figure 4.7 Expression of PTRF in shPTRF HEp-2 cells during and post G418 selection 
Figure 4.8 Western immunoblot of PTRF and CAV1 expression levels in siRNA-transfected 
HEp-2 cells 
 
Figure 5.1 Invasion of M1T15448 into Tween 20-treated HEp-2 cells 
Figure 5.2 Invasion of M1T15448 at varying environmental temperatures 
Figure 5.3  Growth of M1T15448 at 37 and 41 ºC 
Figure 5.4 Invasion of GAS M1T15448 mutant strains into WT and shCAV1 HEp-2 cells 
Figure 5.5 M1T15448 invasion into untreated and OA-treated HEp-2 cells  
Figure 5.6 M1T15448 relative survival in untreated and OA-treated HEp-2 cells 
Figure 5.7.1  Interaction of host LDs with invading M1T15448 at 2 h post-infection 
Figure 5.7.2  Interaction of host LDs with invading M1T15448 at 2 h post-infection followed by 2 h 
gentamicin treatment 
Figure 5.7.3  Interaction of host LDs with invading M1T15448 at 2 h post-infection followed by 4 h 
gentamicin treatment 
Figure 5.8 M1T15448 invasion into Dyngo® 4a-treated HEp-2 cells 
Figure 5.9 M1T15448 invasion into Pitstop2-treated HEp-2 cells  
 
  
 XVIII 
List of Tables 
 
Table 1.1 Clinical symptoms of major GAS diseases 
Table 1.2 GAS cell wall-anchored or anchorless adhesins and their target host receptors 
Table 1.3 Alternate names and proposed functions of the cavin complex proteins 
Table 1.4 Pathogens that co-opt lipid raft/caveolae for uptake into host cells 
 
Table 3.1 Percentage association of invading M1T15448 with host CAV1, quantified by 
immunofluorescence microscopy 
Table 3.2 Percentage association of invading M1T15448 with host caveolae, quantified by TEM 
 
Table 4.1 Optimization of G418 concentration in HEp-2 cells 
Table 4.2 siRNA target sequence used to knockdown PTRF in HEp-2 cells 
 
Table 5.1 Viability of Tween 20-treated HEp-2 cells 
Table 5.2 Viability of HEp-2 cells post temperature treatment 
Table 5.3 Viability of untreated and OA-treated HEp-2 cells during infection with M1T15448 
 
  
 XIX 
List of Abbreviations 
 
AM   Acetoxymethyl 
ANOVA  Analysis of variance 
 
BCA   Bicinchoninic acid  
BECs   Bladder epithelial cells 
BSA   Bovine serum albumin 
BSAT   Bovine serum albumin supplemented with Triton X-100 
 
CAV1   Caveolin-1 
CAV2   Caveolin-2 
CAV3   Caveolin-3 
CD46   Cluster of differentiation 46 (a type of complement regulatory protein) 
CFUs   Colony forming unit/s 
CSD   Caveolin scaffolding domain 
CTB   Cholera toxin B-subunit  
 
DMEM  Dulbecco’s Modified Eagle Medium 
DNA   Deoxyribonucleic acid 
DPBS   Dulbecco’s phosphate buffer saline 
DRMs   Detergent-resistant microdomain/s 
DTT   Dithiothreitol 
 
ECM   Extracellular matrix 
EDTA   Ethylenediaminetetraacetic acid 
EPEC   Enteropathogenic Escherichia coli 
ER   Endoplasmic reticulum 
 
FACS   Fluorescence-activated cell sorting 
FBS   Foetal bovine serum 
FESEM  Field emission scanning electron microscopy 
FRAP   Fluorescent recovery after photo bleaching 
FRT   Fischer rat thyroid cells 
 XX 
 
GAPDH/G3PDH Glyceraldehyde 3-phosphate dehydrogenase 
GAS   Group A Streptococcus (also known as Streptococcus pyogenes) 
GFP   Green fluorescent protein 
g/l   grams per litre 
GPI   Glycosylphosphatidylinositol 
G418   Geneticin 
 
h   hour 
HBA   Horse blood agar 
HEp-2   Human epithelial cell line of HEp-2 lineages 
HTEpiC  Primary human tonsil epithelial cells 
HUVEC  Human umbilical vein endothelial cells 
 
IMB   Institute for Molecular Bioscience, University of Queensland 
 
kDa   Kilodalton, 1000 unified atomic mass units 
 
LDs   Lipid droplet/s 
LDH   Lactate dehydrogenase 
LPS   Lipopolysaccharide 
LTA   Lipoteichoic acid 
 
mAb   Monoclonal antibody 
MβCD   Methyl-β-cyclodextrin 
MDCK  Madin-Darby canine kidney 
Mean ± SEM  Mean ± Standard Error of the Mean 
MEFs   Mouse embryonic fibroblast/s 
min   minutes 
MOI   Multiplicity of infection 
MURC  Muscle-restricted coiled-coil protein 
 
NaCl   Sodium Chloride 
 
 XXI 
OA   Oleic acid 
OD   Optical density 
Opti-MEM  Opti-Minimal Essential Medium 
ORF   Open reading frame 
 
pAb   Polyclonal antibody 
PBS   Phosphate buffered saline 
PBST   Phosphate buffered saline supplemented with Tween 20 
PCR   Polymerase chain reaction 
PC3   Prostate cancer cell line 
PEST   Proline, glutamic acid, serine and threonine domain 
PFA   Paraformaldehyde 
p.i   post-infection 
PKC   Protein kinase C 
PTRF   Polymerase I transcript release factor (or cavin-1) 
PM   Plasma membrane 
PRKCDBP  Protein kinase C delta-binding protein 
PS   Phosphatidylserine 
PVDF   Polyvinylidene difluoride 
 
RNA   Ribonucleic acid 
 
SDR   Serum deprivation response protein 
SDS   Sodium Dodecyl Sulfate 
SDS-PAGE  Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEM   Scanning electron microscopy 
SfbI   Fibronectin binding protein F1 
shRNA  Short hairpin ribonucleic acid 
siRNA   Small interfering Ribonucleic Acid 
SLO   Streptolysin O 
SRBC Serum deprivation response factor-related gene product that binds C-kinase 
SV40   Simian virus 40 
 
TEM   Transmission electron microscopy 
 XXII 
TEMED  Tetramethylethylenediamine 
TEpiCGS  Tonsil epithelial cell growth supplement 
TEpiCM  Tonsil epithelial cell medium 
THY   Todd-Hewitt medium 
THYA   Todd-Hewitt medium agar 
THYB   Todd-Hewitt medium broth 
T3SS   Type III secretion system 
 
UPEC   Uropathogenic Escherichia coli 
UQ   University of Queensland 
UV   Ultraviolet 
 
v/w   volume per weight 
 
WT   Wild type 
w/v   weight per volume 
 
QBI   Queensland Brain Institute, University of Queensland 
 
YFP   Yellow fluorescence protein 
 
α   Alpha 
β   Beta 
ºC   Degrees Celsius 
®   Registered sign 
™   Trade Mark sign 
µ   micro 
x, X   times 
%   Percent sign 
=   Equals sign 
~   Approximate sign 
 
 
 
 1 
1. Literature review 
 
1.1 Group A Streptococcus - An overview 
 
Streptococcus pyogenes, or Group A Streptococcus (GAS), is a Gram-positive, non-spore forming β-
haemolytic bacterium. GAS cells are cocci-shaped, approximately 0.6 – 1.0 µm in diameter and 
usually exist as chains of 10 to 20 cocci. 
 
When cultured on blood agar, GAS typically forms colonies surrounded by a characteristic 1 – 2 mm 
clear zone (β-haemolysis) owing to its ability to completely lyse red blood cells. This visual approach 
can quickly distinguish between α- and β-haemolytic Streptococcus species such as S. pneumoniae, 
S. viridans (both α-haemolytic) and GAS; however, this method is limited in recapitulating diversity 
within the β-haemolytic streptococci. To that end, more sensitive serological methods such as the 
Lancefield classification based on typing bacterial cell wall antigens and marker gene sequencing 
were developed to classify these bacteria. 
 
1.2 Epidemiology and GAS diseases 
 
GAS infections manifest in a wide range of human diseases. GAS commonly colonizes the skin and 
throat mucus membranes to cause superficial infections such as impetigo and pharyngitis, 
respectively. Although generally regarded as an extracellular pathogen, GAS is capable of invading 
and disseminating into sterile body sites leading to severe disease such as necrotizing fasciitis. 
Common GAS-related diseases and associated symptoms are summarized in Table 1.1. 
 
Each year, GAS is responsible for over half a million deaths worldwide. It is estimated that there are 
at least 600 million new cases of superficial GAS infections and more than 2 million new cases of 
severe disease every year (Carapetis et al., 2005). Based on epidemiological surveys of healthy 
populations, 11.5% of asymptomatic young adults carry GAS in the oropharynx (Levy et al., 2005). 
This prevalence is similar to that in school children, where 12% were found to be asymptomatic GAS 
carriers, and the bacterium persisted in their hosts for years without causing disease symptoms 
(Shaikh et al., 2010). Generally, mortality rates from GAS infections are higher in less developed 
countries at an estimated 46 cases per 100,000 people, in contrast to 2.45 cases per 100,000 people 
in developed countries (Carapetis et al., 2005).  
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Table 1.1 Clinical symptoms of major GAS diseases 
 
Table adapted from Walker et al., 2014 
 
 
Disease Symptoms Estimated cases (per year)
Superficial/mild diseases
     Pharyngitis Sore throat, fever, malaise, headache, nausea, muscle ache
     Scarlet fever Fever, rash, strawberry tongue, desquamation
     Impetigo Cellulitis ~ 100 million (existing cases)
Sequele/ severe diseases
     Rheumatic heart disease Chest pains, breathlessness, heart palpitations ~ 280,000
     Acute rheumatic fever Fever, polyarthritis, carditis, abdominal pain ~ 200,000
     Acute post-streptococcal glomerulonephritis Fever, malaise, nausea, hematuria, oliguria, edema ~ 470,000
Invasive diseases
     Bacteremia Sepsis & septic shock, may lead to multiple organ dysfunction
     Cellulitis Pain, tenderness, inflamed & swollen skin, fever
     Puerperal sepsis High fever, malaise, abdominal pain, tender & sub-involuted uterus
     Necrotizing fasciitis Fever, pain, inflammation, tachycardia, diarrhea and vomiting
     Toxic shock syndrome Fever, low blood pressure, confusion, may lead to cardiovascular shock & multiple organ failure
~ 600 million
~ 660,000 collectively
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1.3 Classification of Streptococcus and GAS 
 
Traditionally, streptococci were classified based on the formation of characteristic 1 – 2 mm clear 
zones on blood agar (β-haemolysis). Based on the Lancefield classification system developed in the 
early 1900’s (Lancefield, 1928 & 1933), 104 streptococci strains were initially classified into five 
groups (Groups A, B, C, D and E) broadly representing species delineation. Additional groups were 
created to accommodate subsequently isolated streptococci species that did not belong to any of these 
five groups (Long and Bliss, 1934; Lancefield and Hare, 1935; Facklam, 2002).  
 
1.3.1 M protein serotyping and emm gene sequence typing 
 
Although the Lancefield classification group nomenclature is still widely used, GAS M protein typing 
and emm sequence genotyping allow for GAS serotype-specific identification. The M protein is a 
major virulence factor found on the GAS cell surface and is encoded by the emm gene (Smeesters et 
al., 2010). Classification of M proteins is based on the hyper-variable N-terminal locus (Cunningham, 
2000), but due to the large number of known M types (>200 types) and the need for M type-specific 
antisera for this typing procedure, M protein typing can be difficult to accomplish. Sequencing the 
emm gene instead became more feasible as polymerase chain reactions (PCR) became widely 
available. The emm gene sequence-based typing approach uses two highly conserved primers to PCR-
amplify a portion of the emm gene encoding the M serotype specificity, and has been demonstrated 
to strongly correlate with M protein serotyping (Beall et al., 2000).  
 
1.3.2 T antigen typing 
 
Additional serotyping targets such as the T antigen were introduced to complement emm sequence 
typing. The T antigen is a pilus structure that binds to host extracellular matrices (Mora et al., 2005). 
T antigen serotyping of GAS isolates usually supplements M protein typing and provides strain-
specific classification (Johnson et al., 2006), which is important especially for characterizing 
medically relevant GAS strains. Serotype M1T1 is the most prevalent serotype associated with 
superficial and severe invasive disease in developed countries (Aziz and Kotb, 2008). 
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1.4 Pathogenesis 
 
GAS possesses numerous virulence factors/adhesins that have been implicated in pathogenesis and 
disease. Successful colonization of host tissue first requires adhesion to host cells and subsequently 
GAS may initiate uptake mechanisms to gain entry into host intracellular compartments. In addition, 
GAS can subvert host anti-microbial responses and also fine-tune pathogenicity in order to replicate 
and persist in the host. The following sections describe the general GAS invasion process which 
includes adhesion, colonization, invasion into host cells and evasion of host immune responses.  
 
1.4.1 Adhesion and colonization 
 
Common entry routes for GAS infections are skin wounds and the oral and nasal cavities. GAS 
expresses a wide repertoire of surface proteins that facilitate their colonization of host cells (Nobbs 
et al. 2009) beginning with adhesion to the cell surface. GAS adhesion to host tissue is thought to be 
a two-step process. Lipoteichoic acid (LTA), a common component in the cell walls of Gram-positive 
bacteria, is proposed to mediate an initial adhesion between GAS and host cell surface fibronectins 
through weak hydrophobic interactions (Hasty et al., 1992). LTA-mediated adhesion allows for the 
attachment of GAS to host surfaces and/or receptors via extension of GAS surface appendages such 
as pili, followed by more specific, high affinity protein-protein or lectin-carbohydrate interactions 
(Walker et al., 2014; Brouwer et al., 2016). A number of surface expressed and secreted GAS 
adhesins (summarized in Table 1.2) either covalently linked at the C- terminus (LPxTG motif) to 
host cell wall peptidogylcans via sortases (Barnett et al., 2002; Scott and Barnett, 2006), via N-
terminal modifications to form lipoproteins (Scott and Barnett, 2006; Nobbs et al., 2009) or through 
non-covalent interactions with cell surface components (Nobbs et al., 2009), are implicated in this 
process for successful colonization.  
 
GAS pili 
 
GAS pili, or fimbriae, are long, flexible, protruding rods (up to 3 µm) found on the bacterial cell 
surface (Mora et al., 2005). They are heteropolymeric structures composed of a major backbone pilin 
subunit (Spy0128) and minor protein subunits (Spy0125/Cpa and AP2) (Quigley et al., 2009; Smith 
et al., 2010). Pili contribute to GAS pathogenesis through direct involvement in bacterial adhesion, 
facilitating contact of other GAS surface anchored adhesins to their respective targets. For example, 
pili has been shown to mediate attachment of GAS serotype M1 strain SF370 to human tonsil 
epithelial and primary human keratinocytes (Abbot et al., 2007). Attachment of GAS via pili also  
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Table 1.2 GAS cell wall-anchored or anchorless adhesins and their target host receptors 
 
Table adapted from Walker et al., 2014 and Brouwer et al., 2016 
Cell wall - anchored adhesins Host cell receptor(s) and/or function(s) Reference(s)
Pili
     Spy0130, Spy0128, Cpa Binds collagen, salivary agglutinin gp-340 
Bacteria aggregation, biofilm formation
M and m-like proteins
     M1, M3, M6 Binds fibronectin, fibronogen, plasmin(ogen), collagen type I & IV, Schmidt et al ., 1993; Giannakis et al. , 2002; Frick et al ., 2003;  
factor H, sialic acid, CD46, glycosaminoglycans, immunoglobulins Bober et al ., 2011; Anderson et al ., 2014
     Mrp, Arp, Sir Immunoglobulins Johnson et al ., 1994; Stenberg et al ., 1992 & 1994
Fibronectin binding proteins
     SfBI/Prf1 Binds fibronectin, fibronogen Hanski et al ., 1996
     Prf2/FbaB/PFBP Binds fibronectin Hanski et al ., 1996; Kreikemeyer et al ., 2004; Ramachandran et al ., 2004
     Cpa/AP1 Binds Collagen type I Kreikemeyer et al ., 2005
     SOF/SfbII Binds fibronectin, fibronogen, fibulin-1 Kreikemeyer et al ., 1999; Courtney et al ., 2009; Gillen et al.,  2008
     SfbX Binds fibronectin Jeng et al ., 2003
     FbaA Binds fibronectin Terao et al. , 2001
AgI/II family proteins
     AspA Binds gp-340
Bacteria aggregation
Collagen-like proteins
     Scl1, Scl2 Binds laminin, !2β1 & !11β1 integrins Humtsoe et al ., 2005; Caswell et al ., 2007, 2008 & 2010; 
Chen et al ., 2010; Oliver-Kozup et al ., 2013
Laminin-binding proteins
     Lbp, Lsp Binds laminin Elsner et al ., 2002; Terao et al ., 2002
Plasmin(ogen)-binding proteins
     PAM, Prp, Epf Binds plasmin(ogen) Wistedt et al ., 1995; Sanderson-Smith et al ., 2007; Linke et al ., 2012
Other adhesins
     Protein H Binds Immunoglobulins Frick et al ., 1994
     PulA Binds Glycoproteins Hytönen et al ., 2003
     R28 Unknown, binds to epithelial cells Stalhammar-Carlemalm et al. , 1999
     Slr Binds collagen type I Bober et al ., 2011
     SpyAD Binds human keratin 1, collagen type VI Gallotta et al ., 2014
Anchorless adhesins
Fibronectin-binding proteins
     Fbp54 Binds fibronectin Courtney et al. , 1996; Delvecchio et al ., 2002
Laminin-binding proteins
     Shr Binds laminin, fibronectin Fisher et al ., 2008
Plasmin(ogen)-binding proteins
     GAPDH/SDH/Plr Binds plasmin(ogen), fibronectin, lysozyme, myosin, actin, uPAR/CD87 Lottenberg et al ., 1992; Pancholi et al ., 1992; Jin et al ., 2005
    SEN (!-enolase) Binds plasmin(ogen) Pancholi et al ., 1997 & 1998; Cork et al ., 2009
Mora et al ., 2005; Edwards et al ., 2008; Falugi et al . 2008
Maddocks et al. , 2011; Franklin et al ., 2013
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promotes microcolony and biofilm formation in human pharynx carcinoma cells (Manetti et al., 2007). 
In saliva, pili bind to the salivary agglutinin receptor gp-340 to enhance bacterial aggregation 
(Edwards et al., 2008). This aggregation reduced bacterial adhesion to host cells, suggesting that pili 
may be a target for activating host defence mechanisms (Edwards et al., 2008).  
 
M protein 
 
The M protein, encoded by the emm gene, is an important GAS virulence factor. M protein exists as 
dimers with an alpha-helical coiled-coil structure partially embedded in the bacterial cell wall 
(Phillips et al., 1981) and is anchored to cell wall peptidoglycan through the LPxTG motif (Barnett 
et al., 2002). The N-terminal domain of the M protein exhibits an array of antigenic diversity, 
resulting in diverse range of physiological functions and interactions with host cells (Fischetti et al., 
2016). M proteins from multiple GAS serotypes have been shown to be involved in GAS adherence  
in various cell types such as HEp-2 (Cue et al., 1998) and Detroit 562 epithelial cells (Frick et al., 
2003). Different serotypes bind different host ligands, resulting in different interactions. For instance, 
binding of M proteins serotypes M1, M3 and M6 to host fibronectins (Cue et el., 2001) triggers the 
binding of host fibronectin to host cell surface α5β1 integrins, forming a bridge to strongly adhere 
GAS to the surface of host cells to promote bacterial colonization. This process subsequently activates 
integrin-mediated internalization of GAS into host cells (Talay et al., 2000; Terao et al., 2001; Wang 
et al., 2006). In addition, M6 protein can bind directly to host keratinocyte membrane cofactor CD46 
(Okada et al., 1995; Giannakis et al., 2002) while M18 does not (Feito et al., 2007), and M1 protein 
can bind surface-expressed glycosaminoglycans such as dermatan sulfate, heparan sulfate, and 
heparin (Frick et al., 2003). Another study also demonstrated that M1 proteins promote inter-bacterial 
aggregation to enhance bacterial adherence and invasion into epithelial cells (Frick et al., 2000). 
Although M protein is characterized to have a role in GAS adherence in immortal cell lines, studies 
have also shown in primary human tonsil cells that M1 (Abbot et al., 2007) and M6 (Caparon et al., 
1991) proteins have little to no effect on GAS adhesion. In both studies, the authors noted that mutant 
strains of these M proteins were unable to form aggregates and microcolonies on host cell surfaces. 
These contrasting observations obtained from immortal and primary cell lines indicate that 
functionality of the GAS M protein during adhesion to host cells is likely GAS strain and host cell 
type-specific. 
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1.4.2 Invasion of host cells 
 
Although generally regarded as an extracellular pathogen, GAS has been shown to be able to invade 
cells in vivo and in vitro under experimental conditions and persist intracellularly. To date, multiple 
GAS invasion mechanisms have been described. The most well characterized pathway involves GAS 
fibronectin binding protein and host cell α5β1 integrins (Rezcallah et al., 2005; Wang et al., 2006). 
The engagement of α5β1 integrin initiates a signaling cascade that results in integrin clustering and 
formation of focal adhesion complexes on host cell surfaces (Ozeri et al., 2001) and subsequent 
internalization of GAS via a “zipper-like” mechanism (Ozeri et al., 1998; Dombek et al., 1999). GAS 
M proteins have also been reported to bind host CD46 receptors that subsequently interact with α5β1 
integrin to initiate cytoskeletal rearrangement for endocytosis of GAS (Okada et al., 1995; Rezcallah 
et al., 2005). SfbI is another fibronectin-binding protein implicated in the uptake of GAS (Molinari 
et al., 1997; Jadoun et al., 1998), although GAS strains or mutants deficient in SfbI are still able to 
invade the host intracellular compartment albeit at reduced levels (Jadoun et al., 1998). GAS adhesion 
and invasion therefore does not depend on a single mechanism. For example, fibronectin-binding 
proteins of GAS include FBP54 (Courtney et al., 1996), FbaB (Amelung et al., 2011), protein F2 
(Kreikemeyer et al., 2004), serum opacity factor and SfbX (Jeng et al., 2003), suggesting tight control 
over adhesion and invasion of host cells via the specificity of surface proteins. 
 
There are studies indicating that GAS is internalized into host cells via clathrin-dependent (Logsdon 
et al., 2011) and caveolae-dependent routes (Rohde et al., 2003). Rohde et al. (2003) used scanning 
electron microscopy (SEM) to show that caveolar-like cavities formed around sites of GAS 
attachment to host cells and disruption of host cell membrane cholesterol with the pharmacological 
drugs methyl-β-cyclodextrin and filipin resulted in decreased GAS invasion. Furthermore, ultrathin 
sections of HEp-2 cells infected with SfbI-expressing Streptococcus gordonii also showed caveolae 
derived from the cytoplasm accumulating at sites of infection, which eventually fuse to form large 
invaginations that ultimately engulf bacteria (Rohde et al., 2003). Using SfbI constructs, Rohde and 
colleagues concluded that GAS SfbI is required to trigger caveolae-mediated invasion of host cells at 
least in the GAS strain and cell type tested. 
 
1.4.3 Evasion of cellular innate immune responses 
 
Within host cells, GAS has to evade host immune responses in order to survive. A common host 
response when infected with intracellular pathogens is to induce apoptosis to prevent further pathogen 
proliferation. Some intracellular pathogens such as Legionella pneumophilae and Mycobacterium 
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tuberculosis have developed mechanisms to prevent host cells from triggering apoptosis (Loeuillet et 
al., 2006; Banga et al., 2007). On the other hand, GAS has adopted a strategy to accelerate apoptosis 
(Timmer et al., 2009). When internalized by phagocytic macrophages, GAS first uses a pore-forming 
toxin termed streptolysin O (SLO) to escape endocytic vesicles by forming holes in the vesicle 
membrane, followed by SLO attack on host mitochondrial membranes. Disruption of the 
mitochondrial membrane releases cytochrome C into the cytosolic compartment, from which 
cytochrome C then activates the cellular apoptosis pathway (Garrido et al., 2006). By killing immune 
cells, GAS limits and dampens host cytokine-related immune responses to promote survival in the 
blood stream (Timmer et al., 2009). 
 
In non-phagocytic cells such as the human epithelial HEp-2 cell line, GAS also escapes endocytic 
vesicles via the action of SLO, which eventually leads to cellular apoptosis (Nakagawa et al., 2004; 
Sakurai et al., 2010). However, before apoptosis occurs, bacterial cells were found contained within 
autophagosome-like vacuoles through the action of autophagy (Nakagawa et al., 2004). Autophagy 
is an important innate immune defence mechanism against intracellular pathogenic bacteria (Huang 
and Brumell, 2009). Cytosolic GAS that successfully escape the initial endocytic vesicle are targeted 
for autophagy by host proteins such as p62, NBR1, and NDP52 (Barnett et al., 2013). These 
autophagosome-like vacuoles containing autophagocytosed GAS then fuse with lysosomes to kill the 
pathogens. Nevertheless, GAS serotype M1T1 is capable of avoiding clearance by evading autophagy 
(Barnett et al., 2013). This GAS strain relies on the SpeB cysteine protease to degrade p62, NBR1 
and other host proteins that target it to autophagy, thus promoting intracellular survival and 
replication. In addition, GAS NADase is also implicated in avoiding killing by autophagy 
(O'Seaghdha and Wessels, 2013). Here, GAS serotype M3 strain 188 was contained in 
autophagosomes, but fusion with lysosomes was prevented by NADase thought to drain energy from 
host cells through NAD+ and ATP depletion, thus affecting pathogen resistance and repair 
mechanisms leading to cell death (Michos et al., 2006). These studies provide examples of 
mechanisms GAS has evolved to circumvent their hosts’ immune responses, which undoubtedly have 
contributed to their pathogenesis. 
 
1.5 Caveolae 
 
The eukaryotic cell plasma membrane (PM) is a hydrophobic phospholipid bilayer embedded with 
numerous proteins and components that act as a selectively permeable barrier between the external 
and internal cellular environment. One such component is termed caveolae. Originally described by 
Palade (1953) and Yamada (1955), caveolae are 60 - 80 nm (diameter) uncoated, crater-shaped 
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invaginations of cell PMs (Fig. 1.1; Richter et al., 2008; Schlormann et al., 2010). Caveolae are 
highly stable structures (Thomsen et al., 2002) implicated in many cellular functions including 
endocytosis, transcytosis, lipid homeostasis and various signal transduction pathways (Lisanti et al., 
1994; Kuzchalia and Parton, 1999; Frank et al., 2003; reviewed in Parton and Pozo, 2013). Caveolae 
expression varies in different cells/tissues. For instance, caveolae are abundant in endothelial cells, 
adipocytes, smooth-muscle cells, fibroblasts, and type I pneumocytes (reviewed in Parton and Simons, 
2007), but cells such as lymphocytes, neuroblastoma and neuronal cells are devoid of caveolae 
structures (Fra et al., 1994 & 1995; Gorodinsky and Harris, 1995; Cameron et al., 1997). Caveolar 
density may also be heterogeneous within individual cells, as evident by the concentration of caveolae 
within the basolateral surface of epithelial cells and at the rear of migrating cells (Scheiffele et al., 
1998, Parat et al., 2003).   
 
The appearance, composition and function of caveolae are highly dependent on cell type. Other than 
their characteristic flask shape, caveolae have also been described as flat, vesicular, tubular, grape-
like clusters and/or rosettes (Fig. 1.1A; Parton et al., 1997; Anderson, 1998; Razani et al., 2002). For 
example, caveolae in endothelial cells appear to have a striated coat (Peters et al., 1985) whereas they 
are more constricted in mouth tissue (Stan et al., 1997). Caveolae in muscle cells often form 
composite clusters or straight rows of multiple flask-shaped structures involved in the formation of 
T-tubules (Carozzi et al., 2000). Furthermore, caveolae in epithelial tissue culture cells lack 
diaphragms, are smaller and “exposed” to the extracellular environment at the PM (Rothberg et al., 
1992). 
 
Enrichment of lipids in caveolae is important for proper formation and maintenance of the caveolar 
structure (Brown and London, 1998; Simons et al., 2000; Thomas and Smart, 2001). Caveolae are 
enriched in cholesterol, glycosphingolipids and glycosylphosphatidylinosotol (GPI)-anchored 
molecules (Parton et al., 1994; Schnizer et al., 1995; Fujimoto et al., 1997; Anderson 1998; Ortegren 
et. al., 2004), and form a subset of specialized lipid rafts. Treatment of PM with cholesterol-anchoring 
pharmacological drugs such as filipin or nystatin result in flattened caveolae, disassembly of the 
striated coat (Rothberg et al., 1992; Hill et al., 2008) and a significant decrease of surface caveolae 
in intact Madin-Darby canine kidney (MDCK) and endothelial cells (Schnitzer et al., 1994; 
Hailstones et al., 1998).  
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1.5.1 Caveolin-family proteins 
 
The scaffolding protein components of caveolae are the caveolin family proteins and cavin-1, the 
latter also known as Polymerase I and Transcript Release Factor (PTRF). The multigene caveolin-
family protein is comprised of three proteins: caveolin-1 (CAV1) and caveolin-2 (CAV2) that are 
found in non-muscle cells (Scherer et al., 1996; Scherer et al., 1997), and caveolin-3 (CAV3) that are 
predominantly found in skeletal and smooth muscle cells (Way and Parton, 1995). These proteins are 
structurally similar but immunologically distinct and can be identified by a typical short stretch of 
amino acid sequence (FEDVIAEP) referred to as the “caveolin signature motif”. CAV1 and CAV3 
have greater sequence homology (65% identical, 85% similar) while CAV2 is only 38% identical and 
85% similar to CAV1 (Williams and Lisanti, 2004). 
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Figure 1.1 Morphological features of 
caveolae and caveolin. (A) Caveolae 
adopts various forms. Other than the 
traditional flask-shaped membrane 
invaginations, caveolae can be found in 
vesicular forms, grape-like clusters, 
rosettes and tubular structures. Figure 
adapted from Razani et al., 2002. (B) An 
electron micrograph showing the 
ultrastructure of caveolae in HEp-2 cells. 
The cells were surface labelled with an 
electron-dense marker. Caveolae are 
evident as flask-shaped invaginations, 
vesicles and rosettes (indicated by red 
arrows). Scale bar = 1 µm. (C) Schematic 
structure of caveolae and CAV1 (inset; 
shown as a monomer for simplicity) 
within the PM. Caveolins are key 
components of caveolae and the most 
widely studied member is CAV1. All 
mammalian caveolin proteins, CAV1, 
CAV2 and CAV3 possess a putative 
hairpin domain embedded within the PM 
while both the N- (amino) and C- 
(carboxyl) terminus remains in the 
cytoplasm. 
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Most studies on this family of proteins have been conducted in mammals, but conserved caveolin loci 
have also been found in other vertebrates such as frogs (Xenopus laevis) (Razani et al., 2002), fugu 
fish (Fugu rubripes) (Williams and Lisanti, 2004) and also in the invertebrate Caenorhabditis elegans 
(Tang et al., 1997). Caveolin proteins are important structural backbones for the formation of 
caveolae and have been implicated in many cell signalling events and functions. The focus of this 
thesis is on CAV1, nevertheless, some background is also provided on CAV2 and CAV3 proteins in 
the following sections. The reader is directed to these reviews for more in-depth information on 
CAV2 and CAV3 proteins: Williams and Lisanti, 2004; Parton and Simons, 2007. 
 
1.5.1.1 Caveolin-1 
 
CAV1 was the first described caveolar structural protein and is widely used as a molecular marker 
for caveolae (Glenney and Soppet, 1992; Kurzchalia et. al., 1992). The identification of CAV1 
facilitated research into caveolae, leading to the description of other cavin proteins which are essential 
for the regulation of caveolae biogenesis and structure (reviewed in Briand et. al., 2011). CAV1, also 
known as VIP-21 (Parton, 1996; Anderson, 1998), is an integral membrane protein (22 - 25 kDa) 
with a highly conserved hairpin loop embedded within the PM (Fig. 1.1C; Parton et al., 2006). Both 
amino and carboxyl terminals of CAV1 face the cytoplasm with no part of the protein exposed to the 
extracellular environment (Dupree et al., 1993; Monier et al., 1995). There are also sites of 
palmitoylation and tyrosine phosphorylation within the N- and C-termini (Dietzen et al., 1995; Li et 
al., 1996).  
 
CAV1 proteins can be divided into three main domains: The N-terminus (amino acids 1 - 101) which 
includes the caveolin scaffolding domain (CSD) (amino acids 82-101; Li et. al., 1996) and 
oligomerization domain (amino acids 61 - 101), the intramembrane domain (amino acids 102 - 134), 
and the C-terminus (amino acids 135 - 178; Fig. 1.2). The CSD has been suggested to be important 
for regulating cell signaling (Lisanti et al, 1994; Couet et al, 1997) while the oligomerization domain 
is required for caveolin self-association. This is evident in cells expressing mutations in the caveolin 
oligomerization domain where caveolins were unable to translocate to the PM (Galbati et al., 2001). 
The intramembrane domain has roles in membrane expansion and regulation of membrane curvature 
in caveolae (Parton et al., 2006). This was confirmed by the lack of caveolae formation in mouse 
embryonic fibroblasts (MEFs) upon replacement of amino acid residues in this region (Kirkham et 
al., 2008). The C terminus has been proposed to be required for the association of caveolae with PMs. 
Truncated CAV1 lacking C-terminus residues 135 - 178 did not affect formation of caveolae, but 
instead a reduction in PM association proportional to the size of the truncation was observed 
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(Kirkham et al., 2008). A separate study indicated a lipid interaction role of the C-terminus. It was 
demonstrated that the C-terminus residues of CAV3 (which are conserved in CAV1) were 
constitutively targeted to intracellular lipid storage compartments and when stimulated by cholesterol 
(Le Lay et al., 2006), CAV1 is able to translocate to lipid droplets (LDs) (Pol et al. 2001; Pol et al., 
2004). The structure and domains of CAV1 in the PM bilayer is summarized in Fig. 1.1C and Fig. 
1.2. 
 
 
 
 
Figure 1.2 Schematic representation of domains of the CAV1 protein. CAV1 can be divided into three 
main domains: The N-terminal (residues 1 - 101), which include the CSD and oligomerization domains, 
intramembrane domain (residues 102 - 134) and the C-terminal (residues 135 - 178). CAV1 proteins form 
homo-oligomers via interactions at residues 61 - 101, termed the oligomerization domain (Sargiacomo et al., 
1995; Song et al., 1997). Numbers in the schematic diagram correspond to amino acid residues in the 
mammalian CAV1. Figure adapted from Parton et al., 2006. 
 
CAV1 has two isoforms: α and β. The α isoform is as described in the previous paragraph and shown 
in Fig. 1.2, whereas the β-isoform is produced by an alternate translational start site and is 31 amino 
acids shorter than the α-isoform (Scherer et al., 1995). Both isoforms are conserved throughout the 
hydrophobic region consisting of the CSD and acylated C-terminus region; while only the α-isoform 
possess the N-terminus 31 amino acids (Scherer et al., 1995). CAV1 is able to form homo-oligomers 
of 14 to 16 monomers, first observed in vivo as high molecular mass complexes of 350 - 400 kDa 
using velocity gradient centrifugation (Monier et al., 1995). These complexes are very stable and are 
highly resistant to harsh temperature and detergent treatments (Monier et al., 1995; Li et al., 1996).  
 
To date, CAV1 has been widely used as a protein marker to specifically identify caveolar-structures 
in experimental models because it is a major component for maintaining the structure of caveolae. A 
single caveolae structure in the PM consists of approximately 144 caveolin proteins (Pelkmans and 
Zerial, 2005). CAV1 was implicated in the formation of caveolae when expression of CAV1 in 
lymphocytes (a cell type that normally does not express caveolae) resulted in de novo formation of 
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surface domains with morphology characteristic of caveolae (Fra et al., 1995). Drab and colleagues 
(2001) further confirmed the importance of CAV1 as a major component of caveolae by disrupting a 
targeted area in the CAV1 gene in mice, resulting in caveolae-free mice. There were no caveolae 
found in various tissue and organs (adipose tissue, diaphragm, kidney and heart) and there was 
complete loss of caveolae in endothelial and epithelial lung cells of the knockout mice compared to 
lung cells of wild type (WT) mice (Drab et al., 2001). Compared to WT, caveolae-deficient mice had 
various phenotypes such as aberrations of the endothelial lung cells and defective nitric oxide and 
calcium signaling in the cardiovascular system (Drab et al., 2001), suggesting the importance of 
caveolae as a regulator of multiple signaling pathways.  
 
CAV1 also has high binding affinity for cholesterol (Murata et al., 1995; Li et al., 1996). CAV1 is 
involved in the transport of newly synthesized cholesterol from the endoplasmic reticulum (ER) to 
caveolae and regulation of intracellular cholesterol equilibrium (Smart et al., 1996; Pol et al., 2001). 
A dominant negative CAV1 mutant resulted in accumulation of free intracellular cholesterol and 
decreased surface cholesterol, and reduced cholesterol synthesis and efflux (Pol et al., 2001). 
Furthermore, loss of CAV1 in mice models and human cell lines results in severe lipid dysregulation, 
disruption of lipid storage (Razani et al., 2002; Le Lay et al., 2006) and lipodystrophy (Kim et al., 
2008). Cholesterol also regulates the export of CAV1 from the Golgi (Rothberg et al., 1992; Pol et 
al., 2005), although it is not necessary for the translocation to the PM (Hayer et al., 2010). 
 
1.5.1.2 Caveolin-2 
 
CAV2 was discovered in a study identifying resident proteins of caveolae in adipocytes (Scherer et 
al., 1996). Less is known about the function of CAV2 compared to CAV1, but studies have suggested 
that CAV2 and CAV1 have interdependent roles in regulating cell signaling. Expression of CAV2 is 
tightly linked to expression of CAV1, in which the loss of CAV1 in vivo and in vitro results in overall 
reduced translation of CAV2 proteins but not transcription (Drab et al., 2001), and translated CAV2 
was not transported to membrane caveolae (Parolini et al., 1999). CAV2 remained mostly cytosolic 
and possibly degraded (Drab et al., 2001; Razani et al., 2001). Conversely, reduction of CAV2 does 
not affect expression or localization of CAV1, nor does it affect caveolae formation (Razani et al., 
2002; reviewed in Sowa, 2011). CAV2 is also able to form hetero-oligomers with CAV1 in the Golgi 
apparatus (Hayer et al., 2010). 
 
There are varying reports on the involvement of CAV2 in caveolae biogenesis. In CAV2 knockout 
lung capillary endothelium and perigonadal adipose tissue, the presence of caveolae was observed 
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indicating that CAV2 is not required for caveolae formation in these cells (Razani et al., 2002). In 
MDCK cells, caveolae were observed at the basolateral domain where CAV2 and CAV1 were both 
present, but not in the apical domain where only CAV1 was expressed (Scheiffele et al., 1998). This 
observation was further supported when overexpression of CAV2 in CAV1-deficient MDCK cells 
resulted in increased caveolae formation, indicating a role of CAV2 in caveolae biogenesis (Lahtinen 
et al., 2003). These studies suggest that CAV2 function in caveolae formation is cell-specific and 
additional studies in different cell types are required to fully elucidate the role of CAV2 in caveolae 
biogenesis. 
 
The exact role of CAV2 in signaling, localization and incorporation into caveolae is still not 
thoroughly understood. Recent studies have hinted at the potential roles of CAV2 in cell and tissue-
specific signaling (Sowa, 2011). Phosphorylation of CAV2 at different serine residues indicated that 
CAV2 might play a role in subcellular localization. For example, CAV2 phosphorylated at serine 23 
were isolated from detergent-resistant microdomains (DRMs) and localized to the PM, whereas 
CAV2 phosphorylated at serine 36 were mostly localized to non-DRMs and remained in the 
intracellular perinuclear region (Sowa et al., 2008). Moreover, CAV2 phosphorylated at tyrosine 19 
or 27 was associated with lipid rafts and caveolae but did not form hetero-oligomers with CAV1 (Lee 
et al., 2002; Wang et al., 2004). CAV2 also binds Src homology 2 domain proteins such as c-Src, 
Nck and Ras-GAP, suggesting that these proteins have a role in regulating cell signaling (Lee et al., 
2002; Wang et al., 2004).  
 
1.5.1.3 Caveolin-3 
 
In 1996, Tang and colleagues identified CAV3 (or M-caveolin) while performing standard cDNA 
database screening for potential CAV1 homologous genes. CAV3 shares more sequence similarity to 
CAV1 than CAV2, and can also form large hetero-oligomers with CAV1 in vivo (Tang et al, 1996).  
It is a major component protein of caveolae in muscle tissues (Hagiwara et al., 2000; Galbiati et al., 
2001), and has roles in regulating sarcolemma stability and the modulation of multiple signaling 
pathways (Gazzerro et al., 2010). Maintenance of physiological levels of CAV3 is essential for 
normal skeletal muscle development and postnatal functions (Galbiati et al., 2001; Williams and 
Lisanti, 2004), as mutations in the CAV3 gene led to disease phenotypes such as limb girdle muscular 
dystrophy, rippling muscle disease, hyperCKemia, distal myopathy and familial hypertrophic 
cardiomyopathy (Minetti et al., 1998; Galbiati et al., 2001; Woodman et al., 2004). As CAV3 proteins 
are beyond the scope of this thesis, please refer to Gazzerro et al. (2010) for an in-depth review of 
CAV3. 
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1.5.2 Caveolar coat proteins - The Cavin complex 
 
In addition to caveolin proteins, cavin family proteins are also involved in the assembly/disassembly 
of caveolae. This family consists of four proteins: cavin-1, cavin-2, cavin-3 and cavin-4 (alternate 
names summarized in Table 1.3), all of which are found in their soluble forms in the cytoplasm, 
contain amino-terminal coiled-coil domains, and have been shown to selectively localize to caveolae 
at the PM (Hill et al., 2008; Bastiani et al, 2009; Hansen et al., 2009; McMahon et al., 2009). All 
cavin proteins share sequence homology and are mostly conserved at the N-terminus with more than 
20% protein sequence identity to cavin-1 (Bastiani et al., 2009; Kovtun et al., 2014). They also 
possess putative proline, glutamic acid, serine and threonine (PEST) domains and leucine-rich 
domains that are suggestive of protein-protein interactions (Bastiani et al., 2009). Cavin proteins 
oligomerize to form large complexes, termed the cavin complex, and are recruited to caveolae-rich 
regions of the PM. Studies have indicated that interactions among the cavin family proteins are 
independent of the PM or caveolae (Hayer et al., 2010; Gambin et al., 2014; Kovtun et al., 2014).  
 
Recruitment of cavin to caveolae is a critical regulator of caveolae dynamics (Hansen et al., 2009). 
Among the cavin proteins, cavin-1 has a major role in caveolae biogenesis as induced expression of 
cavin-1, but not cavin-2, 3, or 4 in PC3 prostate cancer cells (these cells lack caveolae) resulted in 
caveolae formation (Bastiani et al., 2009). Overexpression of the cavin proteins also alters the 
morphology and dynamics of caveolae (Briand et al., 2011). Cavin proteins form complexes within 
the cytosol and are only targeted to PM caveolae upon signaling from caveolin (Hill et al., 2008; 
Bastiani et al., 2009). The varied expressions of each member of the cavin complex between cell 
types indicate that cavin proteins regulate caveolae formation and stability in a tissue-specific manner 
(Bastiani et al., 2009).  
 
1.5.2.1 Cavin-1 
 
Cavin-1 (also known as polymerase I and transcript release factor (PTRF) or Cav-p60, BBP) was first 
identified in a yeast two-hybrid screen using transcription termination factor as a bait (Izumi et al., 
1997; Jansa et al., 1998), and its role in maintaining caveolae structure and formation was 
subsequently confirmed through proteomics studies of PM DRMs in MEFs (Hill et al., 2008). Cavin-
1 proteins are found localized to caveolae and have varying expression levels in different cell types 
(Bastiani et al., 2009; Hansen et al., 2013); its expression was also highly correlated with CAV1 
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expression in vitro (Vinten et al., 2005) and in vivo (Hasegawa et al., 2000; Hill et al., 2008). Cavin-
1 selectively co-localizes with CAV1 at the PM and its presence is crucial for the formation of mature  
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Table 1.3   Alternate names and proposed functions of the cavin complex proteins1 
 
1 Bastiani and Parton, 2010; Hansen and Nichols, 2010; Kovtun et al., 2015
Alternate names Proposed functions Reference
Cavin-1
Polymerase 1 & transcript release factor (PTRF) Maintain structure & formation of caveolae Hill et al., 2008
Cavin-2
Serum deprivation response protein (SDR) Maintain caveolae stability & dynamics Hansen et al., 2009
Cholesterol sensing constituent of caveolae Breen et al., 2012
Cavin-3
Serum deprivation response factor-related gene product that binds C-kinase (SRBC) Cell specific interactions with caveolar proteins
Protein kinase C delta-binding protein (PRKCDBP) Caveolar endocytosis & localization
Cavin-4
Muscle-restricted coiled-coil protein (MURC) Muscle biogenesis & other muscle-related functions Tagawa et al., 2008; Bastiani et al., 2009
Hansen et al., 2009
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caveolae (Hill et al., 2008). The absence of cavin-1 reduced CAV1 oligomer size and increased lateral 
mobility, suggesting the need for cavin-1 to sequester CAV1 to form caveolae (Hill et al., 2008). In 
addition, Liu and colleagues (2008) confirmed cavin-1 function in regulating caveolae formation as 
the removal of cavin-1 in vitro resulted in no observable caveolae in all tissues investigated. Cavin-
1-/- mice are viable but the loss of cavin-1 resulted in the loss of CAV1, 2 and 3 proteins suggesting 
that both cavin-1 and caveolin expression are inter-dependent and are essential for caveolae formation 
(Liu et al., 2008; Bastiani et al., 2009). Despite these results, there is little evidence to suggest direct 
interaction between CAV1 and cavin-1 proteins (Hill et al., 2008; Liu and Pilch, 2008). 
 
1.5.2.2 Cavin-2 
 
Cavin-2, also known as serum deprivation response protein (SDR) or PS-p68, derived its name from 
its increased expression upon serum deprivation in NIH3T3 mouse fibroblasts (Gustincich et al., 
1999). Cavin-2 is a phosphatidylserine (PS) binding protein that binds protein kinase C (PKC) in 
vitro (Burgener et al., 1990; Mineo et al., 1998). It plays a structural role in maintaining caveolae 
stability and dynamics as reduced cavin-2 expression resulted in loss of morphologically recognizable 
caveolae (Hansen et al., 2009). Recent evidence proposed that cavin-2 acts as a cholesterol sensing 
constituent for caveolae as cholesterol depletion in adipocytes resulted in rapid proteolytic 
degradation of cavin-2 but not other components of the caveolar coat, internalization of cavin-1 into 
the cytoplasm and subsequent loss of caveolae (Breen et al., 2012). The recruitment of cavin-2 to the 
PM is also cholesterol-dependent and this is required for cavin-1 to return to the PM and for 
restoration of caveolae, further indicating the role of cavin-2 in maintaining caveolae structural 
integrity (Breen et al., 2012).  
 
1.5.2.3 Cavin-3 
 
Cavin-3 interacts with the C-kinase superfamily of PKC-binding proteins (Izumi et al., 1997; 
McMachon et al., 2009). Cavin-3 has cell-specific functions that are determined by its interactions 
with other caveolae proteins (Hansen et al., 2013). It was demonstrated that cavin-3 is involved in 
caveolae endocytosis and localization to the PM (McMahon et al., 2009). Although expression of 
cavin-3 alone was not sufficient to induce caveolae formation (Bastiani et al., 2009), down regulation 
of cavin-3 resulted in reduced number of caveolae at the PM (McMahon et al., 2009). Cavin-3 is also 
transported together with CAV1 and fluorescent recovery after photo-bleaching (FRAP) experiments 
showed increased internalization of CAV1 when cavin-3 was expressed in cells normally lacking the 
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protein (McMahon et al., 2009). In contrast, loss of cavin-3 in endothelial PM did not affect the 
number of caveolae (Hansen et al., 2013), further indicating that its function is cell type-specific. 
 
A study showed that cavin-3 mediates intracellular ERK MAP signaling which controls cell 
proliferation and survival (Hernandez et al., 2013). Loss of cavin-3 reduced ERK signaling, which in 
turn elevates signaling of protein kinase Akt (a key regulator of cell growth and aerobic glycolysis). 
Elevated Akt activity reduces apoptosis, and improves aerobic glycolysis and cell proliferation. These 
processes are characteristics of some cancer cells (Cairns et al., 2011), suggesting that cavin-3 may 
have a role in tumour suppression. These observations were consistent with a study in which breast 
and lung cancer cells were found negative for cavin-3 (Xu et al., 2001). 
 
Cavin-3 has also been shown to anchor caveolae to actin cytoskeleton via protein myosin-1c, 
indicating its role in maintaining caveolae stability at the PM (Hernandez et al., 2013). These studies 
suggest that cavin-3 has a wide array of functions in different tissues and more studies will be needed 
to understand their tissue-specific roles.  
 
1.5.2.4 Cavin-4 
 
Cavin-4 was first identified as a coiled-coil protein whose distribution is restricted to muscle cells. 
Its subcellular distribution and expression pattern are similar to CAV3, with high expression levels 
in skeletal and cardiac muscles (Ogata et al., 2008; Tagawa et al., 2008; Bastiani et al., 2009). 
 
Cavin-4 interacts with cavin-2 (Bastiani et al., 2009) and modulates signalling through the 
RhoA/ROCK pathway to regulate cardiac function (Ogata et al., 2008). Overexpression of cavin-4 in 
the heart also induced cardiac contractile dysfunction and atrioventricular abnormalities (Ogata et al., 
2008). Cavin-4 expression was upregulated during injury-induced muscle regeneration and higher 
levels of cavin-4 was detected in ERK activated immature myofibres, suggesting that cavin-4 is 
essential for skeletal muscle myogenesis (Tagawa et al., 2008). In addition, knockout of CAV1 in 
skeletal muscle cells did not affect levels of cavin-4, suggesting that CAV3 is the main regulator of 
cavin-4 since CAV3 is more abundant than CAV1 in skeletal muscle cells (Bastiani et al., 2009). It 
was observed that both cavin-4 and CAV3 expression were concomitantly upregulated during mouse 
myoblast cell differentiation into muscle myotubules; the expression pattern of cavin-4 and CAV3 
were also similar in patients with rippling muscle disease (a disease usually associated with CAV3 
dysfunction) (Bastiani et al., 2009), suggesting that cavin-4 may act as a marker for caveolin-related 
muscle diseases and has roles in myogenic differentiation.  
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1.6 Role of caveolae in bacterial pathogenesis 
 
Pathogenic bacteria, parasites and viruses have evolved mechanisms to invade and survive in host 
cells (Duncan et al., 2002). In recent years, caveolae have been increasingly recognized as a point of 
pathogen entry into host cells (Shin and Abraham, 2001; Duncan et al., 2002; Parton and Richards, 
2003; Zaas et al., 2005). In fact, some pathogens require specific caveolae proteins for uptake. 
Examples of bacteria reported to target caveolae-cholesterol enriched PM microdomains include 
Escherichia coli, Pseudomonas aeruginosa, various species of Mycobacterium and Chlamydia, and 
others summarized in Table 1.4.  
 
Depending on the experimental cell type and pathogens studied, caveolae can act to facilitate or 
prevent infection (Machado et al., 2012). The following sections outline a few examples of caveolae 
implicated in the facilitation and prevention of toxins, viruses and bacteria uptake into non-phagocytic 
and phagocytic host cells.  
 
1.6.1 Caveolae as a facilitator of pathogen invasion 
 
Cholera toxin, Shiga toxin and Simian virus 40 
 
Caveolae act as endocytic carriers for various molecules such as Simian virus 40 (SV40) particles, 
cholera toxin binding subunit B (CTB) and shiga toxin molecules (Anderson et al., 1996; Pelkmans 
et al., 2001; Kirkham and Parton, 2005; Lafont and Gisou van der Goot, 2005). SV40 and CTB have 
been commonly used as markers for studies to elucidate caveolae-related mechanisms (Pelkmans et 
al., 2001; Parton and Richards, 2003). Initial studies involving CTB showed that binding of CTB to 
GM1 ganglioside receptors clustered within caveolae triggers caveolae-mediated uptake of the toxin 
(Montesano et al., 1982). It was also observed that a subset of CAV1-positive caveolae buds from 
the PM in a cholesterol-dependent manner to mediate uptake of CTB (Kirkham and Parton, 2005). In 
addition, SV40 binding results in enriched caveolae at the PM (Stang et al., 1997; Pelkmans et al., 
2001) and induces caveolae budding by recruiting actin/dynamin as well as tyrosine phosphorylation 
of caveolae-associated proteins (Pelkmans and Helenius, 2002). Stang and colleagues (1997) have 
shown that SV40 particles taken up via the caveolae pathway are directly transported to the ER, 
bypassing lysosomal killing mechanisms for intracellular replication within host cells. 
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Table 1.4 Pathogens that co-opt lipid raft/caveolae for uptake into host cells 
Pathogen Interaction with caveolae Implicated role Reference
Bacteria
     Anaplasma phagocytophilum CAV1 Facilitate invasion Lin et al ., 2003
     Brucella species CAV2 Facilitate invasion Watarai et al ., 2002 & 2004
     Campylobacter jejuni CAV1 Facilitate invasion Wooldridge et al ., 1996; Watson et al.,  2008
     Chlamydia species CAV1 & CAV2 Facilitate invasion Norkin et al ., 2001; Stuart et al .; 2003, Gabel et al ., 2004; Webley et al. , 2004
     Ehrlichia chaffeensis CAV1 Facilitate invasion Lin et al ., 2003
     Escherichia coli CAV1 Facilitate invasion Baorto et al ., 1997; Shin et al. , 2000; Duncan et al ., 2004; Abraham et al. , 2005
     Francisella tularensis CAV1 Facilitate invasion Tamilselvam et al ., 2008; Law et al. , 2011
     Listeria monocytogenes CAV1 Facilitate invasion Seveau et al ., 2004
     Neisseria gonorrhoea CAV1 Facilitate invasion Faulstich et al ., 2013
     Mycobacteria species CAV1 Facilitate invasion Gatfield et al ., 2000; Maldonado-Garcia et al ., 2004
     Porphyromonas gingivalis CAV1 Facilitate invasion Tamai et al ., 2005; Tsuda et al. , 2008
     Pseudomonas aeruginosa CAV1 & CAV2 Facilitate invasion Zaas et al ., 2005 & 2009; Abraham et al ., 2005; Bajmoczi et el. , 2009
     Salmonella typhimurium CAV1 Facilitate invasion Lim et al ., 2010
     Shigella flexneri CAV1 Facilitate invasion Lafont et al ., 2002
     Streptococcus pneumoniae Caveolae Facilitate invasion Gradstedt et al ., 2013
     Streptococcus pyogenes CAV1 Facilitate invasion Rohde et al ., 2003
     Rickettsia conorii CAV2 Facilitate invasion Chan et al ., 2009
     Klebsiella pneumoniae CAV1 Prevent infection Guo et al ., 2012
     Neisseria gonorrhoea CAV1 Prevent invasion Boettcher et al ., 2010
     Staphylococcus aureus CAV1 Prevent invasion Hoffmann et al ., 2010
Parasite
     Leishmania chagasi Caveolae Facilitate invasion Rodríguez et al. , 2006
     Plasmodium falciparum Caveolae Facilitate invasion Olliaro et al ., 1997; Lauer et al ., 2000
     Toxoplasma gondii Caveolae Facilitate invasion Mordue  et al ., 1999
     Tripanosoma cruzi Caveolae Facilitate invasion Barrias et al ., 2007
Viruses
     BK virus CAV1 Facilitate invasion Eash et al ., 2004; Moriyama et al ., 2007
     Echovirus-1 (EV-1) CAV1 Facilitate invasion Marjomaki et al ., 2002
     Human papillomavirus CAV1 Facilitate invasion Smith et al. , 2008; Laniosz et al ., 2009
     Simian virus 40 (SV40) CAV1 Facilitate invasion Anderson et al. , 1996; Pelkmans et al. , 2001; Norkin et al. , 2005
     Respiratory syncytial virus (RSV) CAV1 Facilitate invasion Werling et al . 1999; Brown et al ., 2002
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Escherichia coli 
 
FimH-expressing and type I-piliated E. coli were shown to invade phagocytic mast cells and 
macrophages, and non-phagocytic bladder epithelial cells (BECs) via a caveolae-dependent manner 
(Baorto et al., 1997; Shin et al., 2000; Shin and Abraham, 2001; Duncan et al., 2004). FimH, a 
mannose-binding adhesin, is a major virulence determinant of uropathogenic E. coli (UPEC) that 
facilitates their attachment to and colonization of mucosal surfaces (Johnson et al., 1991). The FimH 
receptor is a GPI-anchored protein termed CD48 in mast cells and macrophages (Baorto et al., 1997), 
or uroplackin-1a in BECs (Mulvery et al., 1998). These receptors localize to caveolae domains during 
bacterial attachment, suggesting that the uptake of E. coli may be caveolae-dependent (Parton et al., 
1994; Baorto et al., 1997; Shin et al., 2000; Duncan et al., 2004). This is supported by the requirement 
of CD48 receptors clustered in the plasmalemmal caveolae of mouse bone marrow-derived mast cells 
and the binding of FimH-positive E. coli to CD48 triggers caveolae-dependent internalization of E. 
coli, in which E. coli remained viable within host cell ‘caveolar vesicles’ (Shin et al., 2000). 
 
In healthy BECs, caveolae usually reside in the basolateral domain. Invading type I-piliated E. coli 
induce the formation of caveolae at apical sites of attachment, whereas chemical disruption of 
membrane cholesterol reduces invasion (Duncan et al., 2004). Internalized E. coli have been observed 
to co-localize with CAV1 and lipid raft components, and the knock down of CAV1 in these cells lead 
to a reduction in bacterial invasion, also suggesting that the invasion of E. coli is caveolae-dependent 
and specifically interacts with CAV1 (Duncan et al., 2004). 
 
Mycobacterium 
 
There are reports relating caveolae-dependent signaling and mycobacterial invasion into mast cells, 
macrophages and alveolar epithelial cells (Gatfield and Pieters, 2000; Shin et al., 2008; Munoz et al., 
2009; Fine-Coulson et al., 2012). Infection of Mycobacterium bovis in macrophages showed 
cholesterol clustering around the bacterium and invasion was reduced upon cholesterol depletion 
(Gatfield and Pieters, 2000). Moreover, invasion of Mycobacterium tuberculosis in mast cells and 
macrophages was suggested to be caveolae-dependent as attachment of M. tuberculosis to host cells 
resulted in cholesterol accumulation and cholesterol-dependent internalization which was inhibited 
using lipid raft inhibitors (Shin et al., 2008; Munoz et al., 2009). Mycobacterial cell wall lipids such 
as lipoarabinomannan then incorporate into membrane rafts in phagosomes and subsequently inhibit 
phagosome/lysosome fusion, thereby allowing the internalized bacterium to survive intracellularly 
(Hayakawa et al., 2007; Welin et al., 2008). More recently, Fine-Coulson and colleagues (2012) 
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found that infection of human type II alveolar epithelial cells with virulent strains of M. tuberculosis 
triggers aggregation of cholesterol–dense lipid rafts that co-localizes with CAV1. As predicted, 
treatment with filipin III to prevent cholesterol aggregation inhibited internalization and reduced the 
number of intracellular viable bacteria (Fine-Coulson et al., 2012). These data collectively show that 
caveolae is associated with mycobacterial infection. The exact mechanism of this process, however, 
is not yet clearly described.  
 
Chlamydia 
 
Chlamydial pathogens co-opt various pathways to invade host cells (Stuart et al., 2003). For example, 
cholesterol disruption/depletion experiments simulating disruption of caveolae prevented entry of C. 
trachomatis serovar D, C. pneumoniae and C. psittaci, but not C. trachomatis serovars A and C into 
HeLa cells and/or Fischer rat thyroid (FRT) cells (Stuart et al., 2003). C. trachomatis serovars A and 
C are hypothesized to invade cells via clathrin-mediated pathways whereas serovars E and K utilize 
mechanisms that are still unknown (Stuart et al., 2003; Gabel et al., 2004). These differences in uptake 
mechanisms may be attributed to their respective host cell types or the differential expression of 
receptors between these bacterial serovars. In vitro immunofluorescence studies showed that C. 
pneumoniae and all serovars of C. trachomatis co-localize with caveolin protein markers. For 
example, CAV2 in HeLa cells (CAV1 positive) and FRT cells (CAV1 negative) was specifically 
associated and accumulated with C. trachomatis serovars A, B, and C within inclusion membranes 
(Norkin et al., 2001; Webley et al., 2004). Invasion rates of C. trachomatis serovars A, B, and C into 
WT and CAV1-null thyroid epithelial cells were identical but inhibited when lipid raft integrity was 
compromised (Stuart et al., 2003), thus suggesting that Chlamydia species have evolved various 
mechanisms to invade the host, and may co-opt host CAV1 and/or CAV2 for effective pathogenesis. 
 
1.6.2 Caveolae as an inhibitor of pathogen invasion 
 
Although most studies currently suggest a role for caveolae in facilitating bacterial uptake, there are 
also studies reporting a protective role of caveolae against pathogen infection (Medina et al., 2006; 
Boettcher et al., 2010; Hoffman et al., 2010; Guo et al., 2012; Hitkova et al., 2013). Type IV pili-
producing Neisseria gonorrhoea triggers recruitment of host cell CAV1 to the site of attachment, 
which leads to actin cytoskeletal rearrangement via tyrosine phosphorylation of CAV1 residues, 
subsequently preventing entry of the bacterium into host cells (Boettcher et al., 2010). The same 
observation was reported for type-IV pili producing enteropathogenic E. coli (EPEC), whereby 
accumulation of CAV1 to the bacterial site of attachment in WT and rapid invasion into CAV1-
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deficient cells were observed (Boettcher et al., 2010). To exclude possible confounding effects due 
to the type III secretion system (T3SS) in EPEC, a type IV pili-positive T3SS mutant was utilized 
and rapid invasion of CAV1 deficient cells was still observed (Boettcher et al., 2010), suggesting that 
CAV1 plays a general role in preventing entry of type IV pili producing bacteria.  
 
CAV1 has also been reported to alter host cell membrane microdomain mobility to prevent the 
endocytosis of Staphylococcus aureus and possibly other fibronectin-binding pathogens (Hoffmann 
et al., 2010). Similar to GAS, S. aureus binds the integrin receptor α5β1 via fibronectin to promote 
internalization and colonization of host cells in vivo (Sinha et al., 1999; Hauck and Ohlsen, 2006). 
The binding of fibronectin to host receptors has been reported to induce formation of large 
invaginations with morphological characteristics of caveolae at the attachment site under the 
bacterium (Agerer et al., 2005). CAV1 deficient cells displayed increased uptake of S. aureus, and 
small interfering RNA (siRNA) and FRAP studies indicated that the scaffolding properties of CAV1 
limits mobility of membrane microdomain components to restrict endocytosis of S. aureus 
(Hoffmann et al., 2010). The mechanism by which CAV1 regulates pathogen invasion could therefore 
be indirect through the restriction of host receptor mobility, limiting their exposure for targeting by 
pathogens. Since GAS also binds α5β1 of their host cells via fibronectin, caveolae could possibly 
interact with GAS cells in a manner similar to S. aureus. 
 
In a separate study, field emission scanning electron microscopy (FESEM) imaging of SfbI positive 
GAS strain A40, but not SfbI negative S. gordonii, indicated that the surface-expressed fibronectin 
binding protein SfbI triggers caveolae accumulation at site of GAS attachment, which ultimately leads 
to formation of large invaginations (sometimes containing caveolae) and subsequent internalization 
into epithelial cells (Rohde et al., 2003). Internalization was also observed in S. gordonii into human 
umbilical vein endothelial cells (HUVEC) when recombinant SfbI was expressed by the bacterium, 
further suggesting that SfbI may be sufficient for triggering clustering of caveolae for GAS entry into 
host cells (Rohde et al., 2003). Cholesterol chelating agents such as methyl-β-cyclodextrin (MβCD) 
and filipin simulating the loss of caveolae in host cells resulted in reduced GAS invasion, indicating 
that host cell caveolae are required for GAS invasion (Rohde et al., 2003). SfbI-expressing GAS that 
co-opt caveolae for invasion are then targeted to caveosomes, a type of intracellular vesicle 
(occasionally containing CAV1) that do not fuse with phagolysosomes. This allowed GAS to survive 
intracellularly without being killed by the classical host lysosomal degradation machinery (Rohde et 
al., 2003).    
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1.8 Project aims 
 
In summary, various factors including host cell type, pathogen identity and the differential attributes 
of caveolae proteins can influence how caveolae dictates the fate of pathogen entry into their host 
cells. Therefore, this thesis aims to dissect the role of caveolae during GAS internalization into non-
phagocytic host cells by investigating how host caveolae are implicated in GAS adherence to host 
cells, invasion and intracellular survival. 
 
The objectives of this thesis are to: 
 
I. determine the role of caveolae in GAS invasion by: 
i. using precise molecular biology approaches such as genetic knockout and knockdown 
cell lines, and 
ii. visualizing interactions between GAS and host cell caveolae using 
immunofluorescence microscopy and electron microscopy 
 
II. investigate the role of caveolae component proteins (i.e. CAV1 and cavin-1/PTRF) during the 
uptake of GAS 
 
III. identify potential GAS or host factors that are involved in GAS-caveolae interactions during 
GAS internalization into host cells, such as:  
i. GAS surface expressed or secreted virulence factors 
ii. Host cell components that have been implicated in pathogen uptake 
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2. Materials and Methods 
 
2.1 Bacterial strains and cultures 
 
GAS strains M1T15448 (Kansal et al., 2003), M6JRS4 (Nakagawa et al., 2004), M12A40 (Rohde et al., 
2003; Amelung et al., 2011; kindly provided by Professor G. Singh Chhatwal, Helmholtz Centre for 
Infection Research, Technische Universität Braunschweig, Germany), M1T15448∆speB (Kansal et al., 
2003), M1T15448∆slo (Venturini et al., 2013), and M1T15448∆emm1 (Cole et al., 2010) were routinely 
grown on Columbia horse blood agar (HBA; 43050, bioMérieux) and in BD Bacto™ Todd-Hewitt 
medium (249240, BD) supplemented with 0.2% yeast extract (THY; 103753, Merck Millipore) at 
37°C. 
 
2.2 Cell lines and cell culture 
 
All MEFs, human epithelial HEp-2 cell lines and their derivatives were obtained from the Parton 
Laboratory at the University of Queensland (UQ) Institute for Molecular Bioscience (IMB) and 
maintained in Dulbecco’s Modified Eagle Medium (DMEM; 11995-065, Gibco®) supplemented with 
10% foetal bovine serum (FBS, 10099-141, Gibco®) and cultured at 37°C, 5% CO2 unless otherwise 
stated. The HEp-2 cell line used in this study (ATCC® CCL-23™) has been shown to have similar 
karyotype to HeLa and HeLa S3 (Chen, 1988). Genotyping results revealed that the HEp-2 cell line 
used in this study was 93.75% identical to HeLa (appendix II Table S2.1). 
  
CAV1-/- and PTRF-/- MEFs were isolated from CAV1-/- or PTRF-/- mice (Razani et al., 2001). Stable 
CAV1 and PTRF knockdown HEp-2 cell lines were generated by Mark Howes (IMB) as previously 
described (Kunath et al., 2003). Briefly, a modified pcDNA 3.1 (+) plasmid vector encoding a human 
H1 RNA pol III promoter was used. The target short hairpin ribonucleic acid (shRNA) sequence 
corresponds to bases 403 - 421 of the human CAV1 or 454 - 474 of the human PTRF open reading 
frame (ORF). Stable down-regulation of either CAV1 or PTRF was achieved by transfecting the 
shRNA as described in section 2.3. Cells were then selected using a rabbit polyclonal antibody (pAb) 
against CAV1 (sc-894, Santa Cruz Biotechnology, Inc.) or rabbit pAb against PTRF (HPA049838, 
Sigma-Aldrich®), or 0.1 mg/ml geneticin (G418) to obtain clonal cell lines. Protein levels were 
determined by western immunoblot analysis to assess knockdown efficiency.  
 
 28 
For seeding of MEFs and HEp-2 cells for experiments, cells were first washed twice with Dulbecco’s 
phosphate buffer saline (DPBS) and then treated with 0.05% Trypsin-EDTA phenol red (25300054, 
Gibco®) for 5 mins at 37°C, 5% CO2. Following that, cells were collected in DMEM supplemented 
with 10% FBS, centrifuged at 600 x g for 5 min and resuspended in fresh 10% DMEM. MEFs (seeded 
at 4 x 104 cells/well in a 24-well plate) used in experiments were from passage one to six while HEp-
2 cells (seeded at 4 x 104 cells/well in a 24-well plate) were from passage six to twelve.  
 
Primary human tonsil epithelial cells (HTEpiC) were purchased from Sciencell ResearchTM 
Laboratories (#2560). HTEpiC cells are maintained in tonsil epithelial cell medium (TEpiCM) (2561, 
Sciencell) supplemented with 1% tonsil epithelial cell growth supplement (TEpiCGS) (2572, 
Sciencell) and cultured at 37°C, 5% CO2. HTEpiC cells used in this thesis were isolated from tonsil 
explants of an individual donor (No. 10474, 10-year-old, male, caucasian) and consist of 
heterogeneous populations of stratified squamous and reticulated epithelial cells.  
 
For seeding of HTEpiC for experiments, cells were first washed twice with DPBS followed by 
addition of trypsin mix (appendix I - cell culture medium) at 37°C, 5% CO2, repeated until most 
cells were visibly detached from the flask. Following this, cells were collected in trypsin 
neutralization buffer (appendix I - cell culture medium), centrifuged at 600 x g for 5 min and 
resuspended in fresh TEpiCM for seeding in pre-coated poly-L-lysine, 0.01% solution (P4707, 
Sigma-Aldrich®; prepared as 30 ul poly-L-lysine in 10 ml distilled water) flasks/plates. HTEpiC cells 
(seeded at 4 x 104 cells/well in a 24-well plate) used for experiments were from passage two to six, 
with replacement of fresh TEpiCM every two to three days. 
 
2.3 DNA constructs and cell transfection 
 
Plasmid deoxyribonucleic acid (DNA) containing GFP-tagged PTRF, YFP-tagged caveolin-1 and 
mCherry-PTRF (Tillu et al., 2015) were supplied by the Parton Laboratory at IMB. Plasmid DNA 
was purified from E. coli using the NucleoBond® Xtra plasmid purification kit/Midiprep (740410, 
Macherey-Nagel) as per manufacturer’s instructions. Briefly, E. coli cultures grown overnight were 
centrifuged at maximum speed for 15 min, supernatant discarded and cell pellet resuspended in 8 ml 
of resuspension buffer RES + RNase A by vortexing. Eight ml of lysis buffer was added for 5 min at 
room temperature followed by 8 ml neutralization buffer. The lysate was then immediately transferred 
to a pre-equilibrated (12 ml equilibration buffer Nucleobond® Xtra column filter and solution 
allowed to flow through. The column was then washed with 5 ml equilibration buffer, 8 ml wash 
buffer and DNA eluted in 5 ml of elution buffer. Room temperature isopropanol (3.5 ml) was then 
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added to the eluted plasmid DNA. Following that, DNA was centrifuged at maximum speed for 30 
min at 4ºC to remove supernatant and then resuspended in 2 ml room temperature 70% ethanol, re-
centrifuged at maximum speed for 5 min at room temperature, supernatant removed and pellet air 
dried. Finally, plasmid DNA was dissolved in sterile distilled water. Plasmid yield and integrity 
determined by ultraviolet (UV) spectrophotometry and agarose gel electrophoresis.  
 
Plasmid DNA was transfected into HEp-2 cells using the Lipofectamine® 2000 Transfection Reagent 
(11668-019, Thermo Fisher Scientific) according to manufacturer’s protocol. Briefly, cells were 
seeded and allowed to grow to 70 - 90% confluent. On day of transfection, for each sample (one well 
in 24-well plate), the following reagents were mixed and incubated for 5 min at room temperature.  
 
Tube 1: 0.7 µg of plasmid DNA : 50 µl Opti-MEM (31985-070, Gibco®) 
Tube 2: 2 µl Lipofectamine 2000 : 50 µl Opti-MEM 
 
Both tubes were mixed and incubated for 20 min at room temperature. 100 µl of this mixture was 
then added to each well (24-well plate) for 3 hours at 37ºC.  
 
For transient transfection of siRNA into HEp-2 cells, Lipofectamine® 3000 Transfection reagent 
(L3000008, Thermo Fisher Scientific) was utilized as per described above with the following 
dilutions and modifications.  
 
Per sample (one well in 6-well plate): 
 
Tube 1: 7.5 - 15 µg of siRNA  : 250 µl Opti-MEM 
Tube 2:  8 - 10 µl Lipofectamine 3000 : 250 µl Opti-MEM 
 
On the day of transfection, Lipofectamine/siRNA mixture was allowed to remain in the media 
(DMEM + 10% FBS or Opti-MEM as per noted in the figures) overnight at 37ºC. The next day, the 
transfection process was repeated and incubated overnight as per described above. Cells were then 
passaged and allowed to grow for another 6 - 24 h before assaying knockdown efficiency and use in 
experiments.  
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2.4 Antibodies 
 
For western immunoblot analyses, primary antibodies used were rabbit monoclonal antibody (mAb) 
against caveolin-1 (3267S, Cell signaling technology®), rabbit pAb against caveolin-1 (N-20) (sc-
894, Santa Cruz Biotechnology, Inc), rabbit pAb against PTRF (HPA049838, Sigma-Aldrich®), 
rabbit mAb against GAPDH (14C10) (2118S, Cell signaling technology®) and rabbit pAb against 
GAPDH/G3PDH (2275-PC-100, R & D Systems®). 
 
Secondary antibodies used for western blots were IRDye® 800CW goat anti rabbit IgG (926-32211, 
LI-COR®), IRDye® 680LT goat anti rabbit IgG (926-68021, LI-COR®), Anti-rabbit IgG (H+L) 
DyLight™ 680 Conjugate (5366, Cell Signaling Technology®) and Anti-rabbit IgG (H+L) DyLight™ 
800 4X PEG Conjugate (5151, Cell Signaling Technology®).  
 
For immunofluorescence microscopy, the primary antibodies used were rabbit pAb against Group A 
Streptococcus carbohydrate (PAB13831, Abnova) and mouse mAb against CAV1 (ab17052, abcam). 
For quantitation of invasion, primary antibodies were directly labelled to prevent cross reactivity 
between antibodies and non-specific binding of GAS to rabbit antigens. Antibody labelling kits used 
were APEXTM Alexa Fluor® 647 Antibody labelling kit (A10475, Life Technologies), APEXTM 
Alexa Fluor® 555 Antibody labelling kit (A10470, Life Technologies) and APEXTM Biotin-XX 
Antibody labelling kit (A10495, Life Technologies). 
 
Secondary antibodies used for immunofluorescence included Alexa Fluor® 488, 555 and 647 
fluorophore-conjugated goat anti-rabbit IgG (H+L) or goat anti-mouse IgG (H+L) antibodies 
(Thermo Fisher Scientific) and Alexa Fluor® 488 Streptavidin (S32354, Life Technologies).  
 
2.5 Preparation of cell lysates 
 
MEFs and HEp-2 cells were cultivated in T75 tissue culture flasks (Greiner Bio-One) to confluent 
monolayers and whole-cell lysates prepared by lysis of cells using lysis buffer (50 mM Tris pH 7.4, 
150 mM NaCl, 1% NP-40, cOmplete™ EDTA-free protease inhibitor (11873580001, Roche), and 
phosphatase inhibitor (PhosSTOP; 04906845001, Roche)) in DPBS. Cell lysates were passed through 
a 23-gauge needle (NN*2325RL, Terumo®) 10 times, and then centrifuged at 5,000 x g for 5 min at 
4°C to remove insoluble materials. After centrifugation, the supernatant was collected and dialyzed 
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against DPBS. The concentrations of protein in resulting samples were measured using a 
Bicinchoninic Acid (BCA) assay. 
 
2.6 BCA protein concentration measurement 
 
The protein concentration of each cell lysate collected was measured using the BCA Protein Assay 
Kit according to manufacturer’s protocol (Sigma-Aldrich, BCA1 and B9643). This kit contains two 
parts: Reagent A (consisting of BCA, sodium carbonate, sodium tartrate and sodium bicarbonate in 
0.1 N NaOH at a final pH of 11.25) and Reagent B (consisting of 4% (w/v) copper (II) sulphate 
pentahydrate). The BCA working reagent was prepared by mixing 8 parts of Reagent A with 1 part 
of Reagent B. In the BCA assay, a range of BCA protein standards (0 - 1000 µg/ml) were prepared 
in the same buffer as the experimental samples (either cell lysis buffer or DPBS) and loaded onto 96-
well plates along with the experimental cell lysates (25 µl per well). 200 µl of BCA working solution 
was then added to each well and plate incubated at 37ºC for 30 min before measuring absorbance at 
560 nm (SpectraMax Plus 384 Microplate reader). A standard curve was plotted using bovine serum 
albumin (BSA) protein standards. This standard curve was used to interpolate absorbance values to 
estimate protein concentration of the cell lysates.  
 
2.7 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE was performed using the mini-PROTEAN Electrophoresis system (Bio-Rad 
Laboratories, Inc.)  as previously described (Laemmli, 1970). Approximately 10 µg of protein sample 
mixed with 1X SDS-PAGE loading buffer and 0.1 M dithiothreitol (DTT) was boiled for 10 min at 
95°C, then loaded onto an SDS-polyacrylamide gel (12% or 15% resolving gel and 4% stacking gel; 
appendix) and electrophoresed at 120 V for approximately 90 min. PageRuler Protein ladder (26616, 
ThermoScientific) was used as a molecular mass standard. 
 
2.8 Western immunoblot analysis 
 
2.8.1 Transfer 
 
Proteins resolved on SDS-PAGE gels were transferred onto Immobilon-FL Polyvinylidene difluoride 
(PVDF) membranes (IPFL00010, Merck Millipore). Membranes were equilibrated with the 
following solutions before use: 100% methanol for 2 min, 1X phosphate buffered saline (PBS) for 2 
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min, and 1X Transfer buffer (20% methanol, 30.3 g/l tris, 144 g/l glycine) for 2 min. The transfer was 
prepared as a ‘sandwich’ containing fibre pads, blotting paper, unstained SDS-polyacrylamide gel, 
and PVDF membrane (Fig. 2.1). Transfer was performed at 100 V for 60 min at 4°C using a Mini-
Trans-Blot Cell (Bio-Rad Laboratories, Inc.). 
 
 
 
Figure 2.1 Schematic diagram showing gel sandwich arrangement of protein transfer from SDS-PAGE 
gel to Immobilon-FL PVDF membrane. The sandwich was constructed using a gel holder cassette starting 
on the black side with fiber pad, blotting paper and SDS-PAGE gel. Any air bubbles were removed using a 
pre-wetted glass pipette. Following which, pre-equilibrated Immobilon-FL PVDF membrane, a second 
blotting paper and fiber pad were stacked above the SDS-PAGE gel in this order. The constructed sandwich 
was closed and placed into the modular electrode assembly with the black side of the cassette facing the black 
negative electrode of the assembly.  
 
2.8.2 Detection 
 
After protein transfer, the membrane was rinsed with 1X PBS (E404, amresco®; made up in reverse 
osmosis water) and allowed to dry at room temperature for 2 h. Next, the membrane was pre-wetted 
in 100% methanol before blocking with Odyssey® Blocking Buffer (927-4000, Li-Cor®) for 1 h at 
room temperature on a shaker. Bands were visualized by immunoblotting with antibodies described 
earlier. All antibody incubations were performed in Odyssey® Blocking Buffer containing 0.2% 
Tween 20 Biochemica (A1389, 0500, PanReac AppliChem). Membranes were incubated with 
primary antibodies overnight on a roller agitator (BTR5-12V, Ratek) at 4°C and subsequently washed 
three times for 5 min with 1X PBST (1X PBS supplemented with 0.2% Tween 20 Biochemica). 
Membranes were then incubated with secondary antibodies in 0.02% SDS for 1 h at room temperature, 
on a roller, and then washed 3 times x 5 min with 1X PBST and twice with 1X PBS. Finally, 
membranes were air-dried and imaged using an Odyssey CLx Infrared Imaging system (LI-COR®). 
Anti- GAPDH/G3PDH antibody was used as positive and loading control for western blots.  
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2.9 Cell viability assay  
 
2.9.1 Non-radioactive cytotoxicity assay  
 
Host cell viability was measured using the CytoTox 96 Non-Radioactive Cytotoxicity assay kit 
according to manufacturer’s protocol (Promega Corporation, G1780). This assay measures 
concentration of the cytosolic enzyme lactate dehydrogenase (LDH) that is released upon cell lysis. 
Briefly, 50 µl of sample supernatant was collected in 96-well plate post experimental treatment. An 
equal volume of CytoTox 96 reagent (1 vial substrate mix + 12 ml assay buffer) was added to each 
well and incubated at 37ºC for 30 min in the dark. 50 µl of Stop solution was then added to the wells 
and absorbance measured at 490 nm using a microplate reader (SpectraMax Plus 384). The intensity 
of colour formed is proportional to the amount of lysed cells, which is a result of enzymatic activity 
between LDH and substrate that converts tetrazolium salt into a red formazan product. A standard 
curve was prepared using supernatant of cells treated with 20% Triton-X100 representing maximum 
cell lysis and culture medium background (DMEM only) representing zero cell lysis. The average 
values of the culture medium background were subtracted from all experimental wells and percentage 
cell viability calculated as follows: 
 
 !"#$"%&'("	$*&+&+,-$-&*	(%) 	= 	2,3"#-4"%&'5	67	490;',-4<4	67	490 	,	100 
 
 
2.9.2 Trypan blue exclusion assay 
 
A second method used to determine number of viable cells was the trypan blue exclusion assay. Non-
viable cells take up blue dye whereas viable cells remain unstained. In this assay, 100 µl of 0.4% 
trypan blue (15250061, Thermo Fisher Scientific) was mixed with 1 ml of cells and loaded onto a 
hemocytometer. The number of viable (white) vs non-viable cells (blue) were counted under a 
microscope and percentage viable cells calculated as the following:   
 
 !"#$"%&'("	>-'?5"	$"55@	 % = 	 A<4?"#	+B	%+%−?5<"	$"55@A<4?"#	+B	?5<"	'%D	%+%−?5<"	$"55@ 		, 100 
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2.10 Gentamicin protection assay 
 
Gentamicin protection assays were used to estimate GAS adhesion and invasion as previously 
described (Conrad et al., 2007), with the exception that penicillin G was omitted as it has been shown 
to kill cytosolic GAS (Barnett et al., 2013). MEFs or HEp-2 cells were seeded onto 24-well plates 
(Greiner Bio-One) at a concentration of 4.0 x 104 cells per well in antibiotic-free DMEM containing 
10% FBS and and cultured for 48 h to confluency. Two sets of cells were prepared for each 
experiment, one for determination of total cell-associated bacteria, and one treated with gentamicin 
for determination of intracellular bacteria. 
 
On the day of experiment, cells were incubated with DMEM containing 1% FBS for 30 min before 
the start of infection. GAS strains were grown in THY broth to early stationary phase (OD600 =1.1 - 
1.4, determined through a growth curve; appendix II Fig. S2.1), harvested by centrifugation and 
washed once with DPBS. The bacteria were then diluted in DMEM containing 1% FBS and cells 
infected at a multiplicity of infection (MOI) of 1. Each plate was centrifuged at 200 x g for 5 min and 
incubated for 2 h (or the indicated duration for time course assays) at 37°C, 5% CO2. After incubation, 
cells from the gentamicin treatment were washed once with DMEM containing 10% FBS and treated 
with DMEM containing 10% FBS supplemented with 100 µg/ml of gentamicin solution (G1272, 
Sigma-Aldrich®; appendix II Fig. S2.2) for a further 2 h. Gentamicin kills extracellular bacteria and 
is unable to penetrate host cell membranes (Medina et al., 2002), leaving only intracellular bacteria 
viable. After the appropriate treatments, all cells were washed four times with DPBS, trypsinized 
with 200 µl of 0.05% Trypsin-EDTA 1X (25300, Gibco®) and lysed with 0.025% TritonTM X-100 
(T8787, Sigma-Aldrich®). The resulting supernatants were serially diluted and plated onto THY agar 
(THYA) supplemented with 0.2% yeast extract to enumerate intracellular bacteria counts (colony 
forming units, CFUs) (appendix II Fig. S2.3). Invasion was calculated as the percentage CFUs of 
intracellular bacteria (gentamicin-treated plate) over total amount of cell-associated bacteria (non 
gentamicin-treated plate).   
 
2.11 Survival assay 
 
Survival assays were performed as per gentamicin protection assay described in the section above, 
with a modification to the duration of gentamicin treatment post infection to estimate GAS 
intracellular survival. Cells were infected with GAS for 2 h followed by an additional 2, 4 or 6 h of 
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gentamicin treatment instead of the usual 2 h. Survival was calculated as a relative ratio of CFUs 
obtained at 2, 4, and 6 h post gentamicin treatment over CFUs at the 2 h post gentamicin time point.  
 
2.12 Flow cytometry  
 
Flow cytometry was used to differentiate populations of mCherry-CAV1-transfected HEp-2 cells 
according to their levels of CAV1 expression. WT HEp-2 cells were seeded in T75 flasks until 70% 
confluent and transfected with mCherry-CAV1 as described in section 2.3. Post transfection, cell 
media was aspirated and cells washed with 13 ml DPBS. Cells were then trypsinized at 37°C for 5 - 
10 min, deactivated with 20 ml DMEM supplemented with 10% FBS and collected in 50 ml Falcon 
tubes. These cells were centrifuged at 1200 x g for 5 min at room temperature, and cell pellets 
resuspended in 10 ml DPS. This step was repeated twice before finally resuspending cells in 3 ml 
DPBS and passed through a syringe into a fresh Fluorescent-activated cell sorting (FACS) tube. The 
prepared samples were two-way sorted (based on cell size and fluorescent intensity of mCherry 
expression, peak absorption/emission = 561 nm/605 - 640 nm) using a BD Influx Cell Sorter System 
at the Flow Cytometry facility, Queensland Brain Institute (QBI), UQ. Sorted cell samples were 
collected in 2 ml DMEM supplemented with 10% FBS and Penicillin + Streptomycin (1:100). Data 
was analyzed using BD FACS™ Sortware. Sorted HEp-2 cells with medium level (101 - 102 events) 
of CAV1 expression were seeded onto glass coverslips until confluent and infected with Calcein-
acetoxymethyl (AM) (C3100MP, Thermo Fisher Scientific Inc.) -tagged M1T15448 as described in 
section 2.13.  
 
2.13 Confocal immunofluorescence microscopy 
 
On the day of the experiment, GAS was grown to OD600 ~ 0.3, centrifuged at 5000 x g for 5 min, and 
then resuspended in 500 µl 10% THY broth. Calcein-AM was used to stain GAS to eliminate cross-
staining reactions between the different antibodies. Modification of carboxylic acids of the AM ester 
groups allows these molecules to permeate into GAS cells, where the AM ester is hydrolyzed to 
produce a green fluorescence. Stationary phase (OD600 ≈1.1 - 1.4) GAS were incubated with 50 µM 
of Calcein-AM for 1 h at 37 ºC, centrifuged at 5000 x g for 5 min and resuspended in 3 ml DPBS.  
 
For co-localization studies, HEp-2 cells seeded onto coverslips were infected with Calcein-AM-
tagged GAS for 5, 10, 60 and 120 min as described in section 2.10. At each timepoint, cells were 
washed with DPBS three times and fixed in 4% paraformaldehyde (PFA; 157-4, Electron Microscopy 
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Sciences) for 20 min at room temperature. Samples were then washed twice with DPBS, 
permeabilized with 0.01% Saponin (47036, Sigma-Aldrich) for 10 min, followed by treatment with 
50 mM NH4Cl for 10 min. After this, samples were incubated in blocking buffer (0.1% BSA (A7906, 
Sigma-Aldrich) + 0.1% fish skin gelatin (G7765, Sigma-Aldrich)) for 30 min followed by incubation 
with primary antibody for 1 h and secondary antibody for 30 min. Antibody incubations were 
performed in blocking buffer. Processed samples were mounted onto glass slides with 5 µl DAKO 
fluorescent mounting medium (S3023, Agilent Technologies) and imaged. All confocal 
immunofluorescence microscopy incubations were performed at room temperature.  
 
For quantification of GAS invasion, HEp-2 cells were seeded onto coverslips, infected with untagged 
GAS and processed as described in the paragraph above. Extracellular GAS were first stained with 
Alexa Fluor 647-conjugated rabbit pAb GAS antibody, followed by permeabilization and staining of 
intracellular GAS with Alexa Fluor 555-conjugated rabbit pAb anti-GAS. GAS invasion was 
calculated by dividing the number of Alexa Fluor 555-stained GAS with the total number of GAS 
(Alexa Fluor 647 and Alexa Fluor 555-stained). At least 360 (120 per replicate) GAS chains were 
scored from three independent experiments. All immunofluorescence samples were imaged on 
confocal microscope (Zeiss LSM 710 upright or Zeiss LSM 710 FCCS; Plan-Apochromat 63x/1.4 
Oil DIC M27 objective) using the ZEN 2009 microscope and imaging software at the IMB, UQ. 
Confocal Z-stacks were analyzed using the Image J Fiji software package (Schindelin et al., 2012). 
 
2.14 Transmission electron microscopy (TEM) 
 
For TEM analysis, HEp-2 cells were seeded onto coverslips and infected with GAS as described 
above at a MOI of 100. At 5, 10, 60 and 120 min post-infection, cells were washed in excess DPBS 
three times (10 min per wash). Washed cells were fixed in either 2.5% glutaraldehyde (002, 
ProSciTech) or 2.5% glutaraldehyde with 1 mg/ml ruthenium red (075, ProSciTech) in PBS for 1 h 
at room temperature as described previously (Parton et al., 2002). Coverslips were subsequently 
processed for TEM by Charles Ferguson (IMB) as follows. Following a second fixation with osmium 
tetroxide, samples were dehydrated in a series of ethanol concentrations and embedded in LX112 
resin followed by polymerization at 60°C overnight. Ultrathin sections (60 nm) were then prepared 
using a Leica UC6 microtome and imaged using a JEOL1011 electron microscope at 80 kV. All TEM 
imaging was performed by Professor Robert Parton at The Centre for Microscopy and Microanalysis 
(the Queensland Node of the Australian Microscopy and Microanalysis Research Facility).  
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2.15 Statistical analysis  
 
All data presented are from three independent replicates unless otherwise stated, and error bars were 
calculated as mean ± standard error of the mean (SEM). Statistical analyses were performed using 
Microsoft Excel and Graph Pad Prism 7 software (t-test or ANOVA) to calculate p-values. The p- 
value threshold for rejecting the null hypothesis was set at p<0.05.  
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3. Investigation of the role of CAV1 in the uptake of Streptococcus 
pyogenes into non-phagocytic host cells 
 
3.1 Introduction 
 
GAS is able to invade various eukaryotic cell types (Molinari et al., 2000; Cywes and Wessels, 2001; 
Amelung et al., 2011; Siemens et al., 2011) via different uptake mechanisms (Cunningham, 2000; 
Molinari et al., 2000; Rohde et al., 2003; see Chapter 1). Successful cellular internalization of GAS 
is thought to be important for evading host immune responses and/or antibiotic therapy (Gastanaduy 
et al., 1980; Gillespie, 1998; Medina et al., 2003; Passàli et al., 2007; Barnett et al., 2013). In recent 
years, studies into caveolae-mediated endocytosis have revealed that caveolae not only facilitate the 
uptake of various macromolecules and pathogens (Gatfield and Pieters, 2000; Shin et al., 2001; 
Duncan et al., 2004; Zaas et al., 2009), but also protect host cells against pathogen infection and 
inflammation (Boettcher et al., 2010; Hoffman et al., 2010; Hitkova et al., 2013). In these studies, 
the caveolae scaffolding protein CAV1 has been heavily implicated as the main regulator of the 
endocytic process.  
 
The most well characterized GAS invasion pathway begins with the formation of a fibronectin cross-
bridge linking GAS to host α5β1 integrins (Dombek et al., 1999; Molinari et al., 2000). Following 
this, it was suggested that some GAS strains recruit host caveolae to gain entry into host cells (Rohde 
et al., 2003). In that study, invading GAS were found to co-localize with host caveolae during 
internalization, and pharmacological disruption of host cholesterol to simulate loss of caveolae 
resulted in decreased invasion (Rohde et al., 2003). However, the mechanism by which caveolae 
facilitates GAS internalization was not described.  
 
Here, we examined the effects of loss of the caveolae component protein CAV1 on GAS invasion 
using gene knockout and RNA interference approaches in model cell lines. Rather than being required 
for invasion, we found that the loss of CAV1 dramatically increased GAS invasion into human 
epithelial cells. In addition, we extensively analyzed the GAS invasion process using quantitative 
electron microscopy, from which we observed no significant association of invading bacteria with 
caveolae in both model cell lines and primary human tonsil epithelial cells. Our results suggest that 
CAV1 protects human epithelial HEp-2 cells against GAS invasion and this protective effect occurs 
via a caveola-independent mechanism.  
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3.2 Results 
 
3.2.1 GAS invasion into CAV1-deficient MEFs 
 
A previous study suggested that GAS invade epithelial cells via caveolae based on observations that 
invading GAS co-localized with CAV1 and caveolae, and cholesterol-depleting pharmacological 
agents reduced GAS internalization (Rohde et al., 2003). Since the use of cholesterol-depleting agents 
to disrupt caveolae may cause off target effects (Rodal et al., 1999; Liu et al., 2002), we chose to use 
CAV1 knockout (CAV1-/-) MEFs to investigate the role of caveolae during GAS invasion (Fig. 3.1). 
Firstly, CAV1 knockout in these fibroblasts was confirmed using western immunoblots, in which we 
also observed a slight reduction in cavin-1/PTRF expression relative to WT cells (Fig. 3.1A). We 
then assayed invasion using the clinically-important GAS serotype M1T1 strain 5448 (hereafter 
termed M1T15448) and a laboratory adapted GAS M6 strain JRS4 (hereafter termed M6JRS4). GAS 
internalization was measured using a gentamicin protection assay, in which CFUs were quantified 
following gentamicin treatment to kill extracellular bacteria. The proportion of intracellular GAS in 
CAV1-/- MEFs post infection was significantly higher compared to WT MEFs for both M1T15448 
(p<0.01, Fig. 3.1B) and M6JRS4 (p<0.001, Fig. 3.1B). These results suggest that the presence of CAV1 
restricts internalization of GAS into MEFs. 
 
 
 
 
Figure 3.1 Invasion of GAS strains M1T15448 and M6JRS4 into WT and CAV1-/- MEFs. (A) Western 
immunoblot of CAV1 and PTRF protein expression levels in WT and CAV1-/- MEFs. (B) Invasion of GAS 
strains M1T15448 and M6JRS4 into WT and CAV1-/- MEFs. Data represented as mean ± SEM, **p<0.01. 
***p<0.001, n=3. 
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3.2.2 GAS invasion into CAV1-deficient HEp-2 cells 
 
In view of the striking effect loss of CAV1 had on GAS invasion into MEFs, we extended our studies 
to human epithelial HEp-2 cells, a cell model commonly used for GAS invasion studies (Rohde et al., 
2003; Amelung et al., 2011; Barnett et al., 2013; see section 2.2 and appendix III Table S2.1 for 
genotypic characterization of this HeLa-like cell line; Chen, 1988). HEp-2 cells stably transfected 
with plasmids encoding shRNA against CAV1 (hereafter termed shCAV1) or a non-targeting 
scrambled shRNA (hereafter termed shScr) were generated as described in section 2.2 (Madaro et al., 
2013). The efficiency of CAV1 silencing was assessed and confirmed using western immunoblots, 
as observed by the reduction in intensity of the 25 kDa molecular weight band in shCAV1 HEp-2 
compared to WT and shScr HEp-2 cells (Fig. 3.2B). We then performed a gentamicin protection 
assay using these shCAV1 HEp-2 cells, in which it was observed that while M1T15448 adhered to WT, 
shCAV1 and shScr HEp-2 cells with equal efficiency (p>0.05, Fig. 3.2A), invasion of M1T15448 into 
shCAV1 HEp-2 was significantly higher compared to WT and shScr cells (p<0.01, Fig. 3.2C and Fig. 
3.2D). GAS infection of HEp-2 cells did not alter CAV1 expression (Fig. 3.3A) or host cell viability 
(Fig. 3.3B - C), indicating that the loss of CAV1 was likely responsible for the increased GAS 
invasion into shCAV1 HEp-2 cells.  
 
To rule out off-target effects associated with the knockdown of CAV1 that may have influenced GAS 
invasion, we transfected shCAV1 HEp-2 cells with plasmid DNA encoding the CAV1 gene product 
translationally fused to yellow fluorescent protein (YFP-CAV1) and investigated M1T15448 invasion 
into these cells. Complementation with YFP-CAV1 reduced the susceptibility of shCAV1 HEp-2 
cells to GAS invasion, such that invasion levels were similar to WT HEp-2 (p>0.05, Fig. 3.2C) 
despite the low levels of YFP-CAV1 expression (appendix III Fig. S3.1). To determine whether 
increased CAV1 expression relative to WT levels also affect M1T15448 invasion, we over-expressed 
CAV1 in WT HEp-2 cells by transfection with YFP-CAV1 and used these transfected cells in a 
gentamicin protection assay with M1T15448. Overexpression of YFP-CAV1 resulted in a significant 
reduction in intracellular GAS compared to WT (p<0.0001, Fig. 3.2C), indicating that increased 
CAV1 levels inhibit GAS invasion into HEp-2 cells. 
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Figure 3.2 M1T15448 invasion into HEp-2 cells. (A) Proportion of M1T15448 adhered to WT, shCAV1 and 
shScr HEp-2 cells. Adherence was measured as a percentage of surface-attached GAS over the total amount 
of GAS inoculated. Data represented as mean ± SEM, p>0.05; n=3. (B) Western immunoblot of CAV1 and 
PTRF expression levels in WT HEp-2 cells and derivatives. (C) M1T15448 invasion into WT HEp-2 cells and 
derivatives. Data represented as mean ± SEM, *p<0.05, ***p<0.001; n=3. (D) Time course (1, 2 and 3 h) of 
M1T15448 invasion into WT, shCAV1 and shScr HEp-2 cells quantified by gentamicin protection assay. Data 
represented as mean ± SEM, **p<0.01, ***p<0.001, n=3. 
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Figure 3.3 CAV1 expression and cell viability during M1T15448 infection of HEp-2 cells. (A) Western 
immunoblot of CAV1 expression levels in uninfected vs. infected HEp-2 cells. (B) Viability of uninfected and 
(C) infected WT, shCAV1 and shScr HEp-2 cells measured using a Trypan blue exclusion assay. Data 
represented as mean ± SEM, p>0.05, n=2.  
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3.2.3 Survival of GAS in CAV1-deficient HEp-2 cells 
 
We inferred that the increased proportion of intracellular GAS in shCAV1 HEp-2 compared to WT 
(Fig. 3.3) could be due to increased susceptibility to GAS invasion or decreased intracellular bacterial 
clearance leading to enhanced GAS intracellular survival. In order to differentiate between these two 
factors, we performed a survival assay to investigate whether intracellular GAS survival was 
improved in shCAV1 HEp-2 cells relative to WT. Survival was measured as proportion of 
intracellular GAS at 2, 4, and 6 h post gentamicin treatment relative to the initial 2 h time point. GAS 
showed better survival in WT HEp-2 cells relative to shCAV1 and shScr (Fig. 3.4), indicating that 
the ability of GAS to survive within HEp-2 cells was not improved by the loss of CAV1. This result 
supports the inference that the increased intracellular GAS CFU counts in shCAV1 HEp-2 cells is 
due to enhanced GAS uptake.  
 
 
 
 
Figure 3.4 Relative survival of M1T15448 in HEp-2 cells. HEp-2 cells were infected with M1T15448 for 2 h 
followed by an additional 2, 4 or 6 h of gentamicin treatment. Survival was calculated as a relative ratio of 
CFUs obtained at 2, 4, and 6 h post gentamicin treatment over CFUs of initial 2 h time point. Data represented 
as mean ± SEM, ****p<0.0001, n=3.  
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3.2.4 Visualizing interactions between GAS and CAV1 in HEp-2 cells using 
immunofluorescence microscopy 
 
To rule out differences in the viability of GAS between treatments and/or experiments that may have 
influenced CFU counts, we also examined the proportion of intracellular GAS in both WT and 
shCAV1 HEp-2 cells using immunofluorescence microscopy (Fig. 3.5). Consistent with GAS 
adherence values derived from CFU counts (Fig. 3.2C and Fig. 3.2D), immunofluorescence images 
showed that GAS adhered to WT, shCAV1 and shScr HEp-2 cells with similar efficiency (p>0.05, 
Fig. 3.5C), and also indicated increased intracellular GAS in shCAV1 HEp-2 cells compared to WT 
and shScr HEp-2 cells (p<0.01, Fig. 3.5D). To investigate whether this protective effect required 
physical interaction between CAV1 and invading GAS, we used confocal fluorescence microscopy 
to examine whether CAV1 co-localized with GAS during the invasion process. WT HEp-2 cells were 
infected with calcein-AM-tagged M1T15448 for 5, 10, 60 and 120 min, fixed and visualized using 
confocal fluorescence microscopy (Fig. 3.6 and Table 3.1). CAV1 did not accumulate around the 
entire periphery of invading GAS (Fig. 3.6) as previously described by Rohde and colleagues (2003), 
which may be attributed to the non-specific binding of GAS to rabbit antibodies used in that study to 
tag CAV1 (see Fig. 3.5B). We observed random associations between invading GAS and individual 
CAV1 puncta (appendix III Fig. S3.2A - C) which we termed ‘mosaic’-type association (1 - 2 puncta 
in association per GAS) or partial association (>2 puncta in association per GAS) (Table 3.1 and 
appendix III Fig. S3.2A - C). While no clear associations between GAS and CAV1 were recorded at 
very early time points (5 - 10 min), there were associations between GAS and individual CAV1 
puncta at 60 min (8.33% partial association, 15.03% ‘mosaic’ association, p<0.001) and 120 min post 
infection (5.95% partial association, 17.28% ‘mosaic’ association, p<0.001; Table 3.1). In shCAV1 
HEp-2 cells, there was no staining of CAV1 (appendix III Fig. S3.2D) indicating that antibody 
staining of CAV1 in WT HEp-2 cells was specific to CAV1. To further exclude the possibility of 
cross staining between antibodies, WT HEp-2 cells were transfected with mCherry-tagged-CAV1, 
flow sorted to obtain a population of cells with medium level of mCherry expression (see section 
2.12) and then infected with calcein-AM-tagged GAS for 2 h (Fig. 3.7). Similar to results obtained 
from immunofluorescence microscopy, no obvious accumulation or association of CAV1 was 
observed with invading GAS (Fig. 3.7 and appendix III Fig. S3.3). Taken together, these findings 
suggest that any associations between invading GAS and CAV1 are unlikely to be specific. 
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Figure 3.5 Assessment of interaction of host CAV1 and invading M1T15448 by immunofluorescence 
microscopy analysis. (A) Representative immunofluorescence image used for quantification of GAS invasion. 
Extracellular cell-associated GAS (cyan) and intracellular GAS (red) were differentiated by staining with 
different Alexa Fluor®-conjugated GAS antibodies. GAS stained both cyan and red were scored as invading 
bacteria (arrow). (B) Representative immunofluorescence image showing non-specific binding of anti-rabbit 
antibody by GAS. WT HEp-2 cells were infected with M1T15448 and stained with Alexa Fluor® 488 goat anti-
rabbit antibody only. Scale bar = 50 nm. (C) Total cell associated M1T15448 in HEp-2 cells. Data obtained by 
scoring at least 140 bacteria chains from three independent experiments. Data represented as mean ± SEM, 
p>0.05; n =3. (D) M1T15448 invasion into HEp-2 cells. Invasion was calculated by taking the number of 
intracellular bacteria divided by the total amount of bacteria scored within the same plane. Data obtained by 
scoring at least 140 bacteria chains from three independent experiments. Data represented as mean ± SEM, 
**p<0.01, n=3.   
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Figure 3.6 Association of host CAV1 and invading M1T15448 by immunofluorescence microscopy 
analysis. Representative immunofluorescence images showing interaction between CAV1 (red) and M1T15448 
(green) at 5, 10, 60 and 120 min (top to bottom) post infection in WT HEp-2 cells. From left to right: panels 1 
to 3 are single confocal slices where the bacteria appear on the cell, panel 4 is the maximum projection of the 
same plane of view. Arrows indicate invading GAS while inset is a zoomed-in image of the invading bacteria. 
Images presented are representative images from three independent experiments. Scale bar = 10 µm.  
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Table 3.1 Percentage association of invading M1T15448 with host CAV1, quantified by immunofluorescence 
microscopy 
 
a Association was calculated as a percentage of each cocci chain scored at random that was either in association 
with host CAV1 in a “mosaic” or partial pattern (see appendix III Fig. S3.2)  
b Time post infection 
c “Mosaic” association = 1 - 2 individual puncta, partial association = >2 individual puncta 
 
 
 
 
 
Figure 3.7 Association of Invading M1T15448 with host CAV1. A single confocal immunofluorescence 
microscopy slice showing localization of invading M1T15448 (green) and host CAV1 (mCherry-red). Imaged 
was obtained by transfecting WT HEp-2 cells with mCherry-tagged CAV1, flow sorted to obtain population 
of cells expressing homeostatic levels of CAV1 and then infected with calcein-AM-tagged M1T15448. Exact 
procedure is described in section 2.12. Image shown is representative of three independent experiments. White 
arrows indicate invading GAS. Scale bar = 10 µm.  
 
 
 
 
 
 
± SEM
Typeᶜ 5-10 minᵇ 60 minᵇ 120 minᵇ
"Mosaic" 0.00 ± 0.00 15.03 ± 1.63 17.28 ± 2.99
Partial 0.00 ± 0.00 8.33 ± 0.00 5.95 ± 1.27
Association (%)ᵃ
mCherry-CAV1 Calcein-AM labelled GAS Merged YZ
XZ
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3.2.5 Visualizing interactions between GAS and CAV1 in HEp-2 cells using TEM 
 
Since it is difficult to resolve caveolae (60 - 80 nm diameter) using immunofluorescence microscopy, 
we proceeded to characterize the GAS invasion process using TEM. WT and shCAV1 HEp-2 cells 
were infected with M1T15448 at a MOI of 100 in order to increase the chances of observing GAS 
associated with the ultrastructure of HEp-2 cells. Optimization experiments were performed to ensure 
that viability of HEp-2 cells was not compromised (Fig. 3.8A), and an invasion assay was conducted 
to show that GAS invasion characteristics were comparable to previous invasion assays under these 
new experimental conditions (Fig. 3.8B). At 5, 10, 60 and 120 min post-infection, cells were fixed 
and ultrathin sections were processed for TEM (Fig. 3.9 - 3.10 and appendix III Fig. S3.4). GAS were 
readily recognizable by their characteristic morphology, often observed as chains of bacteria (see 
appendix III Fig. S3.4). 
 
 
 
 
Figure 3.8 Optimization of M1T15448 infection of HEp-2 cells conditions for TEM. (A) Viability of HEp-
2 cells infected with M1T15448 at MOI 100. Viability measured by Trypan blue exclusion assay. Data 
represented as mean ± SEM, p>0.05, n=1. (B) Invasion of M1T15448 into HEp-2 cells at MOI 100. n=1. 
 
 
At 5 to 10 min post infection, invading GAS in both WT and shCAV1 cells were predominantly 
associated with host filopodia (56.5% in WT, 57.8% in shCAV1; Fig. 3.9A) or featureless PM (38.1% 
in WT, 40.2% in shCAV1; Fig. 3.9B). Although caveolae were locally abundant in these cells (see 
Fig. 3.10.1F), the areas of the PM targeted by invading GAS rarely showed any specific association 
with caveolae (Fig. 3.10.1 and Table 3.2). These images also clearly demonstrate the size contrast 
between caveolae (approximately 65 nm diameter) compared to GAS (600 - 800 nm diameter). 
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Table 3.2 Percentage association of invading M1T15448 with host caveolae, quantified by TEM 
 
a Association was calculated as a percentage of each individual cocci scored at random that was in association 
with either plasma membrane caveolae or intracellular caveolae 
b Time post infection 
 
 
Analysis of the TEM time course invasion images showed clear association between a population of 
GAS with highly characteristic large invaginations of the HEp-2 cell surface (Fig. 3.9C), which we 
infer to be responsible for the internalization of GAS in HEp-2 cells. Visual examination of these 
invaginations revealed morphologically characteristic structures with accumulation of actin filaments 
at the neck of the invading bacteria (appendix III Fig. S3.4C - D). By one to two hours post infection, 
internalized GAS resided in intracellular vacuoles (Fig. 3.10.3 - 3.10.4) sometimes with internal 
vesicles of endosomal/lysosomal origin (see Fig. 3.10.4D and Fig. 3.10.4H). The enclosing 
membrane frequently showed a wavy morphology (Fig. 3.10.1 - 3.10.4) but only rarely contained 
structures resembling caveola morphology. The morphological similarities of these vacuoles between 
WT and shCAV1 knockdown cells (Fig. 3.10.5) further support that these structures are not caveolae. 
Quantitation of GAS within internal vacuoles in WT and shCAV1 knockdown cells indicated an 
increase in GAS internalization in knockdown cells compared to WT (Fig. 3.9D) which is consistent 
with CFU- and immunofluorescence microscopy- derived intracellular bacteria counts. Taken 
together, these results suggest that the major effect of the loss of CAV1 is on the internalization 
pathway. 
  
Host cell component 5-10 minᵇ 60 minᵇ 120 minᵇ
Plasma membrane caveolae 2.6 2.1 0
Intracellular caveolae 0 4.3 1.4
Association (%)ᵃ
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Figure 3.9 Quantitative assessment of association of M1T15448 with HEp-2 cell components: (A) filopodia, 
(B) flat/featureless PM and (C) membrane invaginations. For all quantification analyses, at least 70 bacteria 
were scored randomly under each condition, and association was counted for each individual cell-associated 
bacterium. Data is represented as the percentage of total cell-associated bacteria at each time point. (D) 
Percentage of intracellular M1T15448 in WT and shCAV1 HEp-2 cells during invasion quantified in TEM 
images. Data is represented as a percentage of individual cocci found within host intracellular compartment. 
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Figure 3.10.1 Ultrastructural TEM analysis of GAS association with WT HEp-2 cells at early time points. 
(A - G) Representative electron micrographs of WT M1T15448 invasion into HEp-2 cells at 5 - 10 min post-
infection. HEp-2 cells were infected with M1T15448 for 5 min (A - E) or 10 min (F - G) at 37°C and then 
processed for electron microscopy. GAS were found predominantly associated with filopodia (B - C) but are 
also observed in close apposition to flat/featureless PM or large PM invaginations (D - G), suggestive of 
engulfment of chains of bacteria. No significant enrichment of caveolae was observed in areas of bacterial 
attachment and engulfment. Caveolae (arrowheads) and clathrin coated pits (double arrows) are indicated. 
Scale bar = 1 µm. 
A B C
D E
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Figure 3.10.2 Ultrastructural TEM analysis of GAS interaction with WT HEp-2 cells at 1 h post-
infection. Representative TEM micrographs of surface bacteria. HEp-2 cells were infected with M1T15448 for 
1 h at 37°C and then processed for electron microscopy. Bacteria are seen associated with filopodia, 
flat/featureless PM and very rarely with areas containing caveolae (arrowhead). PM, plasma membrane. Scale 
bar = 1 µm.  
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Figure 3.10.3 Ultrastructural TEM micrographs of intracellular GAS in WT HEp-2 cells at 1 h post-
infection. Representative TEM micrographs of intracellular bacteria. Experiment and processing were 
performed as per Fig. 3.10.2. Intracellular bacteria were observed in association with loose-fitting vacuoles 
with an irregular outline. Electron-dense coat around the vacuoles are suggestive of actin association. Tubules 
and vesicles were often observed in close proximity or connected to the vacuole. Caveolae (arrowheads) were 
occasionally observed in association with the vacuole. PM, plasma membrane. Scale bar = 1 µm.  
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Figure 3.10.4 Ultrastructural TEM analysis of intracellular GAS in WT HEp-2 cells at 2 h post-infection. 
(A - H) Representative TEM micrographs of HEp-2 cells infected with M1T1
5448
 for 2 h at 37°C. Bacteria 
were found mostly intracellular and predominantly associated with intracellular vacuoles which often 
contained internal vesicles (arrows; Fig. 3.10.4A, E & H). These vacuoles exist in close proximity of the 
endoplasmic reticulum (ER) in some regions. Scale bar = 1 µm. 
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Figure 3.10.5 Ultrastructural TEM characterization of GAS invasion into shCAV1 HEp-2 cells 1 h post-
infection. shCAV1 HEp-2 cells were infected with M1T1
5448
 for 1 h at 37°C and then processed for electron 
microscopy. At the cell surface, bacteria were associated with filopodia and flat PM as observed in WT cells. 
Numerous bacteria were observed in intracellular vacuoles at this time point, with similar features to those in 
WT HEp-2 cells (such as internal vesicles (arrows) and ER association). PM, plasma membrane, N, nucleus, 
ER, endoplasmic reticulum. Scale bar = 1 µm.  
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3.2.6 Invasion characteristics of GAS strain M12A40 into shCAV1 HEp-2 cells 
 
We have shown using the clinically relevant GAS strain M1T15448 that CAV1 plays a protective role 
against GAS invasion. To exclude the possibility that the role of CAV1 varies between GAS serotypes 
and/or strains, we repeated gentamicin protection assays using stationary phase GAS serotype M12 
strain A40 (Fig. 3.11A, hereafter termed M12A40). Similar to strain M1T15448, M12A40 recorded 
increased invasion into shCAV1 HEp-2 cells relative to WT (Fig 3.11B), indicating a protective role 
of CAV1 against GAS infection. It was previously reported that the GAS fibronectin binding protein 
SfbI expressed by M12A40 is required for GAS to interact with caveolae (Rohde et al., 2003), however, 
the comparable invasion characteristics of SfbI negative GAS strain M1T15448 and SfbI positive 
M12A40 into shCAV1 and WT HEp-2 (Fig. 3.11B) indicate that SfbI does not influence the interaction 
of CAV1 and GAS. 
 
 
 
 
 
Figure 3.11 Invasion of Sfb1-expressing GAS into HEp-2 cells. (A) Growth of GAS strains M1T15448 (Sfb1-) 
and M12A40 (Sfb1+) in 0.2% THY broth over time. (B) Invasion of GAS strains M1T15448 (SfbI-) and M12A40 
(SfbI+) into WT and shCAV1 HEp-2 cells, quantified by gentamicin protection assay. Data represented as 
mean ± SEM, **p<0.01, n=3. 
 
  
A
0
20
40
60
80
In
va
si
on
 (%
)
M1T15448
(Sfb1-)
A40
(Sfb1+)
Legend
Legend
Legend
B
WT
shCAV1
shScr
0
20
40
80
In
va
sio
n 
(%
)
M1T15448
(SfbI-)
M12A40
(SfbI+)
60
0 2 4 6 8
0.0
0.5
1.0
1.5
Time (h)
M1T15448
M12A4012A40
154
O
D
60
0
1.5
1.0
0.5
0.0
0 2 4 6 8
Ti e (h)
** **
 57 
3.2.7 Determination of interaction between invading GAS and host caveolae in primary 
human tonsil epithelial cells using TEM 
 
From an epidemiological standpoint, the most common GAS related disease is due to colonization of 
mucus membranes in the throat typically resulting in inflammation of the pharynx. Hence, we used 
primary human tonsil epithelial cells which are the natural target of GAS infection to perform 
ultrastructural analyses of the GAS uptake pathway. As shown in Figure 3.12, the observed 
morphological characteristics during infection were comparable to those in HEp-2 cells (Fig 3.10.1 
– 3.10.4). There was no significant association between GAS and areas of tonsil cell PM enriched in 
caveolae. There were large invaginations on the tonsil cell surface near sites of GAS attachment (Fig. 
3.11B - D), identical to those observed in HEp-2 cells. Thus, we conclude that in both a model cell 
line and in primary human epithelial cells, caveolae do not play a major role in mediating GAS uptake. 
The lack of association with caveolae further suggests that any protective effects of CAV1, i.e. 
inhibition of invasion, are due to indirect effects CAV1 exerts on the PM, and is investigated in 
Chapter 5 of this thesis. 
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Figure 3.12 Ultrastructural TEM analysis of GAS interaction with primary human tonsil epithelial cells. 
(A - F) Representative electron micrograph of HTEpiC infected with M1T15448 for 10 min (A - B) or 1 h (C - 
F) at 37°C. Caveolae (large arrowheads, A) and clathrin coated pits (double arrowheads, A) are abundant. (B 
- F) A gallery of representative images of GAS at various stages of engulfment/trafficking. Significant caveolae 
is absent at sites of GAS adherence or engulfment. PM, plasma membrane. Scale bar = 1 µm unless otherwise 
indicated. Scale bar for panel B = 2 µm. 
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3.3 Discussion 
 
GAS is a versatile human pathogen that has evolved to exploit their host cells’ phagocytic machinery 
to invade, overcome defenses, persist and cause disease (Cunningham, 2000). One widely accepted 
model for GAS invasion is via the engagement of fibronectin to trigger uptake through activation of 
host α5β1 integrins (Molinari et al., 2000; Nobbs et al., 2009; Rohde et al., 2016). In this study, we 
investigated the roles of caveolae and its scaffolding protein CAV1 during GAS uptake, providing 
extensive ultrastructural and functional characterization of the GAS invasion process in HEp-2 and 
primary human tonsil cells. Our findings suggest that CAV1 plays an important role in the protection 
of non-phagocytic cell lines against invasion by GAS. This protective effect does not require physical 
interaction between invading GAS and caveolae, and may possibly be elicited through indirect effects 
on the GAS internalization process. 
 
Although the exact mechanism by which GAS invades non-phagocytic cells remains unclear, several 
GAS and host molecules have been implicated in this process. The involvement of GAS fibronectin 
proteins (Molinari et al., 1997; Jadoun et al., 1998; Amelung et al., 2011; Rohde et al., 2011), host 
α5β1 integrin (Dombek et al., 1999; Molinari et al., 2000; Rezcallah et al., 2005) and integrin-linked 
kinase (Wang et al., 2006; Siemens et al., 2011;) suggests internalization via a process that includes 
GAS engagement of integrins through a fibronectin cross bridge, followed by integrin clustering and 
internalization via a “zipper mechanism” reminiscent of Yersinia invasion (Cossart et al., 2004; 
Pizarro-Cerdá et al., 2016). Here, we provide ultrastructural visualization of the entire GAS invasion 
process into HEp-2 cells, and for the first time in primary human tonsil epithelial cells using electron 
microscopy. During early stages of infection, invading GAS cells were significantly associated with 
filopodia and featureless PM in both cell lines. Filopodia are long cylindrical cellular projections 
containing bundles of cross-linked actin filaments (Wood et al., 2002; Mattila et al., 2008;) and have 
been implicated in the entry and/or exit of pathogens from host cells (Tran Van Nhieu et al., 1999; 
Tran Van Nhieu et al., 2000; Lehmann et al., 2005; Chang et al., 2016). As invasion progressed, GAS 
were taken up into large PM invaginations that possess putative actin filaments consistent with 
reported reorganization of the actin cytoskeleton during GAS invasion (Nobbs et al., 2009; Rohde et 
al., 2016). Bacteria internalized via this process often reside in endocytic vesicles and are usually 
targeted to lysosomal compartments (Dombek et al., 1999). This is in agreement with our 
observations in which internalized GAS appear to be contained within vesicles of 
endosomal/lysosomal origin (see Fig. 3.10.4D and Fig. 3.10.4H). These electron micrograph 
visualizations support the current model for GAS invasion into non-phagocytic cells, indicating that 
GAS exploits remodeling of the actin cytoskeleton to gain entry into host cells. 
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In this study, we used precise knockdown (HEp-2) and knockout (MEFs) cell lines to demonstrate 
that CAV1 protects against GAS invasion. SfbI was previously implicated as a protein required for 
GAS invasion via a caveolae-facilitated process since non-invasive SfbI negative Streptococcus 
gordonii were able to recruit small cavity-like structures inferred to be caveolae when transfected 
with SfbI (Rohde et al., 2003). In this study, we showed that internalization of both M1T15448 (SfbI-) 
and M12A40 (SfbI+) were similarly inhibited by CAV1, indicating that CAV1 protects against GAS 
invasion and this protective effect is not SfbI-dependent. We hypothesized that the main reason for 
these contrasting findings of the role of CAV1 is due to the cholesterol depletion approach used to 
simulate the loss of caveolae in that previous study, as more recent experiments have shown that other 
non-caveolar endocytic pathways are highly sensitive to cholesterol depletion (Hoffmann et al., 2010; 
Chaudhary et al., 2014). The role of SfbI in caveolae-regulated GAS invasion remains an open 
question, however, based on findings presented in this chapter we believe that caveolae are not an 
entry portal for GAS. Firstly, there was minimal association of GAS with caveolae at any point 
determined from a comprehensive electron microscopic analysis. Secondly, we showed using genetic 
loss or transient knockdown of CAV1 that caveolae are not essential for GAS entry. In fact, loss of 
CAV1 increased GAS invasion efficiency. Finally, immunofluorescence analysis using antibodies 
against endogenous CAV1 showed no significant recruitment of CAV1 to GAS throughout infection, 
although some overlap of signals could be observed as expected for any plasma membrane-associated 
particle viewed by light microscopy. It is important to note here that CAV1 can be distributed within 
the entire plasma membrane, but cannot be assumed to be a marker for caveola due to the limiting 
concentrations of caveolae accessory proteins such as PTRF (Parton et al., 2013). In this respect, it is 
likely that CAV1 regulates GAS invasion independent of caveolae since there was no physical 
association of caveolae structures with invading GAS. Potential mechanisms of this regulation are 
investigated in Chapter 5 of this thesis.  
 
In summary, we report an independent role of CAV1 protein, but not caveolae, in protecting non-
phagocytic epithelial cells against GAS infection. In addition, we provided an extensive 
ultrastructural representation of the GAS invasion process into HEp-2 cells and primary human tonsil 
epithelial cells that will aid further studies into the invasion process of this important human pathogen.  
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4. Investigation of the role of PTRF in the uptake of Streptococcus 
pyogenes into non-phagocytic host cells 
 
4.1 Introduction 
 
The major component of caveolae is the scaffolding protein CAV1 which oligomerizes to form the 
primary caveolae structure (Monier et al., 1996). While many caveolar studies to date have 
emphasized the crucial role of CAV1 in caveolar biogenesis (reviewed in section 1.5.1.1), it is 
imperative to note that this process also involves the cavin family proteins, namely PTRF, also known 
as cavin-1 (hereafter designated PTRF; Hill et al., 2008; Liu et al. 2008; Liu and Pilch, 2008; Briand 
et al., 2011). PTRF is enriched in caveolar fractions (Aboulaich et al., 2004) and selectively co-
localizes with CAV1 at the PM in vitro (Vinten et al., 2005; Hill et al., 2008). The absence of PTRF 
results in loss of caveolar density and reduced caveolae formation at the PM both in vitro and in vivo 
(Hill et al., 2008; Liu et al., 2008; Liu and Pilch, 2008), indicating that PTRF is an important regulator 
for the formation of caveolae. In addition to its role in regulating caveolae formation, the expression 
of PTRF and CAV1 are co-dependent. The loss of PTRF was accompanied by loss of CAV1, CAV2 
and CAV3 protein expression in their respective tissues, and CAV1-null mice showed reduced PTRF 
expression (Bastiani et al., 2009; Hill et al., 2008). Although there is no evidence to indicate direct 
interaction, PTRF was postulated to require signals from CAV1 oligomers to be recruited to the PM 
to form mature caveolae (Vinten et al., 2005; Bastiani et al., 2009). These and other studies reviewed 
in Chapter 1 of this thesis collectively indicate the tight functional association between PTRF and 
CAV1. 
 
Caveolae and CAV1 have been shown to facilitate or restrict pathogen internalization whereas the 
significance of PTRF during bacterial invasion into host cells has not been investigated. Since PTRF 
is required together with CAV1 to stabilize and form mature caveolae at the PM, and with the new 
protective role of CAV1 against GAS invasion reported in Chapter 3, we predicted that PTRF also 
protects host cells against GAS invasion similar to CAV1. In this chapter, we investigate the role of 
PTRF in regulating GAS invasion using PTRF knockout and knockdown cells.  
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4.2 Results 
 
4.2.1 GAS invasion into PTRF-deficient MEFs 
 
Both CAV1 and PTRF are required for the formation of caveolae in mammalian cells (Liu et al., 
2008; Lo et al., 2015; Faggi et al., 2015). As such, it was predicted based on findings reported in 
Chapter 3 that the loss of PTRF would also result in increased GAS internalization into host cells. 
A gentamicin protection assay was conducted in which WT and PTRF knockout MEFs (PTRF-/- 
MEFs) were infected with M1T15448 and the proportion of intracellular GAS measured. Knockout of 
PTRF resulted in moderate reduction of CAV1 expression (Fig. 4.1A). Surprisingly, we observed a 
significant suppression of M1T15448 invasion into MEFs in the absence of PTRF (p<0.01, Fig. 4.1B). 
To ensure that PTRF knockout did not affect cell viability and thus intracellular GAS counts, a 
viability assay measured by LDH release was conducted in which WT and PTRF-/- MEFs showed 
comparable viability (97.15 ± 0.02% viable for WT and 96.52 ± 0.37% for shCAV1 cells). These 
results indicate that PTRF facilitates GAS internalization into MEFs, which is in contrast to the 
protective role of CAV1.  
 
 
 
 
Figure 4.1 Invasion of GAS strains M1T15448 and M6JRS4 into WT and PTRF-/- MEFs. (A) Western 
immunoblot of PTRF and CAV1 expression levels in WT and PTRF-/- MEFs. (B) Invasion of GAS strains 
M1T15448 and M6JRS4 into WT and PTRF-/- MEFs. Data represented as mean ± SEM, **p<0.01, ****p<0.0001, 
n=3 
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4.2.2 GAS invasion into PTRF-deficient HEp-2 cells 
 
Next, we investigated whether the loss of PTRF in HEp-2 cells also influence GAS internalization. 
Initially, PTRF knockdown HEp-2 cells were generated by transfection with plasmids encoding 
shRNA against PTRF (hereafter termed shPTRF) as described in section 2.2 (Madaro et al., 2013), 
and the efficiency of PTRF knockdown was assessed using western immunoblot. There was a 
reduction in intensity of the 55 kDa band corresponding to PTRF in shPTRF HEp-2 cells compared 
to WT and shScr (Fig. 4.2A). PTRF knockdown did not alter CAV1 expression in these cells as the 
25 kDa band corresponding to CAV1 showed comparable intensities in shPTRF, WT and shScr HEp-
2 cells. These shPTRF HEp-2 cells were then used in a gentamicin protection assay, in which invasion 
of M1T15448 showed no significant difference compared to WT and shScr HEp-2 cells (p>0.05, Fig. 
4.2B and Fig. 4.2C). Cell viability measured by trypan blue exclusion also indicated that viability of 
these HEp-2 cells were not altered throughout the infection experiment (Fig. 4.3). These results 
suggest that PTRF is not involved in GAS invasion into HEp-2 cells and the protective effect elicited 
by CAV1 is independent of PTRF, although care needs to be taken in this interpretation since there 
was a low level of PTRF proteins in the knockdown HEp-2 cells (Fig. 4.2A) which may have 
confounded the invasion assay, however unlikely.  
 
In addition to the effects of PTRF knockdown on GAS invasion into HEp-2 cells, we also investigated 
the effects of PTRF over-expression on GAS invasion. PTRF was overexpressed in WT mHEp-2 
cells by transfection with plasmid DNA encoding the PTRF gene product translationally fused to 
green fluorescent protein (GFP-PTRF). However, western immunoblot screening to assess cellular 
levels of PTRF indicated that PTRF was re-expressed in shPTRF HEp-2 cells comparable to WT 
levels (Fig. 4.4), possibly confounding results of the PTRF overexpression gentamicin protection 
assays. As it was not possible to interpret results from the gentamicin protection assays with certainty, 
we attempted to select for PTRF-deficient shPTRF HEp-2 cells to repeat the gentamicin protection 
assays. The following sections describe two procedures taken to overcome the re-expression of PTRF 
in shPTRF HEp-2 cells, namely by antibiotic selection and RNA silencing.   
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Figure 4.2 M1T15448 invasion into HEp-2 cells. (A) Western immunoblot of CAV1 and PTRF proteins in 
WT, shPTRF and shScr HEp-2 cells. (B) M1T15448 invasion into WT, shPTRF and shScr HEp-2 cells. Data 
represented as mean ± SEM, p>0.05, n=3. (C) Time course (1, 2 and 3 h post infection, p.i.) of M1T15448 
invasion into HEp-2 cells, quantified by gentamicin protection assay. Data represented as mean ± SEM, 
p>0.05, n=3. 
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Figure 4.3 Viability of M1T15448 - infected HEp-2 cells. (A) Viability of uninfected and (B) infected WT, 
shPTRF and shScr HEp-2 cells measured by trypan blue exclusion. p.i., post infection; data represented as 
mean ± SEM, p>0.05, n=2. 
 
 
 
 
 
Figure 4.4 Western immunoblot of PTRF and CAV1 expression levels in WT HEp-2 cells and derivatives. 
Cell lysate was collected from WT HEp-2 cells and derivatives, and tested for PTRF and CAV1 expression. 
Presence of PTRF proteins in shRNA knockdown PTRF cells is highlighted by the red box. GAPDH serves 
as a positive control for the western immunoblot assay. 
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4.2.3 Optimization of G418 antibiotic concentration for selection of shPTRF HEp-2 cells 
 
Since there is a possibility that the shPTRF HEp-2 cells were contaminated with WT HEp-2 cells 
during routine passaging, we attempted to re-select for a population of shPTRF HEp-2 cells using 
G418. The plasmid containing the shRNA sequence against PTRF used to transfect HEp-2 cells 
contains the G418 antibiotic resistance gene. Optimal concentration of G418 was first determined to 
be between 500 - 600 µg/ml by performing an antibiotic killing experiment (Table 4.1). Following 
this, an initial optimization experiment was performed to determine the effectiveness of G418 at these 
concentrations. shPTRF HEp-2 cells were first seeded (~70 - 80% confluent) and allowed to adhere 
onto the culture flasks, and then treated with G418 in DMEM supplemented with 10% FBS. Fresh 
G418 was added to the cell culture medium every two days until the sixth day of the experiment (see 
appendix IV, Fig. S4.1) and cell lysate was collected to check for PTRF expression. At day six post-
treatment with G418, HEp-2 cells began to lose expression of PTRF and this was consistent through 
to day eight (Fig. 4.5). However, the cells became less viable by day ten and there was insufficient 
cell lysate to accurately determine whether the selected population had reduced PTRF expression 
(Fig. 4.5B). From this experiment, we determined that a G418 concentration of 600 µg/ml was 
suitable for the selection of shPTRF HEp-2 cells.  
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Table 4.1 Optimization of G418 concentration in HEp-2 cells 
 
Table legend:  Cells are viable,  Some cells are viable but rounding & some cells are floating, 
 Cells are not viable 
 
 
 
 
WT shCAV1 shPTRF WT shCAV1 shPTRF WT shCAV1 shPTRF
0         
100         
200         
300         
400         
500         
600         
700         
800         
900         
1000         
1200         
1400         
1600         
1800         
2000         
WT shCAV1 shPTRF WT shCAV1 shPTRF WT shCAV1 shPTRF
0         
100         
200         
300         
400         
500         
600         
700         
800         
900         
1000         
1200         
1400         
1600         
1800         
2000         
Concentration of G418 (µg/ml)
Day 4 Day 5 Day 6
Concentration of G418 (µg/ml)
Day 1 Day 2 Day 3
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Figure 4.5 Optimization of G418 antibiotic treatment in shPTRF HEp-2 cells. Western immunoblot of 
PTRF and CAV1 expression levels in shPTRF HEp-2 cell, (A) 3 - 6 days and (B) 7 - 10 days’ post treatment 
with G418. shPTRF HEp-2 cells were seeded in T75 flasks and treated with G418 accordingly as outlined in 
appendix IV Fig. S4.1. Cell lysates were collected and tested for PTRF and CAV1 expression at the indicated 
days. Red boxes indicate gradual loss of PTRF expression under G418 selection. GAPDH serves as a positive 
control for the western immunoblot assay. 
 
 
4.2.4 Selection of shPTRF HEp-2 cells using G418 
 
shPTRF HEp-2 cells showing PTRF expression (Fig. 4.4) were either non-treated (control) or treated 
with 600 µg/ml G418 as described in section 4.2.3. G418 selected for a population of shPTRF cells 
harbouring the antibiotic resistance gene against G418 as observed by the gradual loss of PTRF 
expression from days three to six (Fig. 4.6), raising the possibility that these shPTRF HEp-2 cells 
were contaminated with non shPTRF HEp-2 cells. The G418-selected cells were allowed to recover 
from antibiotic challenge for 6 - 8 days in fresh G418-free DMEM supplemented with 10% FBS. In 
preparation for using these cells in gentamicin protection assays, they were collected and seeded in 
the absence of G418. However, PTRF expression was again detected in these selected cells (Fig. 4.7) 
rendering them unsuitable for experiments. This observation suggests that PTRF knockdown might 
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be detrimental to the fitness of HEp-2 cells, and are outcompeted by contaminating HEp-2 cells that 
retain PTRF expression. 
 
 
 
 
 
Figure 4.6 Western immunoblot of PTRF and CAV1 expression in G418-treated HEp-2 cells. (A) WT, 
(B) shCAV1 and (C) shPTRF HEp-2 cells were seeded in T75 flasks and either not treated (left panel) or 
treated (right panel) with 600 µg/ml G418. Cell lysate was collected for western immunoblot assay to estimate 
levels of PTRF and CAV1 expression. Red box indicates gradual loss of PTRF expression upon selection with 
G418. GAPDH serves as a positive control for the western immunoblot assay. 
 
 
 
 
 
Figure 4.7 Expression of PTRF in shPTRF HEp-2 cells during and post G418 selection. shPTRF HEp-2 
cells were treated with 600 µg/ml G418 to select for a population of cells with no PTRF expression (as outlined 
in appendix IV, Fig. S4.1). After G418 treatment for nine days, cells were cultured for a further seven days 
without G418 to achieve sufficient cell numbers for gentamicin protection assays (days 16 and 17). Cell lysate 
was collected at the indicated days to measure PTRF and CAV1 expression. GAPDH served as a positive 
control for the western immunoblot analysis.  
 
 
  
PTRF55-
GAPDH
CAV125-
40-
shPTRF untreated shPTRF + G418
D3 D4 D5 D6 D3 D4 D5 D6kDa
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
PTRF55-
GAPDH
CAV125-
40-
Day
 70 
4.2.5 Transient siRNA knockdown of PTRF in HEp-2 cells 
 
As antibiotic selection for PTRF-deficient shRNA PTRF knockdown HEp-2 cells was unsuccessful, 
we attempted to create a transient PTRF knockdown in HEp-2 cells using RNA silencing. Three 
siRNA constructs were created (Table 4.2; designated construct #1 - #3 for simplicity) and 
transfected into WT and shPTRF HEp-2 cells using Lipofectamine® 3000 as per manufacturer’s 
protocol (see section 2.3). A negative control oligo (High GC content; 12935100, Thermo Fisher 
Scientific) was included as control for the transfection protocol. Silencing efficiency was monitored 
by the relative band intensity of the 55 kDa PTRF band by western immunoblots, in which there was 
no silencing of PTRF expression observed as the presence of the 55 kDa bands in siRNA transfected 
cells (Fig. 4.8). The siRNA protocol was repeated using non FBS-supplemented Opti-MEM, which 
is a reduced serum media used for improving transient transfection efficiency (Wallenstein et al., 
2010), but was also unsuccessful (appendix IV Fig. S4.2). We were able to achieve successful PTRF 
knockdown using this siRNA protocol in HeLa cells (appendix IV Fig. S4.3), suggesting that PTRF 
expression in HEp-2 cells was not amendable using this approach. We did not further attempt to 
create PTRF-deficient HEp-2 cells due to time and resource constraints.  
 
 
Table 4.2 siRNA target sequence used to knockdown PTRF in HEp-2 cells  
 
1siRNA sequences were designed and manufactured using the Stealth RNAi™ siRNA system (Thermo Fisher 
Scientific) to specifically target PTRF. Please see here for more information: 
https://www.thermofisher.com/au/en/home/life-science/rnai/synthetic-rnai-analysis/stealth-rnai-
technology.html  
 
 
Label number siRNA target sequence
1 GCCGCAACUUUAAAGUCAUGAUCUAUAGAUCAUGACUUUAAAGUUGCGGC
2 CCGGCCAAACUGAGCAUCAGCAAAUAUUUGCUGAUGCUCAGUUUGGCCGG
3 AGGAGUCCCGCGCAGAGAGCGUAUCAAUUGAUACGCUCUGCGCGGGACUCCU
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Figure 4.8 Western immunoblot of PTRF and CAV1 expression in siRNA-transfected HEp-2 cells. WT 
or shPTRF HEp-2 cells were transfected with siRNA (designated siRNA #1 - #3) listed in Table 4.2 or a non-
targeting control oligo sequence. Transfection was performed using Lipofectamine® 3000 with overnight 
incubation in regular DMEM supplemented with 10% serum. Cell lysates were collected and PTRF and CAV1 
expression measured using western immunoblotting. GAPDH serves as a positive control. PTRF expression 
in these cells is highlighted with red boxes.  
 
 
4.3 Discussion 
 
Caveolae and its scaffolding protein CAV1 have been implicated in the uptake of bacterial pathogens 
into various mammalian cell lines, however, it is unknown whether the caveolae-associated PTRF 
protein is also involved in this process. In this chapter, we investigated the role of PTRF in regulating 
GAS invasion into MEFs and HEp-2 cells via PTRF knockout and knockdown, respectively. Taken 
together with the findings from Chapter 3, we propose that the protective effect elicited by CAV1 is 
independent of the formation of caveolae since PTRF-/- MEFs, like CAV1-/- MEFs, also lack caveolae 
but exhibited the opposite GAS invasion phenotype. This is a particularly striking finding in view of 
the fact that PTRF-/- MEFs have reduced CAV1 protein levels (Fig. 4.1A) which should promote 
bacterial invasion. Similarly, CAV1-/- MEFs have reduced PTRF levels due to increased proteasomal 
degradation of PTRF in cells lacking caveolae (Tillu et al., 2015), but have increased GAS invasion 
instead (Fig. 3.1A). Indeed, there is evidence that CAV1 and PTRF both have independent roles in 
prostate cancer cells (reviewed in Nassar et al., 2013), and here we show that their functional 
independence extends to the regulation of GAS invasion into MEFs. Since we also observed an 
accompanying reduction in CAV1 expression in PTRF-/- MEFs (Fig. 4.1A) which should have led to 
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increased GAS invasion, a conclusion compatible with these results would be a significant role of 
non-caveolar pools of these caveolar proteins in either restricting (CAV1) or promoting (PTRF) GAS 
invasion but the dominant effect is the complete loss of the respective proteins.  
 
Since GAS invasion studies are commonly conducted using HEp-2 cells (Molinari et al., 2000), we 
also examined the effect of PTRF knockdown in HEp-2 cells on GAS invasion. Firstly, the apparent 
no effect of PTRF knockdown on GAS invasion could have been confounded by the low level 
presence of PTRF in the PTRF knockdown HEp-2 cells (Fig. 4.2A). Nonetheless, PTRF is known to 
have differing roles depending on cell type, which could also explain the different outcomes observed 
between PTRF deficient MEFs (reduced invasion) and HEp-2 cells (no change in invasion). For 
example, PTRF knockdown results in reduced cell migration in human rhabdomyosarcoma RH30 
and RD cells (Faggi et al., 2015), whereas the same result is achieved in PC3 prostate cancer cells 
through heterologous PTRF expression (Hill et al., 2012). Following the GAS invasion assays into 
PTRF knockdown HEp-2 cells, PTRF became expressed again at levels comparable to WT HEp-2 
cells in the PTRF knockdown HEp-2 cells, and reselection for stable populations of PTRF deficient 
cells was unsuccessful with PTRF becoming re-expressed within days after selection. These findings 
suggest that PTRF is essential in HEp-2 cells as PTRF deficient cells are replaced by populations 
with PTRF expression. PTRF is linked to the functioning of multiple metabolic and housekeeping 
pathways in various cell types, and the loss of this protein is associated with several disorders (see 
review by Low and Nicholson, 2014). It is therefore possible that PTRF deficiency in HEp-2 cells is 
detrimental and cells are quickly replaced by healthy populations; the mechanism by which PTRF 
regulates HEp-2 cell fitness remains to be determined. To resolve the role of PTRF in HEp-2 cells 
and during GAS invasion, more recent gene editing techniques such as the CRISPR/Cas9 system may 
be viable alternatives to generating PTRF null HEp-2 cells, if at all possible.  
 
In summary, PTRF and CAV1 exhibit caveolae-independent roles associated with the regulation of 
GAS invasion in MEFs and possibly HEp-2 cells. Since the expression of PTRF and CAV1 are co-
dependent, it is clear that the relative expression of both proteins have to be taken into account when 
interpreting their roles in pathogen uptake. It is shown here that PTRF and CAV1 have opposite 
effects in the regulation of GAS invasion at least in MEFs and the final outcome appears to be 
dependent on the complete loss of either protein, therefore GAS infection models can provide an 
excellent system to define these opposing roles of the two caveolar assembly proteins. 
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5. Characterization of the underlying mechanism by which CAV1 
protects host cells against Streptococcus pyogenes infection 
 
5.1 Introduction 
 
Chapters three and four investigated roles of the two caveolar assembly proteins CAV1 and PTRF in 
GAS invasion, in which both proteins are required for the formation of caveolae but have independent 
roles during GAS uptake into host cells. CAV1 prevents the entry of GAS into MEFs and HEp-2 
cells, whereas PTRF may facilitate GAS uptake in MEFs. Defining the exact role and mechanism of 
these two proteins in GAS uptake could therefore facilitate understanding of their opposing effects 
and regulation of the GAS invasion process.  
 
Various host and GAS proteins have known associations with the uptake of GAS into host cells (see 
Chapter 1 for review). GAS recruit host α5β1 integrins via fibronectin binding proteins such as SfbI 
and M1 expressed on the bacterial cell surface, and this leads to their internalization initially thought 
to be facilitated by caveolae (Rohde et al., 2003) and also possibly through a clathrin-dependent 
pathway (Logsdon et al., 2011). Following uptake, GAS evades host immune responses by escaping 
from endocytic vesicles using the pore-forming toxin termed SLO, and from autophagosomes using 
the SpeB cysteine protease (Barnett et al., 2013). GAS induce apoptosis of host cells through the 
action of SLO on the mitochondrial membrane thus releasing cytochrome C into the cytosol (Garrido 
et al., 2006), and this limits host cytokine-associated immune responses especially through the killing 
of immune cells (Timmer et al., 2009).  
 
This chapter investigates whether regulation of GAS internalization by CAV1 and PTRF interacts 
with these known GAS virulence factors or other non-caveolar components of the host cell. Using 
GAS mutants deficient for the genes encoding in proteins of interest, we examined whether their 
invasion into CAV1 deficient cells was altered relative to WT. In addition, we investigated whether 
GAS internalization is associated with host clathrin, lipid droplets and PM fluidity. These findings 
will better define the underlying molecular mechanism by which GAS interacts with caveolae during 
invasion.  
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5.2 Results 
 
5.2.1 Investigating the role of CAV1 regulation of plasma membrane mobility on GAS 
invasion into HEp-2 cells 
 
The level of CAV1 expression has been shown to inversely affect PM fluidity (Cai et al., 2004; 
Hoffmann et al., 2010; Chaudhary et al., 2014) and can result in alterations to bacterial attachment 
and entry into host cells (Hoffmann et al., 2010). Since CAV1 prevents GAS entry and does not 
directly interact with invading bacteria (Chapter 3), we hypothesized that the protective effect of 
CAV1 is associated with decreased host membrane fluidity. To test this hypothesis, HEp-2 cells were 
treated with 0.05% Tween 20 for 30 min prior to GAS infection, a treatment reported to increase 
membrane fluidity and enhance bacterial internalization (Hoffmann et al., 2010; Chaudhary et al., 
2014). Cells were then infected with M1T15448 and invasion measured as described in section 2.10, 
with the addition of 0.05% Tween 20 in the cell culture media for the duration of the experiment. 
While no effect of Tween 20 treatment was observed on GAS invasion into WT HEp-2 cells (14.5% 
negative control, 16.5% with Tween 20 treatment), M1T15448 invasion into shCAV1 HEp-2 cells in 
the presence of Tween 20 was decreased relative to the non Tween 20 control (17.5% versus 32.0%, 
Fig. 5.1). This reduction in invasion into shCAV1 HEp-2 cells was not due to reduced host cell 
viability post-detergent treatment (Table 5.1), suggesting that CAV1 regulates PM fluidity and 
restricts GAS invasion via this mechanism although not as per the mechanism initially hypothesized. 
Instead, it is inferred that GAS requires a certain threshold of membrane fluidity for optimal invasion 
which is achieved by the knockdown of CAV1, but is perturbed by the Tween 20 treatment. 
 
 
Table 5.1 Viability of Tween 20 - treated HEp-2 cells 
 
a Viability was measured by LDH release and data represented as mean ± SEM 
 
WT shCAV1 shScr
Untreated 94.85±0.11 92.14±1.01 93.73±0.00
Tween 20-treated 87.67±1.70 88.55±0.21 91.67±0.23
Viability (%)ᵃ
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Figure 5.1 Invasion of M1T15448 into Tween 20-treated HEp-2 cells. WT, shCAV1 and shScr HEp-2 cells 
were either untreated (control) or treated with 0.05% Tween 20 for 30 min at 37°C prior to infection with 
M1T15448. Invasion was measured as per gentamicin protection assay. Data represented as mean ± SEM, 
p>0.05, **p<0.01, n=3.  
 
 
To address the possibility that Tween 20 could have influenced GAS invasion independent of PM 
fluidity, we also simulated increased PM fluidity by increasing the incubation temperature of the 
invasion experiment (Hoffmann et al., 2010). HEp-2 cells were incubated at 37°C or 41°C for 1 h 
prior to infection with M1T15448, and invasion was measured through gentamicin protection assays 
(see section 2.10). As shown for Tween 20 (Fig. 5.1), the level of GAS invasion into WT HEp-2 cells 
at 41°C was not significantly different from 37°C (9.0% versus 16.6%, Fig. 5.2). Incubation of 
shCAV1 HEp-2 at 41°C resulted in lowered GAS invasion compared to incubation at 37°C (13.9% 
versus 38.3%, Fig. 5.2), which was consistent with results from the Tween 20 treatment. Likewise, 
the increased temperature did not adversely affect viability of GAS (Fig. 5.3) and HEp-2 cells (Table 
5.2). Results from this temperature and the previous Tween 20 experiment support the inference that 
CAV1 regulates PM fluidity to control GAS invasion, although the exact mechanism by which this 
occurs is likely not straightforward (i.e. increased invasion by increasing PM fluidity and vice versa) 
and could involve other membrane components and/or characteristics related to membrane fluidity. 
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Figure 5.2 Invasion of M1T15448 at varying environmental temperatures. WT, shCAV1, and shScr HEp-2 
cells were incubated at 37°C or 41°C for 1 h prior to infection with M1T15448. Invasion was measured through 
gentamicin protection assays. Data represented as mean ± SEM, p>0.05, ****p<0.0001, n=3. 
 
 
 
 
 
Figure 5.3 Growth of M1T15448 at 37ºC and 41ºC. GAS were inoculated in 0.2% THYB in duplicate and 
incubated at 37ºC (control) or 41ºC for 1, 2, 3 or 4 h. At the indicated times, GAS were serially diluted and 
plated onto THYA to enumerate CFU counts. n=1. 
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Table 5.2 Viability of HEp-2 cells post temperature treatment 
 
a Viability was measured by LDH release and data presented as mean ± SEM 
 
 
5.2.2 Potential GAS virulence factors involved in the GAS-caveolae interaction during uptake 
 
GAS possess a wide array of surface and secreted virulence factors that facilitate their interaction and 
promote infectivity in host cells. To determine which known virulence determinants are involved in 
interactions between GAS and CAV1, we selected M1T15448 isogenic mutants that were constructed 
within the Nizet laboratory (University of California, San Diego, CA, USA) for gentamicin protection 
assays to measure their invasion potential into HEp-2 cells. 
 
Three isogenic mutants of virulence factors speB, slo, and emm1 were chosen for gentamicin 
protection assays. SpeB is a cysteine protease that degrades host extracellular matrix proteins (Kansal 
et al., 2000) and cleaves several GAS virulence factors including M proteins (Berge and Bjorck, 
1995). SpeB also associates with host cell surfaces (Hytonen et al., 2001) and is a major virulence 
determinant allowing M1T1 GAS to interact with host cell surface integrins to initiate internalization 
(Nyberg et al., 2004; Cole et al., 2006). Since SpeB is epidemiologically associated with various 
superficial GAS diseases (Kansal et al., 2000) and could potentially interact with fibronectin thus 
functioning as an invasin (Stockbauer et al., 1999), we investigated whether SpeB has a role in 
interacting with caveolae in the uptake of M1T15448. SLO is a cholesterol-dependent cytolysin that 
inserts into lipid rafts to form holes in host cell membranes (Prigent and Alouf, 1976; Weis and 
Palmer, 2001). As caveolae are enriched in cholesterol and can influence lipid composition of the 
PM, it was hypothesized that SLO could be targeting caveolae and/or cholesterol rich regions during 
invasion into host cells. Lastly, M protein is an adhesin that initiates GAS attachment and invasion 
into host cells by engaging host α5β1 integrins and/or CD46 (Rezcallah et al., 2005). These cell 
surface receptors are potentially under the influence of CAV1 regulation over PM fluidity, and their 
availability could change depending on CAV1 expression. These changes in receptor availability may 
influence the ability of GAS to initiate invasion into their host cells. 
WT shCAV1 shScr
37 97.97±1.17 99.61±0.14 99.71±0.09
41 91.25±3.50 96.82±0.54 98.03±0.29
Viability (%)ᵃ
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Therefore, to determine whether these virulence factors are involved in GAS-caveolae interactions, 
invasion characteristics of GAS M1T15448 mutants of either speB, slo or emm1 into CAV1 deficient 
cells measured in gentamicin protection assays were compared to M1T15448 (control). For successful 
attachment and invasion into host cells, GAS surface and/or secreted proteins need to engage host 
cell receptors. Since SpeB, SLO and M1 protein are known effectors of GAS pathogenicity, we 
investigated the role of these virulence factors by infecting WT and shCAV1 HEp-2 cells with GAS 
M1T15448 speB, slo and emm1 mutants (denoted as M1T15448ΔspeB, M1T15448Δslo, and 
M1T15448Δemm1, respectively). All three M1T15448 mutants were not impaired in their invasiveness 
in WT HEp-2 cells compared to M1T15448 (control) (p>0.05, Fig. 5.4, black bars), indicating that 
SpeB, SLO and M1 protein are not essential for invasion into HEp-2 cells. In shCAV1 HEp-2 cells, 
M1T15448 (control) and all mutants showed significantly increased invasion relative to WT HEp-2 
cells (p<0.05), and this increase was comparable between WT M1T15448, M1T15448ΔspeB and 
M1T15448Δemm1 but not M1T15448Δslo (Fig. 5.4). These results indicate that SpeB and M1 protein 
are not involved in the CAV1 regulation of GAS invasion in HEp-2 cells whereas the virulence of 
SLO-deficient GAS is impaired in the absence of CAV1 (43.5% vs. 31.3%, invasion of M1T15448 
(control) vs. M1T15448Δslo into shCAV1 HEp-2 cells). We propose that SLO may contribute to 
invasion through interactions with PM-associated cholesterol and/or other components that are 
regulated by CAV1. SpeB and M1 protein are primarily involved in GAS adhesion to the host cell 
surface, and we have previously shown that adhesion is unchanged between WT and shCAV1 HEp-
2 cells (Chapter 3). It was therefore not unexpected that M1T15448ΔspeB and M1T15448Δemm1 could 
invade WT and shCAV1 HEp-2 cells comparable to M1T15448 (control), which also suggests that M1 
protein is not the main fibronectin binding protein M1T15448 used to initiate invasion into HEp-2 cells. 
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Figure 5.4 Invasion of GAS M1T15448 mutant strains into WT and shCAV1 HEp-2 cells. HEp-2 cells were 
infected with either WT M1T15448 (control), M1T15448∆speB, M1T15448∆slo or M1T15448∆emm1 and invasion 
measured through gentamicin protection assays. (A) M1T1ΔspeB invasion compared to control. Data 
represented as mean ± SEM, p>0.05, *p<0.05, ***p<0.001, n=3. (B) M1T1Δslo invasion compared to control. 
Data represented as mean ± SEM, p>0.05, *p<0.05, **p<0.01, ***p<0.001, n=3. (C) M1T1Δemm1 invasion 
compared to control. Data represented as mean ± SEM, p>0.05, *p<0.05, ***p<0.001, n=3.  
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5.2.3 Investigation of the potential involvement of host lipid droplets in facilitating bacterial 
invasion into CAV1-deficient cells 
 
Lipid droplets are round organelles (diameter of 0.1-5.0 µm in non-adipocytes and up to 100 µm in 
white adipocytes) consisting of a lipid ester core and surrounded with a phospholipid monolayer 
(Murphy et al., 1999). They are known to participate in multiple cellular events such as the storage 
and metabolism of lipid esters in a variety of cell types (Fujimoto and Parton, 2011), and CAV1 has 
been shown associate with lipid droplets in fatty acid-loaded cultured cells (Pol et al., 2005) and 
hepatocytes (Fernandez et al., 2006). Studies have also demonstrated that CAV1 is involved in the 
formation and breakdown of these cellular lipid droplets (Cohen et al., 2004b; Ost et al., 2005). 
Specifically, CAV1 can localize to lipid droplets in vivo and in vitro (Brasaemle et al., 2004; Pol et 
al., 2004; Martin and Parton, 2005), and the expression of CAV1 influences the synthesis and 
metabolism of lipid droplets, which can lead to: i) redirection of surface pools of CAV1 to 
intracellular lipid droplets for the formation of lipid droplets (Cohen et al., 2004b), and ii) increased 
bactericidal activity as histones bound to lipid droplets may function as an intracellular antibacterial 
defense system. These histones are released upon the detection of bacterial lipopolysaccharide (LPS) 
or LTA and can kill intracellular bacteria (Anand et al., 2012). 
 
We have shown that intracellular survival of GAS was better in WT compared to shCAV1 HEp-2 
cells (Fig. 3.4). Nevertheless, it remains possible that the protective effect of CAV1 against GAS 
internalization was mediated through the action of lipid droplets. Caveolin expression levels in 
adipocytes has been shown to regulate size and formation of lipid droplets (Blouin et al., 2010), as 
such, we hypothesize that CAV1 knockdown in HEp-2 cells may have reduced lipid droplet 
production and/or intracellular bactericidal activity associated with lipid droplets-bound histones, 
hence increasing GAS invasion and survival. To test this hypothesis, WT and shCAV1 HEp-2 cells 
were treated with oleic acid (OA) to induce lipid droplet production and the invasion and survival of 
intracellular GAS into these OA-treated cells were compared to non-treated HEp-2 cells in a time 
course experiment. 
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5.2.3.1 HEp-2 cell viability, GAS invasion and survival under OA treatment 
 
Firstly, viability of HEp-2 cells was measured to assess the influence of OA addition to the culture 
media. With addition of OA, viability was reduced relative to the no OA treatment (p<0.001) and was 
comparable in WT, shCAV1 and shScr HEp-2 cells (Table 5.3). Viability of these OA treated cells 
was consistently ~80% and did not decline even up to the eight-hour post infection time point, hence 
it was determined that the addition of OA did not affect cell viability in a manner that was detrimental 
to their fitness.  
 
 
Table 5.3 Viability of untreated and OA-treated HEp-2 cells during infection with GAS M1T15448 
 
a Viability was measured by LDH release and data presented as mean ± SEM 
 
 
GAS invasion characteristics into WT and shCAV1 HEp-2 cells remained similar with or without 
OA treatment (Fig. 5.5). shCAV1 HEp-2 cells were more susceptible to GAS invasion in both 
treatments, indicating that OA did not adversely affect the enhanced uptake of GAS into HEp-2 cells 
in the absence of CAV1. In WT HEp-2 cells, the proportion of intracellular GAS was significantly 
higher with OA treatment compared to no OA WT HEp-2 cells, indicating that GAS can either invade 
WT HEp-2 cells more efficiently or have improved intracellular survival with the addition of OA in 
the presence of CAV1. Following this, a survival assay was performed to assess whether GAS 
intracellular survival was influenced by OA. Both OA treated WT and shCAV1 HEp-2 cells showed 
improved GAS survival compared to no OA treatment for the duration of this experiment, although 
this was only significant in OA treated shCAV1 HEp-2 cells compared to no OA shCAV1 HEp-2 
cells at 4 h post gentamicin treatment (Fig. 5.6). It was originally hypothesized that the knockdown 
of CAV1 could have led to reduced lipid droplet bactericidal activity and thus increased intracellular 
without OA with OA without OA with OA without OA with OA
2 96.11±0.98 83.75±0.75 96.24±0.36 81.98±0.69 98.02±0.65 80.72±1.33
4 98.13±0.48 86.25±2.06 97.02±0.28 86.58±1.61 98.24±0.79 84.07±0.89
6 96.68±0.34 77.08±1.75 95.79±0.73 78.25±2.94 94.95±0.61 72.68±3.93
8 96.47±0.96 76.82±3.10 96.07±1.22 72.30±0.22 96.85±0.61 74.53±4.22
shScr
Viability (%)ᵃ
Time (h)
WT shCAV1
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GAS, but these results suggest that GAS survival is in fact enhanced by lipid droplets. In light of this 
result, the increased intracellular GAS shown in WT HEp-2 cells under OA treatment (12.0% vs. 
7.1%, p<0.01) but not in shCAV1 HEp-2 cells (17.4% vs. 14.4%, p = 0.29; Fig. 5.5), and higher 
relative survival in WT HEp-2 cells with or without OA compared to shCAV1 HEp-2 cells (Fig. 5.6) 
could be explained by the action of CAV1 in WT HEp-2 cells promoting lipid droplet formation 
and/or activity thereby enhancing GAS survival. 
 
 
 
 
Figure 5.5 M1T15448 invasion into untreated and OA-treated HEp-2 cells. HEp-2 cells were either not 
treated or treated with OA addition to the 10% FBS culture media for at least 16 h at 37°C, 5% CO2. Following 
OA treatment, cells were infected with M1T15448 for 2 h as per gentamicin protection assay and invasion 
calculated by enumerating GAS CFU counts. Data represented as mean ± SEM, *p< 0.05, **p<0.01, n=3. 
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Figure 5.6 M1T15448 relative survival in untreated and OA-treated HEp-2 cells. HEp-2 cells were either 
not treated or OA-treated in DMEM + 10% FBS for at least 16 h at 37°C, 5% CO2 prior to infection. On day 
of experiment, cells were infected with M1T15448 for 2 h as per gentamicin protection assay. This was followed 
by 2, 4 or 6 h of gentamicin treatment and survival was calculated by enumerating GAS CFU counts. Relative 
survival is calculated as a relative ratio of CFUs obtained at 2, 4, and 6 h post gentamicin treatment over CFUs 
of the initial 2 h time point. Data represented as mean ± SEM, n=3. At 4 h post gentamicin treatment, relative 
survival is significantly increased in shCAV1 HEp-2 cells with OA compared to shCAV1 HEp-2 cells without 
OA, *p<0.05. Relative survival was not significant at all other time points despite consistent increase in OA 
treated cells. 
 
 
5.2.3.2 Localization of host lipid droplets and their interaction with GAS in HEp-2 cells 
 
Since intracellular survival of GAS in HEp-2 cells appeared to be enhanced by lipid droplets in the 
presence of CAV1, TEM micrographs were obtained from WT HEp-2 cells treated with OA and 
infected with M1T15448 to visualize any interactions of GAS with cellular lipid droplets. In TEM 
micrographs, lipid droplets are characterized by their high electron density and ring of peripheral 
staining and GAS are identified by their distinct morphology (Chapter 3). From 0 to 2 h post 
gentamicin treatment, intracellular GAS and lipid droplets were abundant and easily identifiable but 
there was no evident association between GAS cells and lipid droplets (Fig 5.7.1 and Fig. 5.7.2). At 
4 h post gentamicin treatment, GAS and lipid droplets were often found in close proximity and 
enclosed in cytoplasmic vacuoles, suggesting the possibility of physical interaction (Fig. 5.7.3). 
These observations support the inference that GAS interacts with lipid droplets since the addition of 
OA to stimulate lipid droplet formation in WT HEp-2 cells results in enhanced GAS survival. 
Additional assays will be required to determine whether GAS co-opts their host cells’ lipid droplets 
as a mechanism to improve their intracellular survival, similar to Chlamydia trachomatis (Kumar et 
al., 2006).   
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Figure 5.7.1 Interaction of host LDs with invading M1T15448 at 2 h post-infection. WT HEp-2 cells were 
incubated overnight with OA to induce LDs formation and then infected with M1T15448 for 2 h and processed 
for TEM. LDs (yellow asterisks) are evident by their very high electron density and ring of peripheral staining. 
GAS (red asterisks) are evident by their distinct morphology. Representative electron micrographs 2 h 
infection with M1T15448 at low (A) and higher magnification (B) showing abundant bacteria, but no significant 
association of LDs and bacteria. Scale bars as indicated in all panels: (A) Scale bar = 5000 nm, (B) Scale bar 
= 2000 nm  
A
B
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Figure 5.7.2 Interaction of host LDs with invading M1T15448 at 2 h post infection followed by 2 h 
gentamicin treatment. WT HEp-2 cells were incubated overnight with OA to induce LDs formation and then 
infected with M1T15448 for 2 h, followed by 2 h further incubation with gentamicin. LDs (yellow asterisks) are 
evident by their very high electron density and ring of peripheral staining. GAS (red asterisks) are evident by 
their distinct morphology. (A) Representative low magnification overview showing no significant association 
of LDs and GAS (B - C) Representative higher magnification view of the same time point. Scale bars as 
indicated in all panels: (A) Scale bar = 5000 nm, (B - C) Scale bar = 2000 nm.  
A
B C
 86 
 
 
Figure 5.7.3 Interaction of host LDs with invading M1T15448 at 2 h post infection followed by 4 h 
gentamicin treatment. WT HEp-2 cells were incubated overnight with OA to induce LDs formation and then 
infected with M1T15448 for 2 h, followed by 4 h further incubation with gentamicin. LDs (yellow asterisks) are 
evident by their very high electron density and ring of peripheral staining. GAS (red asterisks) are evident by 
their distinct morphology. (A - F) Representative electron micrograph 2 h infection with M1T15448 followed 
by 4 h gentamicin treatment. Note the significant association of LDs with GAS that are enclosed within 
cytoplasmic vacuoles. The membrane of the vacuole is often closely opposed to the monolayer of the LDs 
suggesting a physical interaction between the two organelles. Low and higher magnification views of the same 
areas are shown. Scale bars as indicated in all panels: (A, D - F) Scale bar = 2000 nm, (B - C) Scale bar = 1000 
nm.    
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5.2.4 Investigating the role of CAV1 in dynamin- and/or clathrin-dependent endocytic 
pathways GAS potentially utilizes to gain entry into host cells 
 
In non-phagocytic host cells, clathrin coated pits have been known to be exploited by many viruses, 
and bacterial pathogens to gain entry (Sieczkarski and Whittaker, 2002; Bonazzi and Cossart, 2006). 
Studies have suggested that pathogens exploiting this endocytic machinery into non-phagocytic host 
cell confers an advantage for intracellular survival and persistence in host cells by escaping the host 
defense mechanisms (Gouin et al., 2005; Pizarro-Cerda and Cossart, 2006). Clathrin coated pits are 
clathrin-containing lattice-like coats formed around and on the PM (Kirchhausen et al., 2014). They 
concentrate large extracellular molecules and receptors, hence are implicated in many receptor-
mediated endocytosis of macromolecules and molecular complexes, as well as uptake of bacterial 
pathogens (Veiga and Cossart, 2006; Pizarro-Cerda et al., 2010; Kirchhausen et al., 2014). Previous 
studies have suggested that bacteria that invade cells via the ‘zipper’ mechanism, a process also used 
by GAS for internalization, is clathrin-dependent (Pizarro-Cerda and Cossart, 2006; Veiga et al., 
2007). In this pathway, membrane vesicles that carry internalized cargo require the action of dynamin, 
a GTPase, for membrane fission and subsequent vesicle budding. Since CAV1 was protective against 
GAS invasion in HEp-2 cells (Chapter 3), we investigated whether the uptake of GAS is clathrin-
dependent and if CAV1 has a regulatory role in this cell type. 
 
HEp-2 cells were seeded onto 24-well plates until confluent. An hour prior to start of the experiment, 
cells were serum-starved in serum free DMEM followed by incubation with a series of Dyngo® 4a 
(for dynamin inhibition) (ab120689, Abcam) or Pitstop® 2 (for clathrin inhibition) (ab120687, 
Abcam) concentrations for 30 min at room temperature. Dyngo® 4a is a potent inhibitor of liposome-
stimulated helical dynamin activity and has been shown to be specific in inhibiting dynamin-
dependent endocytosis (McCluskey et al., 2013). Pitstop® 2 is a cell permeable, small molecule 
inhibitor of clathrin that competitively inhibits the clathrin terminal domain to selectively inhibit 
clathrin-mediated endocytosis (Dutta et al., 2012). These cells were then infected with GAS M1T15448 
to determine amount of GAS invasion in the presence of these clathrin inhibitors. 
 
WT, shCAV1 and shScr HEp-2 cells were treated with the dynamin inhibitor Dyngo® 4a at 6, 12 or 
60 µM concentrations, and used in gentamicin protection assays to assess GAS invasion. Invasion 
was measured as the proportion of intracellular GAS in cells receiving Dyngo® 4a treatment relative 
to no Dyngo® 4a negative control. In both WT and shCAV1 HEp-2 cells, relative invasion decreased 
with increasing Dyngo® 4a concentration, and was comparable at all three corresponding treatment 
concentrations (Fig. 5.8). Similarly, relative invasion decreased with increasing Pitstop® 2 
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concentration and was also comparable between WT and shCAV1 HEp-2 cells at the respective 
treatment concentrations (Fig. 5.9). These results indicate that the invasion of GAS into HEp-2 cells 
is dynamin-dependent and involves clathrin, although Pitstop® 2 may have off-target inhibitory 
effects on clathrin-independent endocytosis (Dutta et al., 2012). Furthermore, CAV1 is not directly 
involved in this uptake process as WT and shCAV1 HEp-2 cells showed comparable invasion 
characteristics under Dyngo® 4a and Pitstop® 2 treatment. 
 
 
 
 
Figure 5.8 M1T15448 invasion into Dyngo® 4a-treated HEp-2 cells. HEp-2 cells were pre-treated with 6, 12 
or 60 µM of Dyngo-4a for 1 h at 37°C, 5% CO2 prior to infection with GAS. Invasion was measured through 
gentamicin protection assays, and reported as proportion invasion relative to the no Dyngo® 4a treatment. 
Data represented as mean ± SEM, n=3.  
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Figure 5.9 M1T15448 invasion into Pitstop2-treated HEp-2 cells. HEp-2 cells were pre-treated with 6, 12 or 
60 µM of Pitstop® 2 for 1 h at 37°C, 5% CO2 prior to infection with GAS. Invasion was measured through 
gentamicin protection assays, and reported as proportion invasion relative to the no Pitstop® 2 treatment. Data 
represented as mean ± SEM, n=3.  
 
 
5.3 Discussion 
 
CAV1 is known to have various roles related to cellular properties and functions, such as the 
regulation of PM fluidity, clathrin-dependent endocytosis and the storage and regulation of lipids. In 
this chapter, these roles and also the potential of three GAS virulence factors to interact with CAV1 
were investigated to understand the action of CAV1 in regulating GAS invasion into host cells. Of 
the three GAS mutants tested, GAS SLO but not SpeB or M1 protein showed possible interaction 
with CAV1. Invasion of the GAS SLO mutant into CAV1 knockdown HEp-2 cells was significantly 
reduced compared to WT GAS, indicating that SLO interacts with a PM component or feature that is 
under the regulation of CAV1 (Fig. 5.4). Since SLO is a cholesterol-dependent pore-forming toxin 
and the loss of CAV1 in HEp-2 cells may have altered the PM lipid composition (Hoffmann et al., 
2010; Hoffmann et al., 2011), we propose that loss of CAV1 in HEp-2 cells changes the PM 
membrane lipid composition such that SLO can facilitate GAS invasion more effectively relative to 
CAV1-expressing HEp-2 cells. With regards to this inference, slo-complemented mutants should be 
included in future experiments to ensure that SLO indeed interacts with membrane fluidity 
characteristics to enhance GAS invasion under CAV1-deficient conditions. 
 
Caveolae-independent roles of CAV1 have been reported in the regulation of clathrin-independent 
endocytosis (Lajoie et al., 2009; Chaudhary et al., 2014), uptake of Staphylococcus aureus and other 
integrin-binding bacteria in a variety of cell types (Hoffmann et al., 2010; Hoffmann et al., 2011). 
Consistent with the inference of caveolae-independent roles, our results indicate that CAV1 inhibits 
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GAS invasion independent of its ability to form caveolae since the loss of caveolae either through 
genetic knockout/knockout of CAV1 or PTRF did not have the same outcomes on GAS invasion 
(Chapters 3 and 4). The CAV1 scaffolding domain has been shown to regulate PM fluidity 
(Hoffmann et al., 2010; Chaudhary et al., 2014), and the loss of which is associated with accelerated 
clathrin-independent endocytosis (Chaudhary et al., 2014) and increased uptake of bacterial 
pathogens into host cells (Boettcher et al., 2010; Hoffmann et al., 2010). It appears that CAV1 exerts 
regulatory control over the invasion of GAS into host cells also through a mechanism related to PM 
fluidity, although it is not as straightforward as an increase in fluidity leading to increased invasion 
in the absence of CAV1 and vice versa. The loss of CAV1 increases PM fluidity in a way that allows 
for increased GAS invasion which cannot be replicated by other methods of increasing PM fluidity 
such as detergent treatment (Fig. 5.1) or increased incubation temperatures (Fig. 5.2), suggesting that 
there is an optimal PM fluidity threshold in which GAS can more efficiently invade host cells. 
Whether the increased GAS invasion observed at this optimal fluidity threshold involves the action 
of PM-associated proteins or other membrane features is a topic for future investigation. 
 
GAS can also exploit caveolae-independent internalization pathways to gain entry into host cells, one 
of these being the clathrin-dependent ‘zipper’ mechanism (Pizarro-Cerda and Cossart, 2006). In the 
HEp-2 cells tested, GAS appeared to depend on dynamin and clathrin mediation to gain entry into 
host cells as the use of dynamin and clathrin inhibitors could completely eliminate GAS invasion. In 
the formation and subsequent budding of clathrin-coated endocytic vesicles, the dynamin GTPase 
catalyzes their release from the PM depends by mediating scission of the membrane (Marks et al., 
2001). Dynamin has been detected in caveolae (Henley et al., 1998; Pelkmans et al., 2002), but their 
exact role within caveolae is not completely understood. In our study, treatment with the dynamin 
inhibitor Dyngo® 4a resulted in reduced GAS invasion to comparable levels in both WT and CAV1 
knockdown HEp-2 cells (Fig. 5.8), which was most likely due to the inhibition of GAS-containing 
vacuole release from the PM. The comparable levels of relative GAS invasion into both WT CAV1 
knockdown HEp-2 cells suggest that CAV1 is not involved in this uptake pathway. However, it is 
important to note that pharmacological inhibitors may have off-target effects, hence a potential next 
step in understanding the role of CAV1, dynamin and clathrin in GAS invasion is through the use of 
genetic knockout cell lines to study endocytosis of GAS cells. 
 
Loss of CAV1 has widespread effects on the cellular storage and metabolism of lipids. CAV1 is 
involved in the formation and metabolism of cytosolic lipid droplets in vivo (Cohen et al., 2004b), 
organelles that show bactericidal activity via the release of histones that they normally bind to (Anand 
et al., 2012).  It was originally hypothesized that the increased proportion of intracellular GAS in 
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CAV1 knockdown cells compared to WT was due to reduced bacterial clearance by lipid droplets, 
however, intracellular bacterial load in CAV1 knockdown HEp-2 cells was not significantly reduced 
by the induced formation of lipid droplets. Instead, GAS showed increased intracellular survival in 
both WT and CAV1 knockdown HEp-2 cells with induced lipid droplet formation. This finding is 
striking because lipid droplets have been shown to kill various experimentally introduced or naturally 
intracellular bacteria including Staphylococcus epidermidis, Escherichia coli, Bacillus subtilis and 
Listeria monocytogenes in Drosophila embryos and mouse liver cells (Anand et al., 2012). 
Conversely, lipid droplets are required for the replication of Chlamydia trachomatis (Saka et al., 
2015), most likely owing to their obligate intracellular parasitic lifestyle. From this standpoint, lipid 
droplets were expected to kill intracellular GAS, but the opposite experimental observations suggest 
that GAS can subvert this antimicrobial response. The interactions between GAS and lipid droplets 
should be investigated in more detail, specifically whether lipids or lipid droplet-associated proteins 
are transferred between the host cells and GAS. 
 
In summary, GAS invasion into host cells is a complex and multifactorial process, but the protective 
mechanism of CAV1 against GAS invasion has a generalized effect that controls GAS invasion. 
Based on the findings presented here, it is likely that this protective effect is underpinned by the role 
of CAV1 in regulating membrane fluidity and composition thereby restricting the initiation of 
internalization events by GAS. Future studies should focus on characterizing these responsible 
components that are regulated by CAV1 and targeted by GAS.
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6. General conclusions and future work 
 
Based on the experiments presented in this thesis, there is now a better understanding of the GAS 
M1T15448 invasion pathway into non-phagocytic host cells. It was previously thought that caveolae 
were required for the uptake of SfbI-expressing GAS strain M12A40 into HEp-2 cells (Rohde et al., 
2003), whereas here we show that CAV1 has a caveolae-independent role of protecting HEp-2 cells 
against GAS M1T15448, which is SfbI negative. SfbI positive and negative GAS strains (A40 and A8, 
respectively) have been shown to invade HEp-2 cells via morphologically distinct pathways (Molinari 
et al., 2000). GAS strain A40 induced the formation of large membrane invaginations at sites of 
bacterial attachment that led to their internalization, whereas A8 triggered recruitment of microvilli 
to the focal point of bacterial attachment and the subsequent elongation/fusion of these microvilli to 
surround and engulf attached GAS cells (Molinari et al., 2000). Our data, together with these previous 
studies indicate that the role of CAV1 in GAS invasion is GAS strain and/or host cell type-specific. 
We demonstrate that CAV1 protects against GAS M1T15448 invasion independent of its role in 
caveolae biogenesis in non-phagocytic MEFs and HEp-2 cells. Rather than being internalized by 
caveolae into caveosomes similar to GAS M12A40 (Rohde et al., 2003), TEM imaging showed that 
GAS M1T15448 is taken up into HEp-2 cells and primary human tonsil cells (GAS natural site of 
infection) by initial attachment to host filopodia, resulting in actin cytoskeletal rearrangement and 
subsequently targeted to the lysosomal/endosomal pathway. These findings add ultrastructural 
information to the M1T15448 invasion pathway and demonstrate the lack of physical interaction 
between CAV1 and M1T15448 in restricting the internalization of this pathogen into non-phagocytic 
host cells. The TEM micrographs also provide for the first time an ultrastructural depiction of GAS 
invasion into primary human tonsil cells, and support HEp-2 cells as a suitable model cell line for 
GAS invasion studies.  
 
Additional experiments were conducted in an attempt to resolve the mechanism behind the protective 
effects of CAV1 in these non-phagocytic cell lines, from which it was inferred that CAV1 exerts 
control over fluidity of the host cell PM, thereby regulating the availability of membrane-associated 
receptors available to GAS. The exact process is likely a complex control over membrane components 
and/or characteristics related to PM fluidity, as direct manipulation of membrane fluidity by chemical 
and physical perturbations could not replicate GAS invasion characteristics similar to the loss of 
CAV1. In addition, since WT and SLO mutant M1T15448 have increased invasion into CAV1 
knockdown HEp-2 cells compared to WT HEp-2 cells, and SLO mutants showed impaired invasion 
into CAV1 knockdown HEp-2 cells relative to WT M1T15448 (Fig. 5.4), it was inferred that SLO 
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interacts with a PM component or feature that is under the regulation of CAV1 to facilitate invasion. 
From these observations, we propose that the control CAV1 exerts over the PM to protect host cells 
from invading GAS M1T15448 could be through restricting the initiation of internalization by 
regulating membrane domains/proteins that are targeted by SLO. The next step is to identify the 
internalization initiation receptors that are regulated by the control of CAV1 over PM fluidity, and 
complement GAS SLO mutants to verify that SLO indeed interacts with these membrane components.  
Membrane proteins or domains that show interaction can then be targeted to develop novel methods 
to reduce GAS infections. 
 
CAV1 is also involved in the regulation of cellular lipid droplet organelles that have bactericidal 
activity through release of bound histones (Anand et al., 2012). It was originally hypothesized that 
loss of CAV1 would reduce the bactericidal activity of lipid droplets, however, GAS exhibited 
improved survival within host cells with induced lipid droplet formation. To date, a number of 
bacteria have been shown to be cleared intracellularly by lipid droplet activity (Anand et al., 2012). 
The exception is the obligate intracellular parasitic bacterium Chlamydia trachomatis which hijacks 
the hosts’ lipids (Saka et al., 2015). Potential studies should focus on whether the ability of GAS to 
survive better under induced lipid droplet formation draws parallels with C. trachomatis, and whether 
host and bacterial proteins are transferred between lipid droplets and invading bacteria. These studies 
could reveal interesting and important findings related to basic GAS cell biology and also novel 
mechanisms of intracellular survival in this pathogen. 
 
PTRF, which is also a necessary component of caveolae for its biogenesis, showed different 
regulatory characteristics over GAS invasion in MEFs which further supported the caveolae-
independent role of CAV1 and PTRF in regulating GAS invasion. The expression of CAV1 and PTRF 
are co-dependent (Bastiani et al., 2009; Hill et al., 2008), therefore the relative expression of both 
proteins have to be taken into account when interpreting their roles in pathogen uptake. There was an 
accompanying reduction in CAV1 expression in PTRF knockout MEFs, and vice versa, but the 
regulatory outcome over GAS invasion is determined by the complete loss of the respective CAV1 
(restrict invasion) or PTRF protein (mediate invasion), at least in MEFs. During the course of the 
PTRF experiments, it was noted that PTRF knockdown in HEp-2 cells was frequently outcompeted 
by contaminating PTRF expressing cells, suggesting that PTRF knockdown may negatively affect 
HEp-2 cell fitness. Therefore, to resolve the role of PTRF in GAS invasion into HEp-2 cells, PTRF 
knockout HEp-2 cells could be constructed using gene editing techniques such as the CRISPR/Cas9 
method for use in future invasion assays. 
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The immediate next step of the work presented in this thesis is to confirm the exact mechanism by 
which CAV1 and PTRF elicit their function during GAS invasion into host cells. The current 
inference based on this thesis indicates that PM fluidity is likely the main driving factor, and is 
modified by host and GAS proteins such as CAV1, PTRF and SLO to facilitate or impede GAS 
invasion. It is possible that there are other driving factors behind CAV1/PTRF regulation over GAS 
invasion besides PM fluidity that have not been uncovered, and these should form the basis of future 
experiments following the work presented in chapters three to five. Another potential future step 
following the work in this is to extend the reported findings of CAV1/PTRF regulation over bacterial 
invasion to different cell types and bacterial pathogens, particularly those that invade by a classical 
“zipper mechanism” such as Listeria monocytogenes and Yersinia (Cossart and Sansonetti, 2004; 
Pizarro-Cerda et al., 2012). These disease-causing microorganisms share a common invasion 
mechanism into their respective host cells, and therefore are likely to be also regulated by host CAV1 
and PTRF proteins. 
 
Since GAS invasion into host cells is likely important for their evasion of antibiotic therapy (Passàli 
et al., 2007), and this thesis demonstrates that CAV1 protects non-phagocytic host cells against GAS 
invasion, CAV1 can potentially be exploited as a target for pharmacological agents that stimulate or 
mimic its activity to treat GAS infections. CAV1 proteins are already implicated in a host of human 
diseases (Cohen et al., 2004a), and there is now extra incentive to use these proteins as targets to fight 
bacterial infections. Understanding how CAV1 and PTRF influence GAS pathogenesis and the 
mechanisms underlying host cell invasion is instrumental for formulating effective countermeasures 
against GAS infections and where successful, better control of GAS disease worldwide. This research 
will also provide insight into the physiology of CAV1/PTRF proteins, making invaluable 
contributions towards human medicine. 
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Appendix I: Media solution and Reagents 
 
Bacteria growth media 
 
0.2% Todd-Hewitt Broth (THB) 
Todd-Hewitt Broth      30 g/l 
Yeast extract       10 g/l 
 
0.2% Todd-Hewitt Agar (THA) 
Todd-Hewitt Broth      30 g/l 
Yeast extract       10 g/l 
Agar (281230, BD)      15 g/l 
 
Cell culture medium 
 
DMEM, high glucose, pyruvate (#1195065, Gibco™) 
D-Glucose (Dextrose)     4500 mg/L  
L-Glutamine      584 mg/L 
Phenol red      15 mg/L 
Sodium Pyruvate     110 mg/L 
 
Supplemented with either 1% (v/v) or 10% (v/v) Foetal Bovine Serum albumin (FBS) before use 
 
C02 independant medium (#18045-088, Gibco™)   
GlutaMAX™       4 mM 
 
Supplemented with either 1% (v/v) or 10% (v/v) Foetal Bovine Serum albumin (FBS) before use 
 
TEpiCM (pH 7.4) 
 HEPES and bicarbonate buffered medium  
 
Supplemented with 1% TEpiCGS before use 
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HTEpiC Trypsin mix (in DPBS) 
 1 M HEPES buffer solution (15630-106, Gibco®) 2 mM 
 100 mM sodium pyruvate (11360-070, Gibco®) 0.2mM 
0.25% Trypsin-EDTA (25200-056, Gibco®)  25% (v/v) 
 
HTEpiC Trypsin neutralization solution (in DPBS) 
  1 M HEPES      2 mM 
 FBS       10% (v/v) 
 
SDS-PAGE Reagents 
 
12% Resolving gel 
Sterile dH20      2.25 ml  
40% Acrylamide/Bis solution (37.5:1)  1.55 ml 
 1.5M Tris-HCL (pH 8.8)    1.25 ml 
 10% SDS (w/v)     50.00 µl 
 10% APS (w/v)     25.00 µl  
 TEMED      25.00 µl 
 
15% Resolving gel 
Sterile dH20      1.90 ml  
40% Acrylamide/Bis solution (37.5:1)  1.93 ml 
 1.5M Tris-HCL (pH 8.8)    1.25 ml 
 10% SDS (w/v)     50.00 µl 
 10% APS (w/v)     25.00 µl  
 TEMED      25.00 µl 
 
4% Stacking gel 
Sterile dH20      1.20 ml  
40% Acrylamide/Bis solution (37.5:1)  0.60 ml 
 0.5M Tris-HCL (pH 6.8)    0.60 ml 
 10% SDS (w/v)     25.00 µl 
 10% APS (w/v)     12.50 µl  
 TEMED      12.50 µl 
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5X Loading/Cracking buffer 
 Tris-HCl (pH 6.8)     225 mM    
 Bromophenol blue     0.05% (w/v) 
 Glycerol      50.00% (v/v) 
 SDS       5.00% (w/v) 
 DTT       250 mM 
 
Coomassie™ Blue Rapid Stain 
 Coomassie™ Blue R-250    0.2% (w/v) 
 Methanol      40% (v/v) 
 Glacial acetic acid     10% (v/v) 
 
Rapid destain 
 Methanol      40% (v/v) 
 Glacial acetic acid     10% (v/v) 
 
Final destain 
 Glacial acetic acid     10% (v/v) 
 Glycerol      4% (v/v) 
 
Western blot reagents 
 
Western Transfer buffer (used at 4 )  
 Tris-HCl      3.03 g/l 
 Glycine      14.4 g/l 
 Methanol      20% (v/v) 
 
1X PBS (pH 7.4) 
 NaCl       8 g/l 
 KCl       0.2 g/l  
 Na2HPO4      1.115 g/l 
KH2PO4      1.115 g/l 
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1X PBST (pH 7.4) 
NaCl       8 g/l 
 KCl       0.2 g/l  
 Na2HPO4      1.115 g/l 
KH2PO4      1.115 g/l 
Tween 20      0.05% (v/v) 
 
Confocal Immunofluorescence microscopy reagents 
 
Blocking buffer (BSA) 
 Bovine serum albumin (A7906, Sigma-Aldrich®) 1% (w/v) 
 Sodium azide      0.2% (w/v) 
 
Blocking buffer + Triton X-100 (BSA-T) 
Bovine serum albumin    1% (w/v) 
 Sodium azide      0.2% (w/v) 
 Triton X-100      0.1% (v/v)  
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Appendix II: Supplementary figures for Chapter 2 
 
Table S2.1. Genotyping results of ATCC® CCL-23TM HEp-2 cell line 
 
aCell line identification was performed by analysis of microsatellite profiles using the PowerPlexR 18D system. 
A total of 18 selected and established loci of tetra- and pentanucleotide repeats are amplified via PCR with 
extracted DNA of cell-line cells. 17 short tandem repeats and Amelogenin markers: D3S1358, TH01, D21S11, 
D18S51, Penta E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta D, Amelogenin, vWA, D8S1179, 
TPOX, FGA, D19S433 and D2S1338. The results are then compared to other holdings of the same cell line. 
Profile of more than 80% identical in the cell ID is considered to be a match 
bHEp-2 cell line used in this manuscript was identified as similar to HeLa ATCC CCL and CRL variants (93.75% 
match) 
 
 
HeLa ATCC-CCL 
or CRL variant
D7S820 8, 12 12, 8
CSF1PO 9, 10 10, 9
TH01 7 7
D13S317 12 12, OL
D16S539 9, 10 10, 9
vWA 16, 18 16, 18
TPOX 8, 12 12, 8
D5S818 11, 12 11, 12
D8S1179 13 12, 13
D21S11 27, 28 27
D3S1358 15, 18  15, 18
D2S1338 17, 18 17
D19S433 13, 14 13, 14
D18S51 16 16
Amel X X
FGA 18, 21 18, 21
Penta E 7, 17 17, 7
Penta D 8, 15 8
HEp-2ᵇIDᵃ
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Figure S2.1. Growth curve of GAS M1T15448. GAS were first 16-streaked onto HBA and incubated overnight 
at 37ºC. After which, a single colony was picked and inoculated in THY broth supplemented with 0.2% yeast 
with a starting culture optical density (OD) of 0.3. Cultures were kept at 37ºC and growth measured by OD at 
intervals of 30 min for 8 h. The stationary phase was determined to be between OD of 1.1 - 1.3, and this 
criterion was used for all experiments performed within this thesis.  
 
 
 
 
Figure S2.2. Optimisation of gentamicin concentration for used in gentamicin protection assay. Invasion 
assay was used to measure the minimal concentration required for gentamicin to elicit a response. 100 µg/ml 
was determined to be the optimum concentration of gentamicin and this concentration was used in the 
experiments reported in this thesis.  
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Figure S2.3. Example THY agar used in this thesis to enumerate GAS CFU counts in invasion and 
survival assays. GAS were serially diluted (dilution ratio 40 - 47) and 20 µl of the diluted suspension was 
pipetted onto THYA. The plates were then incubated at 37ºC, 5% CO2 overnight (at least 16 h) and the number 
of colonies were counted and tabulated. Any plate with more than 150 colonies was designated as “too many 
to count” and at least 30 colonies per dilution was counted to ensure that counts were statistically acceptable.   
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Appendix III: Supplementary figures for Chapter 3 
 
 
 
Figure S3.1. Western immunoblot of CAV1 expression levels in WT HEp-2 cells and derivatives. This is 
an overexposed version of the same blot presented in Fig. 3.2B.   
 
 
 
 
Figure S3.2. Classification of co-localization between invading M1T15448 and host CAV1. (A - C) 
Representative images used for the classification of association of invading GAS and host CAV1 in Table 3.1. 
Association was classified as no association (A), “mosaic” (B) and partial association (C). “Mosaic”-type 
association indicates 1 - 2 random puncta (yellow spots) that are found at site where bacteria invade while 
partial association indicates >2 puncta observed.  (D) Representative image of shCAV1 HEp-2 cells stained 
with the same antibody as above and in Fig 3.6 (mouse mAb against CAV1, Abcam). No labeling was observed 
indicating the specificity of the antibody in targeting CAV1 in HEp-2 cells. Inset is a zoomed image of GAS. 
Scale bar: 10 µm.  
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Figure S3.3 Association of invading M1T15448 and host cell CAV1. Representative maximum projection 
immunofluorescence image of the interaction of invading M1T15448 (green) and CAV1 (red) in WT HEp-2 
cells. This is the same image presented in Chapter 3, Fig. 3.7. Scale bar = 10 µm.  
 
 
 
 
Figure S3.4. Ultrastructural TEM characterisation of M1T15448 invading WT HEp-2 cells. (A - B) 
Example electron micrographs showing the existence of M1T15448 within cytokinesis of host HEp-2 cells and 
GAS were mostly found as chains. (C - D) Example images showing concentration of putative actin filaments 
(electron dense coat, arrows) around the site of bacteria invasion (C) and within vacuoles (D). Scale bar = 1 
µm.  
YZ
XZ
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Appendix IV: Supplementary figure for Chapter 4 
 
 
 
 
Figure S4.1. Timeline of G418 treatment of shPTRF HEp-2 cells. This procedure was used in optimization 
and treatment experiments as presented in Fig. 4.5 - 4.7. 
 
 
 
 
Figure S4.2. Western immunoblot of PTRF and CAV1 expression in HEp-2 cells. WT or shPTRF HEp-2 
cells were transfected with siRNA as per Fig. 4.8. in non-supplemented Opti-MEM. Cell lysates were collected 
and PTRF and CAV1 expression measured using western immunoblotting. PTRF expression in these cells is 
highlighted with red boxes. 
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Figure S4.3. Western immunoblot of PTRF and CAV1 expression in HeLa cells. HeLa cells were either 
non-transfected or transfected with siRNA construct #1 (see Table 4.2) against PTRF as per described in 
section 2.3. Post transfection, cell lysates were collected and PTRF and CAV1 expression measured by 
Western immunoblot. Lack of band at the predicted size for PTRF indicate successful knockdown. Knockdown 
of PTRF also resulted in reduced CAV1 expression.  
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